0000822746 false Q2 --12-31 0000822746 2023-01-01 2023-06-30 0000822746 2023-08-10 0000822746 2023-06-30 0000822746 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-06-30 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-12-31 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2022-12-31 0000822746 us-gaap:RelatedPartyMember 2023-06-30 0000822746 us-gaap:RelatedPartyMember 2022-12-31 0000822746 2023-04-01 2023-06-30 0000822746 2022-04-01 2022-06-30 0000822746 2022-01-01 2022-06-30 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-12-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-12-31 0000822746 us-gaap:CommonStockMember 2021-12-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0000822746 us-gaap:RetainedEarningsMember 2021-12-31 0000822746 2021-12-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-03-31 0000822746 us-gaap:CommonStockMember 2022-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0000822746 us-gaap:RetainedEarningsMember 2022-03-31 0000822746 2022-03-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-12-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-12-31 0000822746 us-gaap:CommonStockMember 2022-12-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000822746 us-gaap:RetainedEarningsMember 2022-12-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-03-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-03-31 0000822746 us-gaap:CommonStockMember 2023-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000822746 us-gaap:RetainedEarningsMember 2023-03-31 0000822746 2023-03-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0000822746 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0000822746 2022-01-01 2022-03-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-04-01 2022-06-30 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-04-01 2022-06-30 0000822746 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0000822746 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-01-01 2023-03-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-03-31 0000822746 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000822746 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000822746 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000822746 2023-01-01 2023-03-31 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-04-01 2023-06-30 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-04-01 2023-06-30 0000822746 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0000822746 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-06-30 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-06-30 0000822746 us-gaap:CommonStockMember 2022-06-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000822746 us-gaap:RetainedEarningsMember 2022-06-30 0000822746 2022-06-30 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2023-06-30 0000822746 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2023-06-30 0000822746 us-gaap:CommonStockMember 2023-06-30 0000822746 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0000822746 us-gaap:RetainedEarningsMember 2023-06-30 0000822746 2021-03-30 2021-04-02 0000822746 2021-04-02 0000822746 2022-01-01 2022-12-31 0000822746 AMNI:OperatingAgreementMember AMNI:GMDOCMember 2022-05-03 0000822746 AMNI:OperatingAgreementMember AMNI:GMDOCMember 2022-05-02 2022-05-03 0000822746 2022-05-15 2022-05-16 0000822746 AMNI:CastelliEnergyLLCMember AMNI:OperatingAgreementMember AMNI:GMDOCMember 2022-05-03 0000822746 AMNI:GMDOCLLCMember AMNI:OperatingAgreementMember 2022-05-03 0000822746 us-gaap:SeriesAPreferredStockMember 2023-06-30 0000822746 AMNI:WestTexasIntermediateMember 2022-12-31 0000822746 2012-12-31 0000822746 AMNI:TexasOilAndGasMember 2012-12-31 0000822746 AMNI:WyomingAndColoradoOilAndGasMember 2012-12-31 0000822746 us-gaap:FairValueInputsLevel1Member 2023-06-30 0000822746 us-gaap:FairValueInputsLevel2Member 2023-06-30 0000822746 us-gaap:FairValueInputsLevel3Member 2023-06-30 0000822746 us-gaap:FairValueInputsLevel1Member 2022-12-31 0000822746 us-gaap:FairValueInputsLevel2Member 2022-12-31 0000822746 us-gaap:FairValueInputsLevel3Member 2022-12-31 0000822746 AMNI:CentralKansasUpliftMember 2023-06-30 0000822746 AMNI:CentralKansasUpliftMember 2022-12-31 0000822746 AMNI:HugotonGasFieldMember 2023-06-30 0000822746 AMNI:HugotonGasFieldMember 2022-12-31 0000822746 AMNI:GMDOCLLCMember 2023-03-31 0000822746 AMNI:GMDOCLLCMember 2022-03-31 0000822746 AMNI:GMDOCLLCMember 2022-12-31 0000822746 AMNI:GMDOCLLCMember 2021-12-31 0000822746 AMNI:GMDOCLLCMember 2023-04-01 2023-06-30 0000822746 AMNI:GMDOCLLCMember 2022-04-01 2022-06-30 0000822746 AMNI:GMDOCLLCMember 2023-01-01 2023-06-30 0000822746 AMNI:GMDOCLLCMember 2022-01-01 2022-06-30 0000822746 AMNI:GMDOCLLCMember 2023-06-30 0000822746 AMNI:GMDOCLLCMember 2022-06-30 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-01 2023-06-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-01-01 2023-06-30 0000822746 AMNI:June2022NoteMember 2023-01-01 2023-06-30 0000822746 AMNI:May2022NotesMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableOneMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableTwoMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableThreeMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableFourMember 2022-01-01 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNotesPayableFiveMember 2022-01-01 2022-12-31 0000822746 AMNI:DebtSettlementAgreementMember AMNI:ThreePercentageConvertiblePromissoryNotesMember 2021-03-30 2021-03-31 0000822746 AMNI:DebtSettlementAgreementMember AMNI:ThreePercentageConvertiblePromissoryNotesMember 2021-03-31 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2023-05-04 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 2021-10-29 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-09 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-10 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-05-04 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-08-29 2021-08-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-08-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-08-29 2021-08-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-08-30 0000822746 us-gaap:ConvertibleNotesPayableMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 us-gaap:ConvertibleNotesPayableMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 us-gaap:ConvertibleNotesPayableMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-05-05 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-05-04 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-05-05 2023-05-05 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-04-01 2023-06-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:ConvertibleNotesPayableMember 2023-04-01 2023-06-30 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:ConvertibleNotesPayableMember 2023-01-01 2023-06-30 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:SeriesBPreferredStockMember 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2021-10-28 2021-10-29 0000822746 AMNI:SecondEightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2021-10-28 2021-10-29 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-05-04 2023-05-04 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-05-04 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-06-08 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-06-07 2022-06-08 0000822746 AMNI:SecuritiesPurchaseAgreementMember AMNI:EightPercentageConvertiblePromissoryNotesMember 2023-05-05 2023-05-05 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 AMNI:EightPercentageConvertiblePromissoryNotesMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-13 0000822746 AMNI:MayInvestorMember AMNI:EightPercentageConvertiblePromissoryNotesMember us-gaap:CommonStockMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember us-gaap:BeneficialOwnerMember AMNI:SecuritiesPurchaseAgreementMember 2022-05-12 2022-05-13 0000822746 AMNI:SeniorUnsecuredConvertibleNoteMember AMNI:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2022-05-12 2022-05-13 0000822746 2022-06-29 0000822746 2023-01-10 0000822746 AMNI:May2022NotesMember 2023-01-09 0000822746 AMNI:May2022NotesMember 2023-01-10 0000822746 AMNI:May2022NotesMember 2023-01-13 0000822746 AMNI:May2022NotesMember 2023-01-12 2023-01-13 0000822746 AMNI:May2022NotesMember 2023-06-30 0000822746 AMNI:May2022NotesMember 2022-12-31 0000822746 AMNI:OctoberEightPercentageNotesMember 2023-01-09 2023-01-10 0000822746 AMNI:June2022NoteMember 2023-05-05 0000822746 AMNI:June2022NoteMember 2023-05-05 2023-05-05 0000822746 AMNI:May2022NotesMember 2023-01-09 2023-01-10 0000822746 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0000822746 us-gaap:EmployeeStockOptionMember 2022-04-01 2022-06-30 0000822746 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0000822746 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-06-30 0000822746 us-gaap:RestrictedStockMember 2023-04-01 2023-06-30 0000822746 us-gaap:RestrictedStockMember 2022-04-01 2022-06-30 0000822746 us-gaap:RestrictedStockMember 2023-01-01 2023-06-30 0000822746 us-gaap:RestrictedStockMember 2022-01-01 2022-06-30 0000822746 us-gaap:WarrantMember 2023-04-01 2023-06-30 0000822746 us-gaap:WarrantMember 2022-04-01 2022-06-30 0000822746 us-gaap:WarrantMember 2023-01-01 2023-06-30 0000822746 us-gaap:WarrantMember 2022-01-01 2022-06-30 0000822746 AMNI:TwoThowsandAndFifteenPlanMember 2015-09-25 0000822746 AMNI:TwoThowsandAndTwentyOnePlanMember 2021-10-13 0000822746 AMNI:TwoThowsandAndTwentyOnePlanAndTwoThousandAndFifteenMember 2023-06-30 0000822746 us-gaap:StockOptionMember 2023-04-01 2023-06-30 0000822746 us-gaap:StockOptionMember 2022-04-01 2022-06-30 0000822746 us-gaap:StockOptionMember 2023-01-01 2023-06-30 0000822746 us-gaap:StockOptionMember 2022-01-01 2022-06-30 0000822746 us-gaap:RestrictedStockMember AMNI:OfficersDirectorsAndConsultantMember 2022-05-01 2022-05-31 0000822746 us-gaap:RestrictedStockMember AMNI:OfficersDirectorsAndConsultantMember 2020-08-01 2020-08-31 0000822746 AMNI:ExercisePriceOneMember 2023-06-30 0000822746 AMNI:ExercisePriceOneMember 2023-01-01 2023-06-30 0000822746 AMNI:ExercisePriceTwoMember 2023-06-30 0000822746 AMNI:ExercisePriceTwoMember 2023-01-01 2023-06-30 0000822746 us-gaap:RestrictedStockMember 2021-12-31 0000822746 us-gaap:RestrictedStockMember 2022-06-30 0000822746 us-gaap:RestrictedStockMember 2022-12-31 0000822746 us-gaap:RestrictedStockMember 2023-06-30 0000822746 us-gaap:WarrantMember 2021-12-31 0000822746 us-gaap:WarrantMember 2022-06-30 0000822746 us-gaap:WarrantMember 2022-12-31 0000822746 us-gaap:WarrantMember 2023-06-30 0000822746 us-gaap:WarrantMember 2023-06-30 0000822746 us-gaap:WarrantMember 2023-01-01 2023-06-30 0000822746 us-gaap:WarrantMember 2022-01-01 2022-06-30 0000822746 us-gaap:WarrantMember srt:MinimumMember 2023-06-30 0000822746 us-gaap:WarrantMember srt:MaximumMember 2023-06-30 0000822746 us-gaap:WarrantMember 2023-05-04 0000822746 us-gaap:WarrantMember 2023-04-01 2023-06-30 0000822746 AMNI:LetterAgreementMember 2021-11-09 0000822746 2021-11-09 0000822746 2021-11-08 2021-11-09 0000822746 AMNI:LetterAgreementMember 2021-11-08 2021-11-09 0000822746 AMNI:BoardOfAdvisorsMember AMNI:LetterAgreementMember 2021-11-09 0000822746 AMNI:USNGLetterAgreementMember 2021-11-09 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2023-04-01 2023-06-30 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2022-04-01 2022-06-30 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2023-06-30 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2023-01-01 2023-06-30 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2022-01-01 2022-06-30 0000822746 AMNI:LetterAgreementMember us-gaap:WarrantMember 2021-11-09 0000822746 us-gaap:WarrantMember AMNI:LetterAgreementMember 2021-11-08 2021-11-09 0000822746 us-gaap:MeasurementInputPriceVolatilityMember 2023-05-04 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-05-04 0000822746 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-05-04 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-05-04 0000822746 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2023-05-04 0000822746 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2023-05-04 0000822746 us-gaap:MeasurementInputExercisePriceMember srt:MinimumMember 2023-05-04 0000822746 us-gaap:MeasurementInputExercisePriceMember srt:MaximumMember 2023-05-04 0000822746 us-gaap:MeasurementInputExercisePriceMember 2023-05-04 0000822746 2023-05-04 0000822746 AMNI:ConvertiableNotesPayableTwoMember 2023-04-01 2023-06-30 0000822746 AMNI:ConvertiableNotesPayableTwoMember 2022-04-01 2022-06-30 0000822746 AMNI:ConvertiableNotesPayableTwoMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiableNotesPayableTwoMember 2022-01-01 2022-06-30 0000822746 AMNI:ConvertiableNotesPayableThreeMember 2023-04-01 2023-06-30 0000822746 AMNI:ConvertiableNotesPayableThreeMember 2022-04-01 2022-06-30 0000822746 AMNI:ConvertiableNotesPayableThreeMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiableNotesPayableThreeMember 2022-01-01 2022-06-30 0000822746 AMNI:ConvertiableNotesPayableFourMember 2023-04-01 2023-06-30 0000822746 AMNI:ConvertiableNotesPayableFourMember 2022-04-01 2022-06-30 0000822746 AMNI:ConvertiableNotesPayableFourMember 2023-01-01 2023-06-30 0000822746 AMNI:ConvertiableNotesPayableFourMember 2022-01-01 2022-06-30 0000822746 AMNI:TexasandWyomingWellsMember 2023-06-30 0000822746 AMNI:TexasandWyomingWellsMember 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2023-06-30 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-06-30 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2023-01-01 2023-06-30 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2022-01-01 2022-12-31 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-06-30 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0000822746 us-gaap:WarrantMember 2022-12-31 0000822746 us-gaap:WarrantMember 2021-12-31 0000822746 us-gaap:WarrantMember 2022-06-30 0000822746 srt:MaximumMember 2023-06-30 0000822746 srt:MinimumMember 2023-06-30 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2023-05-04 2023-05-04 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember srt:MinimumMember 2023-05-04 0000822746 us-gaap:WarrantMember us-gaap:MeasurementInputExercisePriceMember 2023-05-04 0000822746 AMNI:ConsultantsMember 2023-06-30 0000822746 2012-10-01 2012-10-31 0000822746 2012-10-31 0000822746 AMNI:CambrianConsultantsAmericaIncMember 2014-12-07 2014-12-08 0000822746 AMNI:TorreyHillsCapitalIncMember 2014-08-14 2014-08-15 0000822746 AMNI:ConsultingAgreementMember 2013-10-17 2013-10-18 0000822746 AMNI:ConsultingAgreementMember 2013-01-01 2013-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-01-13 2023-01-13 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-16 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-05-01 2023-05-04 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-15 2021-03-16 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-05-03 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-05-02 2023-05-03 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-25 2021-03-26 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-03-26 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-01-01 2023-06-30 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-01-01 2022-06-30 0000822746 AMNI:OzarkCapitalLLCMember 2021-03-25 2021-03-26 0000822746 AMNI:OzarkCapitalLLCMember 2021-03-26 0000822746 AMNI:OzarkCapitalLLCMember 2023-06-30 0000822746 AMNI:OzarkCapitalLLCMember 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-06-12 2022-06-15 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-06-15 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-08-01 2022-08-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-09-01 2022-09-30 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-08-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-09-30 0000822746 AMNI:OzarkCapitalLLCMember 2023-05-01 2023-05-04 0000822746 AMNI:OzarkCapitalLLCMember 2023-05-04 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2023-04-01 2023-06-30 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-04-01 2022-06-30 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2023-04-01 2023-06-30 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2023-01-01 2023-06-30 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2022-04-01 2022-06-30 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2022-01-01 2022-06-30 0000822746 AMNI:SeriesAConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-04-01 2023-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2023-01-01 2023-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2022-04-01 2022-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2022-01-01 2022-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesBConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2023-04-01 2023-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2023-01-01 2023-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2022-04-01 2022-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2022-01-01 2022-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember AMNI:OzarkCapitalLLCMember 2022-01-01 2022-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2021-12-31 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2021-12-31 0000822746 AMNI:SeriesAConvertiblePreferredStockMember 2022-06-30 0000822746 AMNI:SeriesBConvertiblePreferredStockMember 2022-06-30 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember us-gaap:WarrantMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNoteMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNoteOneMember AMNI:DebtSettlementAgreementMember 2022-12-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember 2021-03-30 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember 2021-03-31 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2023-06-30 0000822746 AMNI:ConvertiblePromissoryNoteTwoMember AMNI:DebtSettlementAgreementMember us-gaap:RelatedPartyMember 2022-12-31 0000822746 us-gaap:SubsequentEventMember 2023-08-01 2023-08-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure utr:acre utr:bbl

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________.

 

Commission File Number: 000-17204

 

AMERICAN NOBLE GAS INC

(Exact name of registrant as specified in its charter)

 

Nevada   87-3574612

(State or other jurisdiction

of incorporation or organization)

 

(I.R.S. Employer

Identification No.)

 

15612 College Blvd, Lenexa, KS 66219

(Address of principal executive offices) (Zip Code)

 

(913) 955-0532

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of exchange on which registered
   

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of Exchange Act.

 

  Large accelerated filer ☐   Accelerated filer ☐
  Non-accelerated filer   Smaller reporting company
      Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of August 10, 2023, the registrant had 22,924,515 shares of common stock, $0.0001 par value per share outstanding.

 

 

 

 
 

 

TABLE OF CONTENTS

 

  Page
PART I - Financial Information  
Item 1. Financial Statements  
Condensed Balance Sheets: June 30, 2023 (Unaudited) and December 31, 2022 3
Condensed Statements of Operations: Three and six months ended June 30, 2023 and 2022 (Unaudited) 4
Condensed Statements of Changes in Stockholders’ Deficit: Three and six months ended June 30, 2023 and 2022 (Unaudited) 5
Condensed Statements of Cash Flows: Six months ended June 30, 2023 and 2022 (Unaudited) 6
Notes to Condensed Financial Statements (Unaudited) 7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 38
Item 3. Quantitative and Qualitative Disclosures About Market Risk 55
Item 4. Controls and Procedures 55
PART II - Other Information  
Item 1. Legal Proceedings 55
Item 1A Risk Factors 55
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 56
Item 3. Defaults Upon Senior Securities 56
Item 4. Mine Safety Disclosures 56
Item 5. Other Information 56
Item 6. Exhibits 56
Signatures 57

 

2
 

 

PART I - FINANCIAL INFORMATION

 

AMERICAN NOBLE GAS INC

Condensed Balance Sheets

 

   June 30, 2023   December 31, 2022 
   (unaudited)     
ASSETS          
Current assets:          
Cash and cash equivalents  $412,793   $10,163 
Accrued receivable   24,086    47,423 
Prepaid expenses   20,506    12,617 
           
Total current assets   457,385    70,203 
Oil and gas properties and equipment:          
Oil and gas properties and equipment   1,217,016    1,217,026 
Accumulated depreciation, depletion and impairment   (1,135,151)   (1,128,339)
           
Property and equipment, net   81,865    88,687 
           
Investment in unconsolidated subsidiary – GMDOC, LLC   1,130,928    1,101,461 
           
Total assets  $1,670,178   $1,260,351 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable  $1,447,764   $1,387,893 
Accrued liabilities   1,201,037    1,159,403 
Accrued interest - $1,925 and $1,501 to related parties as of June 30, 2023 and December 31, 2022, respectively   72,975    244,038 
Accrued dividends   147,416    77,124 
Warrant derivative liability   210,094    577,269 
Convertible notes payable, net of unamortized discount   1,266,204    1,312,500 
           
Total current liabilities   4,345,490    4,758,227 
           
Asset retirement obligations   1,734,922    1,732,486 
Convertible promissory notes, net of unamortized discount - related parties   28,665    28,665 
           
Total liabilities   6,109,077    6,519,378 
Commitments and contingencies (Note 12)   -    - 
           
Stockholders’ deficit:          
Preferred stock; par value $0.0001 per share, 10,000,000 shares
authorized;
          
- Series A Convertible Preferred stock; – 27,778 shares authorized with stated/liquidation value of $100 per share, 25,276 and 25,526 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively   3    3 
- Series B Convertible Preferred stock; – 50,000 shares authorized with stated/liquidation value of $100 per share, 7,500 and -0- shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively   1     
Common Stock, par value $0.0001 per share, 500,000,000 shares authorized, 22,924,515 shares issued and outstanding at June 30, 2023 and 21,924,515 shares issued and outstanding at December 31, 2022   2,292    2,192 
Additional paid-in capital   118,350,847    117,369,198 
Accumulated deficit   (122,792,042)   (122,630,420)
Total stockholders’ deficit   (4,438,899)   (5,259,027)
Total liabilities and stockholders’ deficit  $1,670,178   $1,260,351 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

3
 

 

AMERICAN NOBLE GAS, INC.

(formerly Infinity Energy Resources, Inc.)

Condensed Statements of Operations

(Unaudited)

 

   2023   2022   2023   2022 
   Three months ended
June 30,
   Six months ended
June 30,
 
   2023   2022   2023   2022 
                 
Revenues  $4,041   $43,563   $12,965   $68,868 
                     
Operating expenses:                    
Oil and gas lease operating expense   133,687    56,178    163,292    142,714 
Depreciation, depletion and amortization   3,411    30,834    6,822    61,668 
Accretion of asset retirement obligation   1,218    302    2,436    580 
Oil and gas production related taxes       82        110 
Other general and administrative expenses   119,644    479,437    531,492    848,144 
                     
Total operating expenses   257,960    566,833    704,042    1,053,216 
                     
Operating loss   (253,919)   (523,270)   (691,077)   (984,348)
                     
Other income (expense):                    
Equity in earnings of unconsolidated subsidiary – GMDOC, LLC   (10,346)   114,336    29,467    114,336 
Interest expense   (22,927)   (332,234)   (60,339)   (425,790)
Gain on exchange and extinguishment of liabilities   24,190        193,152     
Change in warrant derivative fair value   (292)       367,175     
                     
Total other income (expense)   (9,375)   (217,898)   529,455    (311,454)
                     
Loss before income taxes   (263,294)   (741,168)   (161,622)   (1,295,802)
Income tax (expense) benefit                
                     
Net loss   (263,294)   (741,168)   (161,622)   (1,295,802)
                     
Convertible preferred stock dividends   (73,116)   (52,289)   (136,057)   (105,150)
                     
Net loss attributable to common stockholders  $(336,410)  $(793,457)  $(297,679)  $(1,400,952)
                     
Basic and diluted net loss per share:                    
Basic  $(0.01)  $(0.04)  $(0.01)  $(0.07)
Diluted  $(0.01)  $(0.04)  $(0.01)  $(0.07)
Weighted average shares outstanding – basic and diluted   22,524,515    20,550,904    22,441,182    19,882,501 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

4
 

 

AMERICAN NOBLE GAS INC

Condensed Statements of Changes in Stockholders’ Deficit

(unaudited)

 

   Shares   Amount                Shares   Amount   Capital   Deficit   Deficit 
  

Series A

Preferred Stock

 

 

Series B

Preferred Stock

 

  Common Stock   Additional
Paid-in
   Accumulated   Stockholders’ 
   Shares   Amount    Shares     Amount     Shares   Amount   Capital   Deficit   Deficit 
Balance, December 31, 2021   22,076   $2                   $              19,012,015   $1,901   $115,522,952   $(118,690,345)  $(3,165,490)
                                                     
Stock-based compensation                                229,906        229,906 
                                                     
Issuance of common stock pursuant to conversion of convertible preferred stock   (800)                    250,000    25    (25)        
                                                     
Accrual of preferred stock dividends                                (52,861)       (52,861)
                                                     
Net loss                                    (554,634)   (554,634)
                                                     
Balance, March 31, 2022   21,276    2                 19,262,015    1,926    115,699,972    (119,244,979)   (3,543,079)
                                                     
Stock-based compensation                                378,341        378,341 
                                                     
Issuance of common stock in association with the issuance of convertible bridge notes payable                        425,000    42    196,112        196,154 
                                                     
Issuance of restricted common stock as compensation                        1,550,000    155    (155)        
                                                     
Issuance of detachable warrants to purchase common stock in association with issuance of convertible bridge note payable                                136,574        136,574 
                                                     
Issuance of Series A preferred stock with detachable common stock purchase warrants   5,000    1                         499,999        500,000 
                                                     
Issuance of common stock pursuant to conversion of preferred stock   (1,900)   (1)                593,750    60    (59)        
                                                     
Accrual of preferred stock dividends                                (52,289)       (52,289)
                                                     
Net loss                                    (741,168)   (741,168)
                                                     
Balance, June 30, 2022   24,376   $2          $      21,830,765   $2,183   $116,858,495   $(119,986,147)  $(3,125,467)
                                                     
Balance, December 31, 2022   25,526   $3          $      21,924,515   $2,192   $117,369,198   $(122,630,420)  $(5,259,027)
                                                     
Stock-based compensation                                246,091        246,091 
                                                     
Issuance of common stock upon conversion
convertible notes payable and accrued interest
                        500,000    50    49,950        50,000 
                                                     
Accrual of preferred stock dividends                                (62,941)       (62,941)
                                                     
Net income                                    101,672    101,672 
                                                     
Balance, March 31, 2023   25,526    3                 22,424,515    2,242    117,602,298    (122,528,748)   (4,924,205)
                                                     
Stock-based compensation                                71,716        71,716 
                                                     
Issuance of Series B Convertible Preferred stock with detachable common stock purchase warrants for cash             7,500       1              749,999         750,000 
                                                     
Issuance of common stock upon conversion
Series A Convertible Preferred Stock
   (250)   ()                500,000    50    (50)        
                                                     
Accrual of preferred stock dividends                                (73,116)       (73,116)
                                                     
Net loss                                    (263,294)   (263,294)
                                                     
Balance, June 30, 2023   25,276   $3      7,500     $ 1      22,924,515   $2,292   $118,350,847   $(122,792,042)  $(4,438,899)

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

5
 

 

AMERICAN NOBLE GAS INC

Condensed Statements of Cash Flows

(unaudited)

 

   2023   2022 
  

For the six months ended

June 30,

 
   2023   2022 
Cash flows from operating activities:          
Net loss  $(161,622)  $(1,295,802)
Adjustments to reconcile net loss to net cash used in operating activities:          
Equity in earnings of unconsolidated subsidiary – GMDOC, LLC   (29,467)   (114,336)
Change in warrant derivative fair value   (367,175)    
Stock-based compensation   317,807    608,247 
Gain on extinguishment of convertible notes payable   (193,152)    
Depreciation, depletion and amortization   6,822    61,668 
Accretion of asset retirement obligations   2,436    580 
Amortization of discount on convertible notes payable       389,651 
Change in operating assets and liabilities:          
Decrease (increase) in accounts receivable   23,337    (8,729)
Increase in prepaid expenses   (7,889)   (1,967)
Increase in accounts payable   59,871    214,956 
Increase (decrease) in accrued liabilities   41,634    2,055 
Increase in accrued interest   25,793    424 
           
Net cash used in operating activities   (281,605)   (143,253)
           
Cash flows from investing activities:          
Investment in unconsolidated subsidiary – GMDOC, LLC       (850,000)
Investment in Hugoton Gas Field participation agreement       (314,753)
Investment in oil and gas properties and equipment       (15,224)
Net cash used in investing activities       (1,179,977)
           
Cash flows from financing activities:          
Net proceeds from issuance of convertible notes payable       1,200,000 
Repayment of convertible note payable       (425,000)
Net proceeds from issuance of convertible preferred stock with detachable common stock purchase warrants   750,000    500,000 
Cash dividends paid on preferred stock   (65,765)   (105,150)
           
Net cash provided by financing activities   684,235    1,169,850 
           
Net increase (decrease) in cash and cash equivalents   402,630    (153,380)
           
Cash and cash equivalents:          
Beginning   10,163    260,590 
Ending  $412,793   $107,210 
Supplemental cash flow information:          
Cash paid for interest  $

34,547

   $34,027 
Cash paid for taxes  $   $ 
           
Supplemental disclosure of non-cash investing and financing activities:          
Accrual of dividends on Series A and Series B Convertible Preferred Stock  $70,292   $ 
Issuance of common stock upon conversion of convertible notes payable and accrued interest  $50,000   $ 
Conversion of Series A Convertible Preferred Stock to Common Stock  $50   $85 

Modification of warrant exercise price pursuant to dilutive issuance of Series B Preferred Stock

  $

126

   $ 
Issuance of restricted common stock attributable to issuance of notes payable  $   $196,154 
Issuance of detachable common stock purchase warrants attributable to issuance of convertible notes payable  $   $136,574 
Issuance of restricted common stock as compensation  $   $155 

 

The accompanying notes are an integral part of these unaudited condensed financial statements.

 

6
 

 

AMERICAN NOBLE GAS, INC.

Notes to Unaudited Condensed Financial Statements

June 30, 2023

 

Note 1 – Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies

 

Unaudited Interim Financial Information

 

American Noble Gas, Inc. has prepared the accompanying condensed financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These financial statements are unaudited and, in our opinion, include all adjustments consisting of normal recurring adjustments and accruals necessary for a fair presentation of our condensed balance sheets, statements of operations, statements of stockholders’ deficit and cash flows for the periods presented. Operating results for the periods presented are not necessarily indicative of the results that may be expected for the remainder of 2023 due to various factors. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been omitted in accordance with the rules and regulations of the SEC. These condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes in Item 8, “Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC.

 

Nature of Operations

 

The Company has assessed various opportunities and strategic alternatives involving the acquisition, exploration and development of oil and gas oil producing properties in the United States, including the possibility of acquiring businesses or assets that provide support services for the production of oil and gas in the United States.

 

As a result, we are now involved with the following oil and gas producing properties:

 

Central Kansas Uplift - On April 1, 2021, we completed the acquisition of the Central Kansas Uplift Properties, for a purchase price of $900,000. The Central Kansas Uplift Properties include the production and mineral rights/leasehold for oil and gas properties, subject to overriding royalties to third parties, in the Central Kansas Uplift geological formation covering over 11,000 contiguous acres (the “Properties”). The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

 

We commenced rework of the existing production wells after completion of the acquisition of the Properties and have performed testing and evaluation of the existence of noble gas reserves on the Properties including helium, argon and other rare earth minerals/gases. Testing of the Properties for noble gas reserves has provided encouraging but not conclusive results and the Company has yet to determine the possibility of commercializing the noble gas reserves on the Properties. The Company plans to assess the Properties’ existing oil and gas reserves while continuing the evaluation of the existence of new oil and gas zones and other mineral reserves and specifically the noble gas reserves that the Properties may hold.

 

During the year ended December 31, 2022, the Company changed its strategy regarding the Central Kansas Uplift considering the reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of June 30, 2023 and December 31, 2022 and is considering the reworking the conventional wells on the property to emphasize crude oil production that may be present behind casing pipe in the deeper producing zones. Accordingly, the Company has recorded an impairment charge of $712,812 to reduce the capitalized tangible and intangible costs related to its Central Kansas Uplift properties to zero as of June 30, 2023 and December 31, 2022.

 

7
 

 

Hugoton Gas Field Farm-Out - On April 4, 2022, the Company acquired a 40% participation in a Farmout Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor (“Scout”) with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Company has joined three other parties to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement (collectively the “Hugoton JV”).

 

The Farmout Agreement covers drilling and completion of up to 50 wells, with the first exploratory well spudded on May 7, 2022. The Hugoton JV will utilize Scout’s existing infrastructure assets including water disposal, gas gathering and helium processing. The Farmout Agreement provides the Hugoton JV with rights to take in-kind and market its share of helium at the tailgate of Jayhawk Gas Plant, which will enable the Hugoton JV to market and sell the helium produced at prevailing market prices.

 

The Hugoton JV also acquired the right to all brine minerals subject to a ten percent (10%) royalty to Scout, across Finney and Haskell Counties. Brine minerals are harvested from the formation water produced from active, and to be drilled, oil and gas wells and may include a variety of dissolved minerals including bromine and iodine. The Hugoton JV plans to target brine minerals with commercial quantities of bromine and iodine. The Company through the Hugoton JV is currently developing proprietary technology to recover brine minerals, particularly with respect to bromine, which is well underway and has demonstrated recovery efficiency and is expected to be available for use in existing and future development wells.

 

The Hugoton JV believes that its unconventional theory has not previously been targeted for exploration by historical operations in the field. The initial exploratory well was spud on May 7, 2022 near Garden City, Kansas, with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production and sales of natural gas, natural gas liquids and helium on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout and whether it should attempt to extend the time period before it has to drill additional wells in Hugoton Gas Field per the farm-out agreement.

 

The Company performed the ceiling test to assess potential impairment of the capitalized costs relative to its Hugoton Gas Field Project. The ceiling test indicated an impairment charge of $192,762 was required to reduce the total capitalized costs to $88,687 as of December 31, 2022. Accordingly, the Company has recorded an impairment charge of $192,762 to reduce the capitalized tangible and intangible costs related to its Hugoton Gas Field properties to $88,687 as of December 31, 2022. The Company recorded an addition to depreciation and amortization expense of $3,411 during the three months ended June 30, 2023.

 

Investment in GMDOC, LLC - On May 3, 2022, the Company entered into an operating agreement (the “Operating Agreement”) pursuant to which the Company acquired 17 (or 60.7143%) of 28 limited liability membership interests (the “Interests”) in GMDOC, LLC, a Kansas limited liability company (“GMDOC”), for an aggregate purchase price of $4,037,500, and was subsequently admitted as a member of GMDOC.

 

The Company paid the cash contribution for the membership interests of $850,000, during May 2022. The remainder of the Company’s capital contribution, or $3,187,500, was financed by the Bank Loan (as defined below).

 

GMDOC had previously acquired 70% of the working interests (the “Acquisition”) in certain oil and gas leases (the “GMDOC Leases”) from Castelli Energy, L.L.C., an Oklahoma limited liability company (“Castelli”). The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC Leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis.

 

GMDOC is managed by two members: Darrah Oil Company, LLC, and Grand Mesa Operating Company, (collectively the “Managing Members”), which also serve as the operating companies under the GMDOC Leases.

 

8
 

 

Going Concern

 

The Company has incurred losses from operations, has a stockholders’ deficit, incurred net cash used in operating activities and has a significant working capital deficit as of and for the three and six months ended June 30, 2023 and as of and for the year ended December 31, 2022. The Company must raise substantial amounts of debt and equity capital from other sources in the future in order to fund (i) the development of the Properties acquired on April 1, 2021; (ii) our obligations for exploration and development under the Hugoton Farmout Agreement; (iii) normal day-to-day operations and corporate overhead; and (iv) outstanding debt and other financial obligations as they become due, as described below. Most of the Company’s outstanding debt and other financial obligations are currently past due and the Company must negotiate forbearance and/or restructuring agreements with the holders of such debt. These are substantial operational and financial issues that must be successfully addressed during 2023 and beyond.

 

The Company has made substantial progress in resolving many of its existing financial obligations and acquiring oil and gas producing properties to deploy its new operational strategy during the period through June 30, 2023.

 

The Company will have significant financial commitments executing its planned exploration and development of the Properties and the Hugoton Gas Field. The Company may find it necessary to raise substantial amounts of debt or equity capital to fund such exploration and development activities and may seek offers from industry operators and other third parties for interests in the Properties in exchange for cash and a carried interest in exploration and development operations or other joint venture arrangement. There can be no assurance that it will be able to obtain such new funding or be able to reach agreements with industry operators and other third parties or on what terms.

 

Due to the uncertainties related to the foregoing matters, there exists substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financials are issued. The unaudited condensed financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

 

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” and the series of related accounting standard updates that followed, using the modified retrospective method of adoption. Adoption of the ASU did not require an adjustment to the opening balance of equity and did not change the Company’s amount and timing of revenues.

 

The Company’s revenues are primarily derived from its interests in the sale of oil and natural gas production. To date, such revenues have only included the sale of oil and natural gas however the Company expects to begin generating more substantial revenues from the sale of noble gases in the future. The Company recognizes revenue from its interests in the sales of oil and gas in the period that its performance obligations are satisfied. Performance obligations are satisfied when the customer obtains control of product, when the Company has no further obligations to perform related to the sale, when the transaction price has been determined and when collectability is probable. The sales of oil and gas are made under contracts which the third-party operators of the wells have negotiated with customers, which typically include variable consideration that is based on pricing tied to local indices and volumes delivered in the current month. The Company receives payment from the sale of oil and gas production from one to three months after delivery. At the end of each month when the performance obligation is satisfied, the variable consideration can be reasonably estimated and amounts due from customers are accrued in trade receivables, net in the balance sheets. Variances between the Company’s estimated revenue and actual payments are recorded in the month the payment is received, however, differences have been and are insignificant. The Company’s oil is typically sold at delivery points under contracts terms that are common in our industry.

 

Cash and Cash Equivalents

 

For purposes of reporting cash flows, cash consists of cash on hand and demand deposits with financial institutions. The Company’s policy is that all highly liquid investments with an original maturity of three months or less when purchased would be cash equivalents and would be included along with cash as cash and equivalents.

 

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with several financial institutions if necessary to remain below the federally insured limit of $250,000 per bank. At June 30, 2023 and December 31, 2022, the uninsured balance amounted to $152,630 and $-0-, respectively.

 

9
 

 

Convertible Instruments

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)” which is intended to reduce complexity in applying GAAP to certain financial instruments with characteristics of liabilities and equity. The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in Accounting Standards Codification (“ASC”) 470-20, Debt: Debt with Conversion and Other Options that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. The amendments in ASU 2020-06 further revise the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares.

 

The Company early adopted ASU 2020-06 effective January 1, 2021 and applied ASU 2020-06 to all outstanding financial instruments as of January 1, 2021.

 

Conversion options that contain variable settlement features such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract generally result in their bifurcation from the host instrument.

 

Derivative Instruments

 

The Company accounts for derivative instruments or hedging activities under the provisions of ASC 815 Derivatives and Hedging. ASC 815 requires the Company to record derivative instruments at their fair value. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in other comprehensive earnings (loss) and are recognized in the statement of earnings when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized in earnings. Changes in the fair value of derivatives that do not qualify for hedge treatment are recognized in earnings.

 

The purpose of hedging is to provide a measure of stability to the Company’s cash flows in an environment of volatile oil and gas prices and to manage the exposure to commodity price risk. As of June 30, 2023 and December 31, 2022 and during the periods then ended, the Company had no oil and natural gas derivative arrangements outstanding.

 

As a result of certain terms, conditions and features included in certain common stock purchase warrants issued by the Company (Notes 4 and 11), those warrants were required to be accounted for as derivatives at estimated fair value, with changes in fair value recognized in operations.

 

Fair Value of Financial Instruments

 

The carrying values of the Company’s accounts payable, accrued liabilities and short-term notes represent the estimated fair value due to the short-term nature of the accounts.

 

In accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.

 

10
 

 

ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

 

  Level 1 — Quoted prices in active markets for identical assets and liabilities.
       
  Level 2 — Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities).
       
  Level 3 — Significant unobservable inputs (including the Company’s own assumptions in determining the fair value.

 

The estimated fair value of warrant derivative liabilities, which are related to detachable warrants issued in connection with the Series A Convertible Preferred Stock, par value $0.001 per share (the “Series A Convertible Preferred Stock”) were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock, par value $0.001 per Share (the “Common Stock”) and current interest rates. The fair values for the warrant derivatives as of June 30, 2023 and December 31, 2022 were classified under the fair value hierarchy as Level 3.

 

The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022:

 

June 30, 2023  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $210,094   $210,094 
   $   $   $210,094   $210,094 

 

December 31, 2022  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $577,269   $577,269 
   $   $   $577,269   $577,269 

 

There were no changes in valuation techniques or reclassifications of fair value measurements between Levels 1, 2 or 3 during the three and six months ended June 30, 2023 and 2022.

 

Management Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include, but are not limited to, oil and gas reserves; depreciation, depletion and amortization of proved oil and gas properties; future cash flows from oil and gas properties; impairment of long-lived assets; fair value of derivatives; asset retirement obligations, our control over equity method investments, fair value of equity compensation; warrants issued in connection with convertible debt; the realization of deferred tax assets; fair values of assets acquired and liabilities assumed in business combinations.

 

Oil and gas properties

 

Central Kansas Uplift Properties - On April 1, 2021, we completed the acquisition of the Properties, under the terms of the Asset Purchase Agreement, for a purchase price of $900,000. The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

 

11
 

 

The Company has performed workovers of the wells subsequent to the Properties purchase which was necessary to put the lease back into production status. Therefore, these tangible and intangible workover costs were expensed as lease operating expenses rather than capitalized in the full cost pool through December 31, 2022. In addition, the Company is currently evaluating the Properties for oil and gas reserves and specifically the potential for noble gas reserves such as helium, argon and krypton. Based on these evaluations, the Company may redirect its efforts to the production of noble gases rather than crude oil on the Properties. These noble gas evaluation costs have also been expensed as lease operating costs through June 30, 2023.

 

Hugoton Gas Field Farm-Out -The first exploratory well commenced on May 7, 2022 near Garden City, Kansas with a goal to evaluate its unconventional theory of where substantial oil, natural gas and noble gases may be present in the Hugoton Gas Field. The initial well in which the Company has acquired a 40% participation together with three other venture partners was spud on May 7, 2022 with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves.

 

The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout and whether it should attempt to extend the time period before it has to drill additional wells in Hugoton Gas Field per the farm-out agreement.

 

Full Cost Accounting

 

The accounting for, and disclosure of, oil and gas producing activities require that we choose between two GAAP alternatives: the full cost method or the successful efforts method. We adopted and use the full cost method of accounting, which involves capitalizing all exploration, exploitation, development and acquisition costs. Once we incur costs, they are recorded in the depletable pool of proved properties or in unproved properties, collectively, the full cost pool. Our unproved property costs, which include unproved oil and gas properties, properties under development, and major development projects, were zero as of June 30, 2023 and December 31, 2022, and are not subject to depletion. We review our unproved oil and gas property costs on a quarterly basis to assess for impairment and transfer unproved costs to proved properties as a result of extensions or discoveries from drilling operations or determination that no proved reserves are attributable to such costs. We expect these costs to be evaluated in one to seven years and transferred to the depletable portion of the full cost pool during that time. The full cost pool is comprised of intangible drilling costs, lease and well equipment and exploration and development costs incurred plus acquired proved and unproved leaseholds.

 

When we acquire significant amounts of undeveloped acreage, we capitalize interest on the acquisition costs in accordance with FASB ASC Subtopic 835-20 for Capitalization of Interest. When the unproved property costs are moved to proved developed and undeveloped oil and gas properties, or the properties are sold, we cease capitalizing interest.

 

Capitalized costs to acquire oil and natural gas properties are depreciated and depleted on a units-of-production basis based on estimated proved reserves. Capitalized costs of exploratory wells and development costs are depreciated and depleted on a units-of-production basis based on estimated proved developed reserves. Under this method, the sum of the full cost pool, excluding the book value of unproved properties, and all estimated future development costs are divided by the total estimated quantities of proved reserves. This rate is applied to our total production for the quarter, and the appropriate expense is recorded. Support equipment and other property, plant and equipment related to oil and gas producing activities, as well as property, plant and equipment unrelated to oil and gas producing activities, are recorded at cost and depreciated on a straight-line basis over the estimated useful lives of the assets.

 

Sales, dispositions and other oil and gas property retirements are accounted for as adjustments to the full cost pool, with no recognition of gain or loss, unless the disposition would significantly alter the amortization rate and/or the relationship between capitalized costs and Proved Reserves.

 

Pursuant to Rule 4-10(c)(4) of Regulation S-X, at the end of each quarterly period, companies that use the full cost method of accounting for their oil and gas properties must compute a limitation on capitalized costs, or ceiling test. The ceiling test involves comparing the net book value of the full cost pool, after taxes, to the full cost ceiling limitation defined below. In the event the full cost ceiling is less than the full cost pool, we must record a ceiling test write-down of our oil and gas properties to the value of the full cost ceiling. The full cost ceiling limitation is computed as the sum of the present value of estimated future net revenues from our proved reserves by applying average prices as prescribed by the SEC Release No. 33-8995, less estimated future expenditures (based on current costs) to develop and produce the proved reserves, discounted at 10%, plus the cost of properties not being amortized and the lower of cost or estimated fair value of unproved properties included in the costs being amortized, net of income tax effects.

 

12
 

 

The ceiling test is computed using the simple average spot price for the trailing twelve-month period using the first day of each month. The trailing twelve-month reference price was $94.14 per barrel for the West Texas Intermediate oil at Cushing, Oklahoma through December 31, 2022. This reference price for oil is further adjusted for quality factors and regional differentials to derive estimated future net revenues. Under full cost accounting rules, any ceiling test write-downs of oil and gas properties may not be reversed in subsequent periods. We recognized an impairment charge of $905,574 as of June 30, 2023 and December 31, 2022 which is attributable to changing our strategy to exploring for noble gases and away from crude oil production at our Central Kansas Uplift properties which resulted in a large decrease in estimated future cash flows.

 

The ceiling test calculation is based upon estimates of proved reserves. There are numerous uncertainties inherent in estimating quantities of proved reserves, in projecting the future rates of production and in the timing of development activities. The accuracy of any reserve estimate is a function of the quality of available data and of engineering and geological interpretation and judgment. Results of drilling, testing and production subsequent to the date of the estimate may justify revision of such estimate. Accordingly, reserve estimates are often different from the quantities of oil and gas that are ultimately recovered.

 

Equity Method Investments

 

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of the net income or loss of these investees is included in our Statements of Operations. Judgment regarding the level of influence over each equity method investment includes considering key factors such as the Company’s ownership interest, legal form of the investee, representation on the board of directors, participation in policy-making decisions and material intra-entity transactions.

 

The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when reviewing an equity method investment for impairment include the length of time and the extent to which the fair value of the equity method investment has been less than cost, the investee’s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than temporary is recognized in the period identified.

 

The Company accounts for distributions received from equity method investees under the “nature of the distribution” approach. Under this approach, distributions received from equity method investees are classified on the basis of the nature of the activity or activities of the investee that generated the distribution as either a return on investment (classified as cash inflows from operating activities) or a return of investment (classified as cash inflows from investing activities).

 

Issuance of Debt Instruments With Detachable Stock Purchase Warrants

 

Proceeds from the issuance of a debt instrument with stock purchase warrants (detachable call options) are allocated to the two elements based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portion of the proceeds allocated to the warrants are recorded as additional paid-in capital. The remainder of the proceeds are allocated to the debt instrument portion of the transaction. Such issuances generally result in a discount (or, occasionally, a reduced premium) relative to the debt instrument, which is amortized to interest expense using the effective interest rate method.

 

Asset Retirement Obligations

 

The Company records estimated future asset retirement obligations pursuant to the provisions of ASC 410. ASC 410 requires entities to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred with a corresponding increase in the carrying amount of the related long-lived asset. Subsequent to its initial measurement, the asset retirement liability is required to be accreted each period. The Company’s asset retirement obligations consist of costs related to the plugging of wells, the removal of facilities and equipment, and site restoration on oil and gas properties.

 

13
 

 

During April 2021, the Company acquired the Properties and assumed the related asset retirement obligation existing at the date of acquisition. The asset retirement obligation assumed for the Properties relates to the plug and abandonment costs when the wells acquired are no longer useful. The Company determined the value of the liability by obtaining quotes for this service and estimated the increased costs that the Company will face in the future. We then discounted the future value based on an intrinsic interest rate that is appropriate for us. If costs rise more than what we have expected there could be additional charges in the future; however, we monitor the costs of the abandoned wells and we will adjust this liability if necessary.

 

As of December 31, 2012, the Company had divested all of its domestic oil properties that contained operating and abandoned wells in Texas, Colorado and Wyoming. The Company may have obligations related to the divestiture of certain abandoned non-producing domestic leasehold properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. Management believes the Company has been relieved from asset retirement obligation related to Infinity-Texas because of the sale of its Texas oil and gas properties in 2011 and its sale of 100% of the stock in Infinity-Texas in 2012. The Company has recognized an additional liability of $734,897 related to its former Texas oil and gas producing properties (included in asset retirement obligations) to recognize the potential personal liability of the Company and its officers for the Infinity-Texas oil and gas properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. In addition, management believes the Company has been relieved from asset retirement obligations related to Infinity-Wyoming because of the sale of its Wyoming and Colorado oil and gas properties in 2008; however, the Company has recognized since 2012 an additional liability of $981,106 related to its former Wyoming and Colorado oil and gas producing properties (included in asset retirement obligations) to recognize the potential liability of the Company and its officers should the new owner not perform its obligations to reclaim abandoned wells in a timely manner.

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes. This method requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between financial accounting bases and tax bases of assets and liabilities. The tax benefits of tax loss carryforwards and other deferred taxes are recorded as an asset to the extent that management assesses the utilization of such assets to be more likely than not. Management routinely assesses the realizability of the Company’s deferred income tax assets, and a valuation allowance is recognized if it is determined that deferred income tax assets may not be fully utilized in future periods. Management considers future taxable earnings in making such assessments. Numerous judgments and assumptions are inherent in the determination of future taxable earnings, including such factors as future operating conditions. When the future utilization of some portion of the deferred tax asset is determined not to be more likely than not, a valuation allowance is provided to reduce the recorded deferred tax asset. When the Company can project that a portion of the deferred tax asset can be realized through application of a portion of tax loss carryforward, the Company will record that utilization as a deferred tax benefit and recognize a deferred tax asset in the same amount. There can be no assurance that facts and circumstances will not materially change and require the Company to adjust its deferred income tax asset valuation allowance in a future period. The Company recognized a deferred tax asset, net of valuation allowance, of $-0- at June 30, 2023 and December 31, 2022.

 

The Company is potentially subject to taxation in many jurisdictions, and the calculation of income tax liabilities (if any) involves dealing with uncertainties in the application of complex income tax laws and regulations in various taxing jurisdictions. It recognizes certain income tax positions that meet a more-likely-than not recognition threshold. If the Company ultimately determines that the payment of these liabilities will be unnecessary, it will reverse the liability and recognize an income tax benefit. No liability for unrecognized tax benefit was recorded as of June 30, 2023 and December 31, 2022.

 

Stock-based compensation

 

The Company applies ASC 718, Stock Compensation, which requires companies to recognize compensation expense for share-based payments based on the estimated fair value of the awards. ASC 718 also requires tax benefits relating to the deductibility of increases in the value of equity instruments issued under share-based compensation arrangements to be presented as financing cash inflows in the statement of cash flows. Compensation cost is recognized based on the grant-date fair value for all share-based payments granted and is estimated in accordance with the provisions of ASC 718.

 

14
 

 

Related Party Transactions

 

The Company’s financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances and similar items in the ordinary course of business. Disclosure of related party transactions include: 1) the nature of the relationships involved, 2) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements, 3) the dollar amounts of the transactions for each periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period, and 4) amounts due from or to related parties as of the date of each balance sheet presented and if not otherwise apparent,5) the terms of settlement.

 

Basic and Diluted Income (Loss) Per Share

 

Net income (loss) per share is calculated in accordance with FASB ASC 260, Earnings Per Share, for the periods presented. Basic net loss per share is based upon the weighted average number of shares of Common Stock outstanding. Diluted net earnings (loss) per share is based on the assumption that all dilutive convertible shares, warrants and stock options were converted or exercised or excluded from the calculations if their inclusion would be antidilutive. Dilution is computed by applying the if-converted/treasury stock method. Under this method, options and warrants are assumed exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase shares of Common Stock at the average market price during the period. The Company has outstanding convertible notes payable, Series A Convertible Preferred Stock and Series B Convertible Preferred Stock all of which are potentially dilutive. Such potential dilutive effect is included in diluted earnings (loss) per share at the beginning of the period (or at the time of issuance, if later) if they have a dilutive effect or such potentially dilutive securities are excluded from the calculations if their inclusion would be antidilutive.

 

The adoption of ASU 2020-06 requires the Company to assume share settlement when an instrument can be settled in cash or shares at the entity’s option. This applies both to convertible instruments and freestanding arrangements that could result in cash or share settlement. ASU 2020-06 also stipulates that an average market price for the period should be used in the computation of the diluted earnings (loss) per share denominator in cases when the exercise price of an instrument may change based on an entity’s share price or changes in the entity’s share price may affect the number of shares that would be used to settle a financial instrument. Lastly, an entity should use the weighted-average share count from each quarter when calculating the year-to-date weighted average share count for all potentially dilutive securities.

 

During the three and six months ended June 30, 2023 and 2022, the Company had outstanding the following securities that were potentially dilutive: i) Series A and Series B Convertible Preferred Stock, ii) various convertible notes payable, iii) warrants to purchase Common Stock and iv) options to purchase Common Stock. All potentially dilutive securities were considered for inclusion or exclusion from the calculation of diluted income (loss) per share for the three and six months ended June 30, 2023 and 2022. Any potentially dilutive security that were considered anti-dilutive were excluded from the net income (loss) per share reported for the three and six months ended June 30, 2023 and 2022.

 

Debt – Modifications and Extinguishments / Troubled Debt Restructuring:

 

In accordance with ASC 470, the Company assesses restructuring of debt as troubled debt restructuring if the creditor for economic or legal reasons related to the debtor’s financial difficulties grant a concession to the debtor that it would not otherwise consider. The Company records a gain on restructuring of payables when it transfers its assets to a creditor to fully settle a payable. The gain is measured by the excess of the carrying amount of the payable over the fair value of the assets transferred or fair value of equity interest granted.

 

15
 

 

The Company follows ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), which requires the Company to assess whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires the Company to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different based on an analysis of the present value of the future cash flows under the terms of the new debt instrument compared to the present value of the remaining cash flows under the terms of the original instrument. The accounting treatment is different depending on whether such difference in the present value of future cash flows is greater than or less than 10 percent as follows:

 

  Difference is less than 10% - If the modification results in a difference in present value of future cash flows for the new and old debt instruments is less than 10% then it is considered to be not significant and is treated as a modification of the existing debt. Under a modification of debt, no gain or loss is recognized at the date of the modification. Rather a new effective interest rate is calculated, and interest expenses are accounted for under the interest method using the new effective interest rate on a prospective basis.
     
  Difference is more than 10% - If the modification results in a difference in present value of future cash flows for the new and old debt instruments is more than 10% then it is considered as significant and is treated as an extinguishment of the old debt instrument and issuance of the new debt instrument. Under extinguishment accounting, the old debt instrument is extinguished, and the new debt instrument is recorded at fair value. The difference in the carrying amount of the old debt instrument compared to the fair value of the new debt instrument is recognized as a gain or loss from extinguishment of debt as of the date of modification. Interest expense is accounted for under the interest method using the new effective rate.

 

Recent Accounting Pronouncements

 

Business Combinations - In October 2021, FASB issued ASU 2021-08 Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities were recognized by the acquirer at fair value on the acquisition date. The Company adopted this ASU on January 1, 2023 and its adoption did not have a material impact on our financial statements.

 

Other accounting standards that have been issued by the FASB or other standards-setting bodies are not expected to have a material impact on the Company’s financial position, results of operations and cash flows.

 

Note 2 – Oil and Gas Properties and Equipment

 

Oil and gas properties and equipment is comprised of the following at June 30, 2023 and December 31, 2022:

 

 

   June 30, 2023   December 31, 2022 
Central Kansas Uplift - Oil and gas production equipment  $913,425   $913,425 
Hugoton Gas Field - Oil and gas production equipment   96,831    96,831 
Central Kansas Uplift – Leasehold costs   15,225    15,225 
Hugoton Gas Field – Leasehold costs   191,535    191,535 
           
Subtotal   1,217,016    1,217,016 
Less: Accumulated impairment   (905,574)   (905,574)
Less: Accumulated depreciation, depletion and amortization   (229,577)   (222,755)
Oil and gas properties and equipment, net  $81,865   $88,687 

 

Note 3 – Investment in unconsolidated subsidiary – GMDOC

 

A summary of the Company’s investment in unconsolidated subsidiary-GMDOC during the three and six months ended June 30, 2023 and 2022 follows:

 

    2023     2022     2023     2022  
    Three months ended
June 30,
    Six months ended
June 30,
 
    2023     2022     2023     2022  
                         

Investment in unconsolidated subsidiary-GMDOC, at beginning of period

  $ 1,141,274     $     $ 1,101,461     $  
Purchase of membership units in GMDOC, LLC           850,000             850,000  
Equity in earnings (loss) of GMDOC     (10,346 )     114,336       29,467       114,336  
Distributions during period                        
                                 
Investment in unconsolidated subsidiary-GMDOC at end of period   $ 1,130,928     $ 964,336     $ 1,130,928     $ 964,336  

 

16
 

 

The following table presents summarized balance sheet financial information of the Company’s unconsolidated subsidiary – GMDOC as of June 30, 2023 and December 31, 2022:

 

   June 30, 2023   December 31, 2022 
ASSETS          
Assets:          
Cash  $103,061   $208,450 
Accrued revenue & prepaid expenses   173,625    320,212 
Oil and gas properties and equipment, net   7,042,620    7,359,905 
           
Total assets  $7,319,306   $7,888,567 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Accounts payable and accrued liabilities  $97,188   $207,244 
General managing members advances   150,000     
Mortgage note payable, net   4,328,036    4,984,821 
Asset Retirement Obligations   916,211    882,331 
Member’s equity   1,827,871    1,814,171 
           
Total liabilities and member’s equity  $7,319,306   $7,888,567 

 

The following table presents summarized income statement financial information of the Company’s unconsolidated subsidiary – GMDOC for the three and six months ended June 30, 2023 and 2022:

 

   2023   2022   2023   2022 
   Three months ended
June 30,
   Six months ended
June 30,
 
   2023   2022   2023   2022 
                 
Oil and gas revenues  $433,998   $788,964   $1,064,213   $788,964 
Lease operating expenses   (216,023)   (244,276)   (524,115)   (244,276)
Production related taxes   (4,888)   (22,912)   (20,777)   (22,912)
Ad valorem taxes   (5,982)   (10,755)   (16,737)   (10,755)
Depreciation expense   (134,206)   (131,514)   (268,413)   (131,514)
Accretion of asset retirement obligation   (16,940)   (16,987)   (33,880)   (16,987)
General and administrative expenses   (5,129)   (100,054)   (11,811)   (100,054)
Interest expense   (67,871)   (74,147)   (139,946)   (74,147)
                     
Net income (loss)   (17,041)   188,319    48,534    188,319 
AMGAS member’s percentage   60.7143

%

   60.7143    60.7143%   60.7143%
                     
Equity in earnings (loss) of unconsolidated subsidiary – GMDOC  $(10,346)  $114,336   $29,467   $114,336 

 

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

 

17
 

 

Note 4 – Debt Obligations

 

Debt obligations were comprised of the following at June 30, 2023 and December 31, 2022:

 

   June 30, 2023   December 31, 2022 
Notes payable:          
           
3% convertible notes payable due March 30, 2026 (the 3% Notes)  $28,665   $28,665 
8% convertible notes payable due September 30, 2023 (the October 8% Notes)   500,000    500,000 
8% convertible note payable due September 30, 2023 (the 8% Note)   100,000    100,000 
8% convertible note payable due October 29, 2022 (the Second 8% Note) (in default)   50,000    50000 
8% Convertible promissory notes payable due September 30, 2023 (the June 2022 Note)   350,000    350,000 
8% Convertible promissory notes payable due September 30, 2023 (the May 2022 Notes)   266,204    312,500 
           
Total notes payable   1,294,869    1,341,165 
Less: Long-term portion   28,665    28,665 
Notes payable, short-term  $1,266,204   $1,312,500 

 

Debt obligations become due and payable as follows:

 

Years ended 

Principal

balance due

 
     
2023 (Ju1y 1, 2023 through December 31, 2023)  $1,266,204 
2024    
2025    
2026   28,665 
2027    
2028    
Total  $1,294,869 

 

3% Convertible Notes Payable due March 30, 2026

 

On March 31, 2021, the Company entered into Debt Settlement Agreements with six creditors (five of which were related parties) which extinguished accounts payable and accrued liabilities totaling $2,866,497 in exchange for the issuance of $28,665 in principal balance of 3% convertible notes payable (the “3% Notes”) with detachable warrants to purchase 5,732,994 shares of Common Stock for fifty cents ($0.50) per share (the “3% Note Warrants”). The 3% Notes allow for prepayment at any time with all principal and accrued interest becoming due and payable at maturity on March 30, 2026 (the “Maturity Date”). The 3% Notes are convertible as to principal and any accrued interest, at the option of the holder, into shares of Common Stock at any time after the issue date and prior to the close of business on the business day preceding the Maturity Date at the rate of fifty cents ($0.50) per share, subject to normal and customary adjustment.

 

8% Convertible Notes Payable due September 30, 2023

 

On October 29, 2021, the Company issued to two accredited investors (the “October 8% Note Investors”) unsecured convertible notes payable due October 29, 2022 (the “October 8% Notes”), with an aggregate principal face amount of approximately $500,000. The October 8% Notes are, subject to certain conditions, convertible into an aggregate of 1,000,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued five and one half-year Common Stock purchase warrants to purchase up to 1,500,000 shares of Common Stock at an exercise price of $0.50 per share, subject to customary adjustments (the “October 8% Note Warrants”) which are immediately exercisable. The conversion price of the October 8% Note and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The October 8% Note Investors purchased the October 8% Notes and October 8% Note Warrants from the Company for an aggregate purchase price of $500,000 and the proceeds were used for general working capital purposes. The Company also granted the October 8% Note Investors certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the October 8% Note Warrants and the conversion of the October 8% Notes unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

18
 

 

The October 8% Notes all bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note and the October 8% Notes shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the October 8% Notes, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the October 8% Note Investor.

 

The conversion of the October 8% Notes and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the October 8% Note Investors may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

The Company and the October 8% Note Investors have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

 

The Company did not pay the principal balance due on the October 8% Notes upon their original maturity on October 29, 2022 and the remaining balance remained due and payable and was therefore in technical default as of December 31, 2022. The Company reached an agreement with the two October 8% Note Investors on January 10, 2023. On January 10, 2023, the Company and the October 8% Note Holders amended each of the notes by entering into a Letter Agreement between the October 8% Note Investors and the Company. The Letter Agreement modifies the terms of the October 8% Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes.

 

The Company evaluated the terms of the January 10, 2023 Letter Agreement which amended the October 8% Notes. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The amendment of the Fixed Conversion Price to $0.10 from $0.50 per share, as provided for in the Letter Agreement, would be considered substantive based on the likelihood of the conversion option being exercised in the future. Accordingly, the Company accounted for the amendment of the Notes as an extinguishment of the original Bridge Notes.

 

19
 

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

 

  

As of

January 10, 2023

 
Carrying value of the original convertible notes payable     
Principal balance  $500,000 
Accrued interest   120,753 
Total carrying value of original convertible note payable   620,753 
      
Less: Net present value of future cash flows on amended convertible notes payable   (516,776)
      
Gain on extinguishment of convertible notes payable  $103,977 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $103,977 during the six months ended June 30, 2023.

 

The conversion rate on the October 8% Notes was reduced to $0.05 per share as a result of the dilutive issuance of the Series B Convertible Preferred Stock that occurred on May 4, 2023 (See Note 13).

 

8% Convertible Note Payable due September 30, 2023

 

On August 30, 2021, the Company issued to an accredited investor (the “8% Note Investor”) an unsecured convertible note due October 29, 2022 (the “8% Note”), with an aggregate principal face amount of approximately $100,000. The 8% Note is, subject to certain conditions, convertible into an aggregate of 200,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five and one half-year Common Stock purchase warrant to purchase up to 200,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “8% Note Warrant”) which are immediately exercisable. The conversion price of the 8% Note and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023.The 8% Note Investor purchased the 8% Note and 8% Note Warrant from the Company for an aggregate purchase price of $100,000 and the proceeds were used for general working capital purposes. The Company also granted the 8% Note Investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the 8% Note Warrant and the conversion of the 8% Note unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

The 8% Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the 8% Note, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the 8% Note Investor.

 

The conversion of the 8% Note and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

20
 

 

The Company and the 8% Note Investor have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

 

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

 

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $100,000 outstanding principal balance of the 8% Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable was cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable. The Company treated the refinancing of the $100,000 8% Note Payable as an extinguishment of the old note which resulted in a gain on extinguishment of $24,190 during the three months ended June 30, 2023.

 

The Company evaluated the modification of the 8% Note that occurred on May 5, 2023. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The analysis of the present value of future cash flows under the new debt instrument compared to the old debt instrument resulted in a difference in excess of 10%. Accordingly, the Company accounted for the amendment of the Note as an extinguishment of the original 8% Note.

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment:

 

  

As of

May 5, 2023

 
Carrying value of the original convertible note payable     
Principal balance  $100,000 
Accrued interest   28,877 
Total carrying value of original convertible note payable   128,877 
      
Less: Net present value of future cash flows on amended convertible note payable   (104,687)
      
Gain on extinguishment of convertible notes payable  $24,190 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $24,290 during the three and six months ended June 30, 2023.

 

21
 

 

8% Convertible Notes Payable due October 29, 2022 (in default)

 

On October 29, 2021, the Company issued to an accredited investor (the “Second 8% Note Investor”) an unsecured convertible note payable due October 29, 2022 (the “Second 8% Notes”), with an aggregate principal face amount of approximately $50,000. The Second 8% Note is, subject to certain conditions, convertible into an aggregate of 100,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued five and one half-year Common Stock purchase warrants to purchase up to 150,000 shares of Common Stock at an exercise price of $0.50 per share, subject to customary adjustments (the “Second 8% Note Warrants”) which are immediately exercisable. The conversion price of the Second 8% Notes and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023.The Second 8% Note Investor purchased the Second 8% Note and the Second 8% Warrants from the Company for an aggregate purchase price of $50,000 and the proceeds were used for general working capital purposes. The Company also granted the Second 8% Note Investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the Second 8% Note Warrants and the conversion of the Second 8% Note unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

The Second 8% Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the Second 8% Note shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the Second 8% Note, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the Second 8% Note Investor.

 

The conversion of the Second 8% Note and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

The Company, the Second 8% Note Investor have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

 

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

 

The Company has accrued default interest aggregating $12,349 and $10,668 as of June 30, 2023 and December 31, 2022, respectively related to the repayment default on this note.

 

The conversion rate on the Second 8% Note was reduced to $0.05 per share as a result of the dilutive issuance of the Series B Convertible Preferred Stock that occurred on May 4, 2023 (See Note 13).

 

8% Convertible Notes Payable due September 30, 2023

 

On June 8, 2022, the Company issued to an accredited investor an unsecured convertible note due September 15, 2022 (the “June 2022 Note”), with an aggregate principal face amount of $350,000. The June 2022 Note is, subject to certain conditions, convertible into an aggregate of 700,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five-year Common Stock purchase warrant to purchase up to 700,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “June 2022 Warrants”) which are immediately exercisable. The investor purchased the June 2022 Note and June 2022 Warrant from the Company for an aggregate purchase price of $350,000 and the proceeds were used for drilling and completion costs on the initial well drilled under the Hugoton Gas Field participation agreement and general working capital purposes. The Company also granted the investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares of Common Stock underlying the June 2022 Warrant and the conversion of the June 2022 Note unless the shares of the Company commence to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

22
 

 

The June 2022 Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to the remaining principal amount of the underlying note and any accrued and unpaid interest.

 

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

 

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including the June 2022 Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

 

The Company evaluated the modification of the 8% Note that occurred on May 5, 2023. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The analysis of the present value of future cash flows under the new debt instrument compared to old debt instrument resulted in a difference less than 10%. Accordingly, the Company accounted for the amendment of the Note as a modification of the original 8% Note resulting in no gain or loss on the date of modification. Rather a new effective interest rate is calculated, and interest expenses are accounted for under the interest method using the new effective interest rate on a prospective basis.

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment:

 

  

As of

May 5, 2023

 
Carrying value of the original convertible note payable     
Principal balance  $350,000 
Accrued interest   35,595 
Total carrying value of original convertible note payable   385,595 
      
Less: Net present value of future cash flows on amended convertible note payable   (366,400)
      
Difference  $19,195 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment was less than 10%. As a result, the Company did not record a gain on extinguishment of convertible notes payable.

 

23
 

 

8% Convertible Notes Payable due September 30, 2023 (the “May 22 Notes”)

 

The Company entered into a securities purchase agreement with two accredited investors for the Company’s 8% convertible notes payable due June 29, 2022 (the “May 2022 Notes”), with an aggregate principal amount of $850,000. The May 2022 Notes are, subject to certain conditions, convertible into an aggregate of 2,125,000 shares of Common Stock, at a price of forty cents ($0.40) per share. The conversion price of the May 22 Notes and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The Company also issued an aggregate of 425,000 shares of Common Stock as commitment shares (“Commitment Shares” and, together with the May 2022 Notes and Conversion Shares, the “Securities”) to the investors as additional consideration for the purchase of the May 2022 Notes. The closing of the offering of the Securities occurred on May 13, 2022, when the investors purchased the Securities for an aggregate purchase price of $850,000. The Company has also granted the Investors certain automatic and piggy-back registration rights whereby the Company has agreed to register the resale by the Investors of the Conversion Shares. The proceeds of this offering of Securities were used to purchase the Company’s membership interests in GMDOC.

 

The May 2022 Notes bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time (subject to the occurrence of an event of default) in an amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest, and shall be mandatorily repaid in cash in an amount equal to a) fifty percent (50%) of the then outstanding principal amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 but not greater than $3,000,000; or b) one hundred percent (100%) of the then outstanding principal amount equal to 120% of the principal amount of a May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of in excess of $3,000,000. In addition, pursuant to the May 2022 Notes, so long as such May 2022 Notes remain outstanding, the Company shall not enter into any financing transactions pursuant to which the Company sells its securities at a price lower than the $0.40 per share conversion price, subject to certain adjustments, without the written consent of the investors.

 

The conversion of the May 2022 Notes are each subject to beneficial ownership limitations such that the investors may not convert the May 2022 Notes to the extent that such conversion or exercise would result in an investor being the beneficial owner in excess of 4.99% (or, upon election of the Investor, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

Pursuant to the purchase agreement for the Securities, for a period of twelve (12) months after the closing date, the investors have a right to participate in any issuance of the Company’s Common Stock, Common Stock equivalents, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of the subsequent financing.

 

The Company also entered into that certain registration rights side letter, pursuant to which, in the event the Company’s shares of Common Stock have not commenced trading on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date, and, thereafter, the Company agreed to file a registration statement under the Securities Act to register the offer and sale, by the Company, of Common Stock underlying the May 2022 Notes in the event that such notes are not repaid prior to such 120-day period.

 

The Company paid half of the May 2022 Notes principal balance upon its maturity on June 29, 2022 and an additional $112,500 in September 2022 and the remaining balance remains due and payable and was therefore in technical default as of December 31, 2022.

 

The Company and the two May 2022 Note Holders reached an agreement on January 10, 2023. On January 10, 2023, the Company amended each of those notes by entering into a Letter Agreement between the investors and the Company. The Letter Agreement modifies the terms of the May 2022 Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes.

 

24
 

 

The Company evaluated the terms of the January 10, 2023 Letter Agreement which amended the May 2022 Notes. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the May 2022 Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The amendment of the Fixed Conversion Price to $0.10 from $0.50 per share, as provided for in the Letter Agreement, would be considered substantive based on the likelihood of the conversion option being exercised in the future. Accordingly, the Company accounted for the amendment of the Notes as an extinguishment of the original Bridge Notes.

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

 

  

As of

January 10, 2023

 
Carrying value of the original convertible notes payable     
Principal balance  $312,500 
Accrued interest   75,471 
Total carrying value of original convertible note payable   387,971 
      
Less: Net present value of future cash flows on amended convertible notes payable   (322,986)
      
Gain on extinguishment of convertible notes payable  $64,985 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $64,985 during the six months ended June 30, 2023.

 

On January 13, 2023, one of the May 22 Note holders exercised its right to convert $46,296 of principal and $3,704 accrued interest into 500,000 shares of common stock. The remaining outstanding principal balance on the two May 2022 Notes totaled $266,204 and $312,500 as of June 30, 2023 and December 31, 2022, respectively.

 

Note 5 – Accrued liabilities

 

Accrued liabilities consisted of the following at June 30, 2023 and December 31, 2022:

 

   June 30, 2023   December 31, 2022 
Accrued rent  $614,918   $614,918 
Accrued Nicaragua Concession fees   544,485    544,485 
Accrued lease operating costs   41,634     
           
Total accrued liabilities  $1,201,037   $1,159,403 

 

The accrued rent balances relate to unpaid rent for the Company’s previous headquarters in Denver, Colorado and represents unpaid rents and related costs for the period June 2006 through November 2008. The Company has not had any correspondence with the landlord for several years and will seek to settle and/or negotiate the matter when it has the financial resources to do so.

 

25
 

 

From 2009 to 2020, the Company had pursued the exploration of potential oil and gas resources in the United States and in the Perlas and Tyra concession blocks in offshore Nicaragua in the Caribbean Sea (the “Concessions”), which contain a total of approximately 1.4 million acres. In January 2020, the Company decided to cease its activities, exploration and production in the Concessions. The accrued Nicaraguan Concession fees were accrued during the time the Concessions had lapsed and the Company was attempting to negotiate extensions to the underlying concessions with the Nicaraguan government which were unsuccessful. The Company abandoned all efforts to negotiate an extension to the Concessions effective January 1, 2020 and ceased the accrual of all related fees at that time.

 

Note 6 – Stock Options

 

Total stock-based compensation is comprised of the following for the three and six months ended June 30, 2023 and 2022:

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2023   2022   2023   2022 
Stock-based compensation – stock option grants  $   $51,000   $   $127,499 
                     
Stock-based compensation – restricted stock grants       255,625    174,375    336,875 
                     
Stock-based compensation – warrants issued for services pursuant to USNG Letter Agreement   71,716    71,716    143,432    143,873 
                     
Total stock-based compensation  $71,716   $378,341   $317,807   $608,247 

 

The Company applies ASC 718, Stock Compensation, which requires companies to recognize compensation expense for share-based payments based on the estimated fair value of the awards. ASC 718 also requires tax benefits relating to the deductibility of increases in the value of equity instruments issued under share-based compensation arrangements to be presented as financing cash inflows in the statement of cash flows. Compensation cost is recognized based on the grant-date fair value for all share-based payments granted and is estimated in accordance with the provisions of ASC 718.

 

At the Company’s Annual Meeting of Stockholders held on September 25, 2015, the stockholders approved the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”) and the Company reserved 500,000 shares for issuance under the 2015 Plan. At the Company’s Annual Meeting of Stockholders held on October 13, 2021, the stockholders approved the 2021 Stock Option and Restricted Stock Plan (the “2021 Plan”) and the Company reserved 5,000,000 shares for issuance under the 2021 Plan.

 

The 2021 Plan and the 2015 Plan provide for under which both incentive and non-statutory stock options may be granted to employees, officers, non-employee directors and consultants. An aggregate of 5,500,000 shares of the Company’s Common Stock is reserved for issuance under the 2021 Plan and the 2015 Plan. Options granted under the 2021 Plan and 2015 Plan allow for the purchase of shares of Common Stock at prices not less than the fair market value of such stock at the date of grant, become exercisable immediately or as directed by the Company’s Board of Directors and generally expire ten years after the date of grant. The Company has issued stock options and restricted stock awards that are not pursuant to a formal plan with terms similar to the 2021 and 2015 Plans.

 

As of June 30, 2023, 5,500,000 shares were available for future grants under the 2021 Plan and the 2015 Plan.

 

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the expected term of the option award, expected stock price volatility and expected dividends. These estimates involve inherent uncertainties and the application of management judgment. For purposes of estimating the expected term of options granted, the Company aggregates option recipients into groups that have similar option exercise behavioral traits. Expected volatilities used in the valuation model are based on the expected volatility based on historical volatility. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The Company’s forfeiture rate assumption used in determining its stock-based compensation expense is estimated based on historical data. The actual forfeiture rate could differ from these estimates.

 

26
 

 

Stock option grants

 

The following table summarizes stock option activity for the six months ended June 30, 2023 and 2022:

 

   Number of Options  

Weighted Average Exercise

Price Per

Share

  

Weighted

Average

Remaining
Contractual
Term

 

Aggregate

Intrinsic

Value

 
Outstanding at December 31, 2021   1,892,000   $1.93   9.07 years  $ 
Granted                
Exercised                
Forfeited   (350,000)   0.50         
Outstanding at June 30, 2022   1,542,000   $2.26   8.49 years  $ 
Outstanding and exercisable at June 30, 2022   1,542,000   $2.26   8.49 years  $ 
                   
Outstanding at December 31, 2022   1,442,000   $2.38   7.96 years  $ 
Granted                
Exercised                
Forfeited   (2,000)   30.00         
Outstanding at June 30, 2023   1,440,000   $2.34   7.47 years  $ 
Outstanding and exercisable at June 30, 2023   1,440,000   $2.34   7.47 years  $ 

 

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of June 30, 2023:

 

    Outstanding options  Exercisable options

Exercise price

per share

  

Number of

options

   Weighted average
remaining
contractual life
 

Number of

options

   Weighted average
remaining
contractual life
                   
$0.50    1,350,000   7.93 years   1,350,000   7.93 years
$30.00    90,000   0.54 years   90,000   0.54 years
                   
 Total    1,440,000   7.47 years   1,440,000   7.47 years

 

There were no stock options granted during the three and six months ended June 30, 2023 and 2022. The Company recorded stock-based compensation expense in connection with the vesting of stock options granted aggregating $-0- and $51,000 for the three months ended June 30, 2023 and 2022, respectively and $-0- and $127,499 for the three months ended June 30, 2023 and 2022, respectively.

 

The intrinsic value as of June 30, 2023 and December 31, 2022 related to the vested and unvested stock options as of that date was $-0-. There is no unrecognized compensation cost as of June 30, 2023 related to the unvested stock options as of that date.

 

Restricted stock grants.

 

During May 2022, the Board of Directors granted 1,550,000 shares of restricted stock awards to our officers, directors and consultants. In addition, during August 2020 the Board of Directors granted 5,000,000 shares of restricted stock awards to our officers, directors and a consultant. Restricted stock awards are valued on the date of grant and have no purchase price for the recipient. Restricted stock awards typically vest over a period of time generally corresponding to yearly anniversaries of the grant date. Unvested shares of restricted stock awards may be forfeited upon the termination of service of employment with the Company, depending upon the circumstances of termination. Except for restrictions placed on the transferability of restricted stock, holders of unvested restricted stock have full stockholder’s rights, including voting rights and the right to receive cash dividends.

 

27
 

 

A summary of all restricted stock activity under the equity compensation plans for the six months ended June 30, 2023 and 2022 is as follows:

 

  

Number of

restricted

shares

  

Weighted

average

grant date

fair value

 
Nonvested balance, December 31, 2021   1,250,000   $0.13 
Granted   1,550,000    0.45 
Vested   (1,637,500)   (0.21)
Forfeited        
Nonvested balance, June 30, 2022   1,162,500   $0.45 
           
Nonvested balance, December 31, 2022   387,500   $0.45 
Granted        
Vested   (387,500)   (0.45)
Forfeited        
Nonvested balance, June 30, 2023      $ 

 

The Company recorded stock-based compensation expense in connection with the issuance/vesting of restricted stock grants aggregating $-0- and $255,625 during the three months ended June 30, 2023 and 2022, respectively and $174,375 and $336,875 during the six months ended June 30, 2023 and 2022, respectively.

 

The Company estimated the fair market value of these restricted stock grants based on the closing market price on the date of grant. As of June 30, 2023, there were $-0- of total unrecognized compensation costs related to all remaining non-vested restricted stock grants as all restricted stock granted to date have fully vested.

 

Note 7 – Warrants

 

The following table summarizes warrant activity for the six months ended June 30, 2023 and 2022:

 

  

Number of

Warrants

  

Weighted

Average

Exercise Price

Per Share

 
Outstanding and exercisable at December 31, 2021   17,580,784   $0.47 
Issued in connection with issuance of Series A Convertible Preferred Stock (See Note 13)   1,666,667    .30 

Issued in connection with issuance of 8% Convertible Promissory Note (See Note 4)

   700,000    .50 
Exercised        
Forfeited/expired        
Outstanding and exercisable at June 30, 2022   19,947,451   $0.45 
           
Outstanding and exercisable at December 31, 2022   20,430,783   $0.45 
Issued   15,000,000    .05 
Exercised        
Forfeited/expired        
           
Outstanding and exercisable at June 30, 2023   35,430,783   $0.19 

 

The weighted average term of all outstanding Common Stock purchase warrants was 4.2 years as of June 30, 2023. The intrinsic value of all outstanding Common Stock purchase warrants and the intrinsic value of all vested Common Stock purchase warrants was zero as of June 30, 2023 and 2022.

 

The warrant exercise price on warrants to acquire 9,056,409 shares of common stock were adjusted from their original exercise price (ranging from $0.30 per share to $0.50 per share) to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. A total of 3,799,999 of the total warrants effected by the dilutive issuance are treated as equity-based warrants and 5,256,410 of the total were treated as derivative-liability-based warrants. The modification in warrant exercise prices resulted in a total increase in their fair value as of May 4, 2023 (the modification date) totaling $793. The portion of the fair market value increase attributable to warrants treated as equity-based totaled $126 and recorded as an issuance cost of the Series B Convertible Preferred Stock (as a charge to additional paid-in capital) and an increase to additional paid-in capital. The portion of the fair market value increase attributable to warrants treated as derivative-liability-based totaled $667 and was included in the Change in warrant derivative fair value for the three and six months ended June 30, 2023. The following is a summary of the assumptions used in calculating estimated fair value of such warrants as of the May 4, 2023:

 

  

As of

May 4, 2023 with original exercise price

  

As of

May 4, 2023 with new exercise price

 
         
Volatility – range   345.8%   345.8%
Risk-free rate   3.41%   3.41%
Contractual term   3.4 to 4.8 years    3.4 to 4.8 years 
Exercise price  $0.30 to 0.50    $0.05 
Number of warrants in aggregate   9,056,409    9,056,409 

 

28
 

 

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase common shares as of June 30, 2023:

 

 

    Outstanding and exercisable warrants

Exercise price

per share

  

Number of

warrants

  

Weighted average

remaining contractual life

$0.05    24,056,409   4.7 years
$0.50    11,374,374   3.0 years
           
 Total    35,430,783   4.2 years

 

Warrants issued pursuant to USNG Letter Agreement

 

On November 9, 2021, the Company entered into a letter agreement (the “USNG Letter Agreement”) with U.S. Noble Gas, LLC (“USNG”), pursuant to which USNG provides consulting services to the Company for exploration, testing, refining, production, marketing and distribution of various potential reserves of noble gases and rare earth element/minerals on the Company’s recently acquired 11,000-acre oil and gas properties in the Otis Albert Field located on the Properties. The USNG Letter Agreement would cover all of the noble gases, specifically including helium, and rare earth elements/minerals potentially existing on Properties and the Company’s future acquisitions, if any, including the Hugoton Gas Field.

 

The USNG Letter Agreement also provides that USNG will supply a large vessel designed for flows up to 5,000 barrels of water per day at low pressures, known as a gas extraction/separator unit. The gas extraction/separator unit is a dewatering vessel that the Company may use for multiple wells in the future.

 

The USNG Letter Agreement requires the Company to establish a four-member board of advisors (the “Board of Advisors”) comprised of various experts involved in noble gas and rare earth elements/minerals. The Board of Advisors will help attract both industry partners and financial partners for developing a large helium, noble gas and/or rare earth element/mineral resources that may exist in the region where the Company currently operates. The industry partners would include helium, noble gas and/or rare earth element/mineral purchasers and exploration and development companies from the energy industry. The financial partners may include large family offices or small institutions.

 

Pursuant to the USNG Letter Agreement, the Company will pay USNG a monthly cash fee equal to $8,000 per month beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore, there has been no payment or accrual liability relative to this cash fee provision as of June 30, 2023 and December 31, 2022.

 

The USNG Letter Agreement has an initial term of 5 years, which shall thereafter continue for successive one-year periods, provided that there is no uncured breach, unless otherwise terminated by either party upon a written notice of intent to non-renew.

 

In consideration for the consulting services to be rendered and pursuant to the terms of the USNG Letter Agreement, the Company issued warrants to purchase, in the aggregate, 2,060,000 shares of its Common Stock at an exercise price of fifty cents ($0.50) to three of USNG’s principal consultants and four third-party service providers. The Company issued warrants to purchase, in the aggregate, 1,200,000 shares of Common Stock at fifty cents ($0.50) per share exercise price to three members of the Board of Advisors. The Company granted a total of 3,260,000 warrants to purchase its Common Stock with an exercise price of fifty cents ($0.50) per share in connection with the USNG Letter Agreement and the arrangements described therein. The warrants expire five years after the date of the USNG Letter Agreement.

 

The fair value of the warrants to purchase Common Stock in consideration for services to be rendered under the USNG Letter Agreement with USNG is estimated on the date of grant using the Black-Scholes option-pricing model.

 

29
 

 

The Company recognized $71,716 and $71,716 of compensation expense relative to the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement during the three months ended June 30, 2023 and 2022, respectively $143,432 and $143,873 during the six months ended June 30, 2023 and 2022, respectively. There have been no exercises or forfeitures of the warrants to purchase Common Stock relative to the USNG Letter during the three and six months ended June 30, 2023 and 2022.

 

The total grant date fair value of the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement on November 9, 2021 was $1,434,313 in total or $0.44 per share. Total unrecognized compensation costs related to the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement, as of June 30, 2023 was $956,207 which will be amortized over the next forty months.

 

Note 8 – Income Taxes

 

The effective income tax rate on income (loss) before income tax benefit varies from the statutory federal income tax rate primarily due to the net operating loss history of the Company maintaining a full reserve on all net deferred tax assets during the three and six months ended June 30, 2023 and 2022.

 

The Company has incurred operating losses in recent years, and it continues to be in a three-year cumulative loss position at June 30, 2023. Accordingly, the Company determined there was not sufficient positive evidence regarding its potential for future profits to outweigh the negative evidence of our three-year cumulative loss position under the guidance provided in ASC 740. Therefore, it determined to continue to provide a 100% valuation allowance on its net deferred tax assets. The Company expects to continue to maintain a full valuation allowance until it determines that it can sustain a level of profitability that demonstrates its ability to realize these assets. To the extent the Company determines that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed.

 

For income tax purposes, the Company has net operating loss carry-forwards of approximately $64,710,000 in accordance with its 2021 Federal Income tax return as filed. Approximately $61,045,000 of such net operating loss carry-forwards expire from 2028 through 2037 while $1,935,000 of such net operating loss carry-forwards have an indefinite carryforward period in accordance with the Tax Cuts and Jobs Act. In addition, the Tax Cuts and Jobs Act limits the usage of net operating loss carryforwards to 80% of taxable income per year.

 

The Company has recently completed the filing of its tax returns for the tax years 2012 through 2021. Therefore, all such tax returns are open to examination by the Internal Revenue Service.

 

The Internal Revenue Code contains provisions under Section 382 which limit a company’s ability to utilize net operating loss carry-forwards in the event that it has experienced a more than 50% change in ownership over a three-year period. Management has completed its review of whether such ownership changes have occurred, and based upon such review, management believes that the Company is not currently subject to an annual limitation or the possibility of the complete elimination of the net operating loss carry- forwards. In addition, the Company may be limited by additional ownership changes which may occur in the future.

 

30
 

 

Note 9 – Gain on Extinguishment of Convertible Notes Payable

 

During the three and six months ended June 30, 2023 and 2022, the Company recorded gains on the extinguishment of convertible notes payable through negotiation and settlements with certain creditors as follows:

 

   2023   2022   2023   2022 
   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2023   2022   2023   2022 
Gain on extinguishment of convertible notes payable:                    
Gain on extinguishment of convertible notes
payable – the May 22 Notes (see Note 4)
  $24,190   $   $24,190   $ 
Gain on extinguishment of convertible notes
payable – the October 8% Notes (See Note 4)
           103,977     
Gain on extinguishment of convertible notes
payable – the May 22 Notes (see Note 4)
           64,985     
                     
Total gain on exchange and extinguishment of liabilities  $24,190   $   $193,152   $ 

 

Note 10 – Asset Retirement Obligations

 

The Company’s asset retirement obligations primarily relate to the Company’s portion of future plugging and abandonment costs for wells and related facilities. The following table presents the changes in the asset retirement obligations for the six months ended June 30, 2023 and 2022:

 

   Amount 
     
Asset retirement obligation at December 31, 2021  $1,730,264 
Additions    
Accretion expense during the period   580 
      
Asset retirement obligation at June 30, 2022  $1,730,844 
      
Asset retirement obligation at December 31, 2022  $1,732,486 
Additions    
Accretion expense during the period   2,436 
      
Asset retirement obligation at June 30, 2023  $1,734,922 

 

Approximately $1,716,003 of the total asset retirement obligation existing at June 30, 2023 and December 31, 2022 represent the remaining potential liability for oil and gas wells the Company had owned in Texas and Wyoming prior to their sales/disposal in 2012. The Company was not in compliance with then existing federal, state and local laws, rules and regulations for its previously owned Texas and Wyoming domestic oil and gas properties. All domestic oil and gas properties held by Infinity-Wyoming and Infinity-Texas were disposed of in 2012 and in years prior to 2012; however, the Company may remain liable for certain asset retirement costs should the new owners not complete their asset retirement obligations. Management believes the total asset retirement obligations recorded relative to all the Company wells including these Texas and Wyoming wells of $1,733,704 and $1,732,486 as of June 30, 2023 and December 31, 2022, respectively are sufficient to cover any potential noncompliance liabilities relative to the plugging of abandoned wells, the removal of facilities and equipment, and site restoration on oil and gas properties for its current and former oil and gas properties.

 

31
 

 

Note 11 – Warrant Derivative Liability

 

The estimated fair value of the Company’s derivative liabilities, all of which were related to the detachable warrants issued in connection with Series A Convertible Preferred Stock, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates. The detachable warrants issued in connection with the issuance of certain Series A Convertible Preferred Stock (See Note 13 - March 2021 Issuance) contained a provision allowing the holder to require cash settlement in certain situations were fundamental transaction, as defined in the warrant agreements have occurred. An event occurred on December 31, 2022 that activated the Holder’s ability to utilize such provisions therefore the related derivative liability was recognized on December 31, 2022 and also at June 30, 2023.

 

The following is a summary of the assumptions used in calculating estimated fair value of such derivative liabilities as of the June 30, 2023 and December 31, 2022:

 

  

As of

June 30, 2023

  

As of

December 31, 2022

 
         
Volatility – range   347.2%   342.2%
Risk-free rate   4.13%   3.99%
Contractual term   3.24 years    3.74 years 
Exercise price  $0.05   $0.39 
Number of warrants in aggregate   5,256,410    5,256,410 

 

The following table provides a summary of the changes in fair value, including net transfers in and/or out, of the derivative financial instruments, measured at fair value on a recurring basis using significant unobservable inputs for both open and closed derivatives:

 

 

   Amount 
Balance at December 31, 2021  $ 
Unrealized derivative gains included in other income/expense for the period    
Balance at June 30, 2022  $ 
      
Balance at December 31, 2022  $577,269 
      
Unrealized derivative gains included in other income/expense for the period   (367,175)
      
Balance at June 30, 2023  $210,094 

 

The warrant exercise price on warrants to acquire 5,256,410 shares of common stock treated as derivative liability-based were adjusted from their original exercise price of $0.39 per share to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The modification in warrant exercise prices resulted in an increase in their fair value as of May 4, 2023 (the modification date) totaling $667 was included in the unrealized derivative gains included in other income/expense for the three and six months ended June 30, 2023. The following is a summary of the assumptions used in calculating estimated fair value of such derivative warrants as of the May 4, 2023:

 

  

As of

May 4, 2023 with original exercise price

  

As of

May 4, 2023 with new exercise price

 
         
Volatility – range   345.8%   345.8%
Risk-free rate   3.41%   3.41%
Contractual term   3.4 years    3.4 years 
Exercise price  $0.39   $0.05 
Number of warrants in aggregate   5,256,410    5,256,410 

 

Note 12 – Commitments and Contingencies

 

Lack of Compliance with Law Regarding Domestic Properties

 

The Company was not in compliance with then existing federal, state and local laws, rules and regulations for domestic oil and gas properties owned and disposed of in 2012 and in years prior to 2012 and could have a material or significantly adverse effect upon the liquidity, capital expenditures, earnings or competitive position of the Company. All domestic oil and gas properties held by Infinity-Wyoming and Infinity-Texas were disposed of in 2012 and in years prior to 2012; however, the Company may remain liable for certain asset retirement costs should the new owners not complete their obligations. Management believes the total asset retirement obligations recorded for these prior matters of $1,716,003 as of June 30, 2023 and December 31, 2022 are sufficient to cover any potential noncompliance liabilities relative to the plugging of abandoned wells, the removal of facilities and equipment, and site restoration on oil and gas properties for its former oil and gas properties.

 

USNG Letter Agreement commitment

 

Pursuant to the USNG Letter Agreement (see Note 7), the Company will pay USNG a monthly cash fee equal to $8,000 per month beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore there has been no payment or accrual liability relative to this cash fee provision as of June 30, 2023 and December 31, 2022.

 

32
 

 

The USNG Letter Agreement has an initial term of 5 years, which shall thereafter continue for successive one-year periods, provided that there is no uncured breach, unless otherwise terminated by either party upon a written notice of intent to non-renew.

 

Litigation

 

The Company is subject to various claims and legal actions in which vendors are claiming breach of contract due to the Company’s failure to pay amounts due. The Company believes that it has made adequate provision for these claims in the accompanying financial statements.

 

The Company is currently involved in litigation as follows:

 

In October 2012, the State of Texas filed a lawsuit naming Infinity-Texas, the Company and the corporate officers of Infinity-Texas, seeking $30,000 of reclamation costs associated with a single well, in addition to administrative expenses and penalties. The Company engaged in negotiations with the State of Texas in late 2012 and early 2013 and reached a settlement agreement that would reduce the aggregate liability, in this action and any extension of this action to other Texas wells, to $45,103, which amount has been paid. Certain performance obligations remain which must be satisfied in order to finally settle and dismiss the matter.
   
  Pending satisfactory performance of the performance obligations and their acceptance by the State of Texas, the Company’s officers have potential liability regarding the above matter, and the Company’s officers are held personally harmless by indemnification provisions of the Company. Therefore, to the extent they might actually occur, these liabilities are the obligations of the Company. Management estimates that the liabilities associated with this matter will not exceed $780,000, calculated as $30,000 for each of the 26 Infinity-Texas operated wells. This related liability, less the payment made to the State of Texas in 2012 in the amount of $45,103, is included in the asset retirement obligation on the accompanying balance sheets, which management believes is sufficient to provide for the ultimate resolution of this dispute.

 

Cambrian Consultants America, Inc. (“Cambrian”) filed an action in the District Court of Harris County, Texas, number CV2014-55719, on September 26, 2014 against the Company resulting from certain professional consulting services provided for quality control and management of seismic operations during November and December 2013 on the Nicaraguan Concessions. Cambrian provided these services pursuant to a Master Consulting Agreement with the Company, dated November 20, 2013, and has claimed breach of contract for failure to pay amounts due. On December 8, 2014, a default judgment was entered against the Company in the amount of $96,877 plus interest and attorney fees. The Company has included the impact of this litigation as a liability in its accounts payable, which management believes is sufficient to provide for the ultimate resolution of this dispute.

 

Torrey Hills Capital, Inc. (“Torrey”) notified the Company by letter, dated August 15, 2014, of its demand for the payment of $56,000, which it alleged was unpaid and owed under a consulting agreement dated October 18, 2013. The parties entered into a consulting agreement under which Torrey agreed to provide investor relations services in exchange for payment of $7,000 per month and the issuance of 15,000 shares of Common Stock. The agreement was for an initial three month-term with automatic renewals unless terminated upon 30 days’ written notice by either party. The Company made payments totaling $14,000 and issued 15,000 shares of Common Stock during 2013. The Company contends that Torrey breached the agreement by not performing the required services and that it had provided proper notice of termination to Torrey. Furthermore, the Company contends that the parties agreed to settle the dispute on or about June 19, 2014 under which it would issue 2,800 shares of Common Stock in full settlement of any balance then owed and final termination of the agreement. Torrey disputed the Company’s contentions and submitted the dispute to binding arbitration. The Company was unable to defend itself and the arbitration panel awarded Torrey a total of $79,594 in damages. The Company has accrued this amount in accounts payable as of June 30, 2023 and December 31, 2022, which management believes is sufficient to provide for the ultimate resolution of this dispute.

 

33
 

 

Note 13 – Stockholder’s Deficit

 

Conversion of 8% Convertible Notes Payable to Common Stock.

 

On January 13, 2023, a holder of 8% Convertible Notes Payable exercised its right to convert $46,296 of principal and $3,704 of accrued interest into 500,000 shares of common stock.

 

Convertible Preferred Stock

 

As of June 30, 2023 and December 31, 2022, the Company is authorized to issue up to 10,000,000 shares of preferred stock, par value $0.0001 per share.

 

Series A Convertible Preferred Stock Authorization - On March 16, 2021, the Company approved and filed a Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock (“COD”) with the Secretary of State of the State of Delaware. The COD provides for the issuance of up to 27,778 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share. Pursuant to the provisions of the COD, the Series A Convertible Preferred Stock is convertible, at the option of the holders thereof, at any time, subject to certain beneficial ownership limitations, into shares of Common Stock determined on a per share basis by dividing the $100 stated/liquidation value of such share of Series A Convertible Preferred Stock by the $0.32 per share conversion price, which conversion price is subject to certain adjustments. The conversion price of the Series A Convertible Preferred Stock was adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. In addition, the COD provides for the payment of 10% per annum cumulative dividends, in (i) cash, or (ii) shares of Common Stock, to the holders of the Series A Convertible Preferred Stock based on the stated/liquidation value, until the earlier of (i) the date on which the shares of Series A Convertible Preferred Stock are converted to Common Stock or (ii) date the Company’s obligations under the COD have been satisfied in full. The shares of Series A Convertible Preferred Stock also (i) vote on an as-converted to Common Stock basis, subject to certain beneficial ownership limitations, (ii) are subject to mandatory conversion into Common Stock upon the closing of any equity financing transaction consummated after the original issue date, pursuant to which the Company raises gross proceeds of not less than $5,000,000, (iii) rank senior to the Common Stock and any class or series of capital stock created after the Series A Convertible Preferred Stock and (iv) have a special preference upon the liquidation of the Company.

 

Series B Convertible Preferred Stock Authorization - On May 3, 2023, the Company approved and filed a COD of the Series B Convertible Preferred Stock with the Secretary of State of the State of Delaware. The COD provides for the issuance of up to 50,000 shares of Series B Convertible Preferred Stock with a stated/liquidation value of $100 per share. Pursuant to the provisions of the COD, the Series B Convertible Preferred Stock is convertible, at the option of the holders thereof, at any time, subject to certain beneficial ownership limitations, into shares of Common Stock determined on a per share basis by dividing the $100 stated/liquidation value of such share of Series A Convertible Preferred Stock by the $0.05 per share conversion price, which conversion price is subject to certain adjustments. In addition, the COD provides for the payment of 8% per annum cumulative dividends, in (i) cash, or (ii) shares of Common Stock, to the holders of the Series A Convertible Preferred Stock based on the stated/liquidation value, until the earlier of (i) the date on which the shares of Series A Convertible Preferred Stock are converted to Common Stock or (ii) date the Company’s obligations under the COD have been satisfied in full. The shares of Series A Convertible Preferred Stock also (i) vote on an as-converted to Common Stock basis, subject to certain beneficial ownership limitations, (ii) are subject to mandatory conversion into Common Stock upon the closing of any equity financing transaction consummated after the original issue date, pursuant to which the Company raises gross proceeds of not less than $5,000,000, (iii) rank senior to the Common Stock and any class or series of capital stock created after the Series B Convertible Preferred Stock and (iv) have a special preference upon the liquidation of the Company.

 

The following summarizes the activity in the Series A and Series B Convertible Preferred Stock for the three months ended June 30, 2023 and 2022:

 

   Six months ended
June 30, 2023
   Six months ended
June 30, 2022
 
   Series A   Series B   Series A   Series B 
                 
Outstanding at beginning of period:   25,526        22,076     
Issued       7,500    5,000     
Converted to common stock   (250)       (2,700)    
Redeemed                 
                     
Outstanding at end of period   25,276    7,500    24,376     

 

34
 

 

Series A - March 2021 Issuance - On March 26, 2021, the Company entered into a securities purchase agreement with five (5) accredited investors providing for an aggregate investment of $2,050,000 by the investors for the issuance by the Company to them of (i) 22,776 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “March 2021 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 5,256,410 shares of Common Stock at an exercise price of thirty-nine ($0.39) per share, subject to customary adjustments thereunder. The conversion price of the March 2021 Series A Convertible Preferred Stock and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. Holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. Net proceeds from the issuance of March 2021 Series A Convertible Preferred Stock totaled $1,929,089 after deducting the placement agent fee and other expenses of the offering. The Company used the proceeds of the March 2021 Series A Convertible Preferred Stock offering to complete the acquisition and development of the Properties, to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the acquisition of the Properties, which occurred on April 1, 2021, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the closing of the acquisition of the Properties, which occurred on April 1, 2021. The Company completed the required registration of these shares on Form S-1, which the Securities and Exchange Commission declared effective on August 4, 2021.

 

The holders of March 2021 Series A Convertible Preferred Stock exercised their right to convert 250 shares of the March 2021 Series A Convertible Preferred Stock into 500,000 shares of Common Stock during the six months ended June 30, 2023. The holders exercised their rights to convert a total of 2,700 shares of March 2021 Series A Convertible Preferred Stock into 843,750 shares of Common Stock during the six months ended June 30, 2022.

 

On March 26, 2021, Ozark Capital, LLC (“Ozark”) acquired 1,111 shares of March 2021 Series A Convertible Preferred Stock (convertible into 2,222,000 shares of Common Stock), together with warrants to acquire 256,410 shares of Common Stock at five cents ($0.05) per share for a total cash of $100,000. Ozark and its affiliates hold over 10% of the shares of the Company’s Common Stock as of June 30, 2023 and December 31, 2022.

 

All holders of the March 2021 Series A Convertible Preferred Stock, including Ozark, have agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days’ advance notice to the Company.

 

Series A - June 2022 Issuance - On June 15, 2022, the Company entered into a securities purchase agreement with an accredited investor providing for an aggregate investment of $500,000 by the investor for the issuance by the Company of (i) 5,000 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “June 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 1,666,667 shares of Common Stock at an exercise price of thirty cents ($0.30) per share, subject to customary adjustments thereunder. The conversion price of the June 2021 Series A Convertible Preferred Stock and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The holder of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the June 2022 Series A Convertible Preferred Stock totaled $500,000. The Company used the proceeds of the June 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

 

35
 

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the of the June 2022 Series A Preferred Stock, which occurred on June 15, 2022, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the closing of the offering, which occurred on June 15, 2022.

 

The holder of the June 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its June 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

Series A - August/September 2022 Issuances – During August and September 2022, the Company entered into a securities purchase agreement with three accredited investors providing for an aggregate investment of $145,000 by the investors for the issuance by the Company of (i) 1,450 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “August/September 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 483,332 shares of Common Stock at an exercise price of thirty ($0.30) per share, subject to customary adjustments thereunder. The conversion price of the August/September 2021 Series A Convertible Preferred Stock and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the August/September 2022 Series A Convertible Preferred Stock totaled $145,000. The Company used the proceeds of the August/September 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

 

The holders of the August/September 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its August/September 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

Series B - May 2023 Issuance - On May 4, 2023, the Company entered into a securities purchase agreement with three (3) accredited investors providing for an aggregate investment of $750,000 by the investors for the issuance by the Company to them of (i) 7,500 shares of Series B Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “May 2023 Series B Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 15,000,000 shares of Common Stock at an exercise price of five ($0.05) per share, subject to customary adjustments thereunder. The May 2023 Series B Convertible Preferred Stock is convertible into an aggregate of up to 15,000,000 shares of Common Stock. Holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. Net proceeds from the issuance of May 2023 Series B Convertible Preferred Stock totaled $750,000 which was used for general working capital purposes.

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the acquisition of the Properties, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof.

 

The holders of the May 2023 Series B Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its May 2023 Series B Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

The holders of May 2023 Series B Convertible Preferred Stock did not exercise their rights to convert any of the May 2023 Series B Convertible Preferred Stock into shares of Common Stock during the three and six months ended June 30, 2023 and 2022.

 

36
 

 

On April 27, 2023 and May 4, 2023, Ozark Capital, LLC (“Ozark”) acquired 2,500 shares of May 2023 Series B Convertible Preferred Stock (convertible into 5,000,000 shares of Common Stock), together with warrants to acquire 5,000,000 shares of Common Stock at five cents ($0.05) per share for a total cash of $250,000. Ozark and its affiliates hold over 10% of the shares of the Company’s Common Stock as of June 30, 2023 and December 31, 2022.

 

The estimated fair value of the detachable warrants issued in connection with Series B Convertible Preferred Stock, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates.

 

Such warrants are equity-classified with an estimated fair value of $899,963 as of the date of their issuance. The following is a summary of the assumptions used in calculating estimated fair value of the detachable warrants issued in relation to the Series B Convertible Preferred Stock issuance as of the May 4, 2023, their issuance date:

 

  

As of

May 4, 2023

 
      
Volatility – range   345.8%
Risk-free rate   3.41%
Contractual term   5.5 years 
Exercise price  $0.05 
Number of warrants in aggregate   15,000,000 

 

Series A Convertible Preferred Stock Dividends – The Company has accrued preferred dividends totaling $63,516 and $126,457 relative to the Series A Convertible Preferred Stock which was charged to additional paid in capital during the three and six months ended June 30, 2023, respectively and $52,289 and $105,150 relative to the Series A Convertible Preferred Stock during the three and six months ended June 30, 2022, respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $137,816 and $77,124 relative to the Series A Convertible Preferred Stock as of June 30, 2023 and December 31, 2022, respectively.

 

Accrued dividends on Series A Convertible Preferred Stock attributable to Ozark were $2,770 and $5,509 for the three and six months ended June 30, 2023, respectively and $2,739 and $5,479 for the three and six months ended June 30, 2022. The Company has outstanding accrued and unpaid preferred dividends totaling $2,770 and $2,800 relative to the Ozark’s Series A Convertible Preferred Stock as of June 30, 2023 and December 31, 2022, respectively.

 

Series B Convertible Preferred Stock Dividends - The Company has accrued preferred dividends totaling $9,600 and $9,600 relative to the Series B Convertible Preferred Stock which was charged to additional paid in capital during the three and six months ended June 30, 2023, respectively and there was no Series B Convertible Preferred Stock Series outstanding during the three and six months ended June 30, 2022. The Company has outstanding accrued and unpaid preferred dividends totaling $9,600 and $-0- relative to the May 2023 Series B Convertible Preferred Stock as of June 30, 2023 and December 31, 2022, respectively.

 

Accrued dividends on Series B Convertible Preferred Stock attributable to Ozark were $3,353 and $3,353 for the three and six months ended June 30, 2023 and $-0- and $-0- for the three and six months ended June 30, 2022 respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $3,353 and $-0- relative to the Ozark’s Series B Convertible Preferred Stock as of June 30, 2023 and December 31, 2022, respectively.

 

Note 14 – Related Party Transactions

 

The Company does not have any employees other than its Chief Executive Officer, Chief Operating Officer and Chief Financial Officer. In previous years, certain general and administrative services (for which payment is deferred) had been provided by the Company’s Chief Financial Officer’s accounting firm at its standard billing rates plus out-of-pocket expenses consisting primarily of accounting, tax and other administrative fees. The Company no longer utilizes its Chief Financial Officer’s accounting firm for such support services and was not billed for any such services during the years ended December 31, 2022 and 2021. On March 31, 2021, the parties entered into a Debt Settlement Agreement whereby all amounts due to such firm for services totaling $762,407 were extinguished upon the issuance of $7,624 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Note 4. Total amounts due to this related party was $-0- as of June 30, 2023 and December 31, 2022.

 

The Company had accrued compensation to its officers and directors in years prior to 2018. The Board of Directors authorized the Company to cease the accrual of compensation for its officers and directors, effective January 1, 2018. On March 31, 2021, the parties entered into Debt Settlement Agreements whereby all accrued amounts due for such services totaling $1,789,208 were extinguished upon the issuance of $17,892 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Note 4. Total amounts due to the officers and directors related to accrued compensation was $-0- as of June 30, 2023 and December 31, 2022.

 

Offshore Finance, LLC was owed financing costs in connection with a subordinated loan to the Company which was converted to common shares in 2014. The managing partner of Offshore and the Company’s Chief Financial Officer are partners in the accounting firm which the Company used for general corporate purposes in the past. On March 31, 2021, the parties entered into a Debt Settlement Agreement whereby all amounts due for such services totaling $26,113 were extinguished upon the issuance of $261 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Note 4. Total amounts due to this related party was $-0- as of June 30, 2023 and December 31, 2022.

 

In connection with the Hugoton Gas Field Farmout Agreement, John Loeffelbein, the Company’s previous Chief Operating Officer, was granted a 3% carried interest through drilling in the Hugoton JV. Such carried interest was burdened only to the three other partners in the Hugoton JV and not the Company’s interest. On April 18, 2022, John Loeffelbein resigned from his position as Chief Operating Officer with the Company.

 

Note 15 – Subsequent Events

 

On August 2, 2023 the Company’s Board of Directors granted stock purchase options to acquire a total of 10,000,000 shares of common stock to its newly-appointed Chief Executive Officer/Chief Financial Officer, its independent board members and a consultant. The options have an exercise price of $0.05 per share and vest ratably on a quarterly basis over the next two years beginning September 30, 2023. The stock options have a term of ten years.

 

**********************

 

37
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Note Regarding Forward Looking Statements

 

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”), and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which are intended to be covered by the safe harbors created thereby. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” “intends,” and other variations of these words or comparable words. These statements include statements relating to trends in or expectations relating to the effects of our existing and any future initiatives, strategies, investments, outlooks and plans.

 

Actual results or events may differ materially from those anticipated and as reflected in forward-looking statements included in this report. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others: our ability to successfully develop and operate our properties; changes in the competitive environment in our industry and the markets we serve, and our ability to compete effectively; our cash needs and the adequacy of our cash flows and earnings; our ability to service our debt obligations; our ability to attract and retain qualified personnel; changes in applicable laws or regulations; litigation; public health epidemics or outbreaks (such as the novel strain of COVID-19 and related variants); accidents, equipment failures or mechanical problems; and other risks.

 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this report. Except as required by law, we do not undertake to update or revise any of the forward-looking statements to conform these statements to actual results, whether as a result of new information, future events or otherwise.

 

As used in this quarterly report, “AMGAS,” the “Company,” “we,” “us” and “our” refer collectively to American Noble Gas Inc., its predecessors and subsidiaries or one or more of them as the context may require.

 

Overview

 

The Company has assessed various opportunities and strategic alternatives involving the acquisition, exploration and development of oil and gas oil producing properties in the United States, including the possibility of acquiring businesses or assets that provide support services for the production of oil and gas in the United States.

 

As a result, we are now involved with the following oil and gas producing properties:

 

Central Kansas Uplift - On April 1, 2021, we completed the acquisition of the Central Kansas Uplift Properties, for a purchase price of $900,000. The Central Kansas Uplift Properties include the production and mineral rights/leasehold for oil and gas properties, subject to overriding royalties to third parties, in the Central Kansas Uplift geological formation covering over 11,000 contiguous acres (the “Properties”). The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

 

38
 

 

We commenced rework of the existing production wells after completion of the acquisition of the Properties and have performed testing and evaluation of the existence of noble gas reserves on the Properties including helium, argon and other rare earth minerals/gases. Testing of the Properties for noble gas reserves has provided encouraging but not conclusive results and the Company has yet to determine the possibility of commercializing the noble gas reserves on the Properties. The Company plans to assess the Properties’ existing oil and gas reserves while continuing the evaluation of the existence of new oil and gas zones and other mineral reserves and specifically the noble gas reserves that the Properties may hold.

 

During the year ended December 31, 2022, the Company changed its strategy regarding the Central Kansas Uplift considering the reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of June 30, 2023 and December 31, 2022 and is considering the reworking the conventional wells on the property to emphasize crude oil production that may be present behind casing pipe in the deeper producing zones. Accordingly, the Company has recorded an impairment charge of $712,812 to reduce the capitalized tangible and intangible costs related to its Central Kansas Uplift properties to zero as of June 30, 2023 and December 31, 2022.

 

Hugoton Gas Field Farm-Out - On April 4, 2022, the Company acquired a 40% participation in a Farmout Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor (“Scout”) with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Company has joined three other parties to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement (collectively the “Hugoton JV”).

 

The Farmout Agreement covers drilling and completion of up to 50 wells, with the first exploratory well spudded on May 7, 2022. The Hugoton JV will utilize Scout’s existing infrastructure assets including water disposal, gas gathering and helium processing. The Farmout Agreement provides the Hugoton JV with rights to take in-kind and market its share of helium at the tailgate of Jayhawk Gas Plant, which will enable the Hugoton JV to market and sell the helium produced at prevailing market prices.

 

The Hugoton JV also acquired the right to all brine minerals subject to a ten percent (10%) royalty to Scout, across Finney and Haskell Counties. Brine minerals are harvested from the formation water produced from active, and to be drilled, oil and gas wells and may include a variety of dissolved minerals including bromine and iodine. The Hugoton JV plans to target brine minerals with commercial quantities of bromine and iodine. The Company through the Hugoton JV is currently developing proprietary technology to recover brine minerals, particularly with respect to bromine, which is well underway and has demonstrated recovery efficiency and is expected to be available for use in existing and future development wells.

 

The Hugoton JV believes that its unconventional theory has not previously been targeted for exploration by historical operations in the field. The initial exploratory well was spud on May 7, 2022 near Garden City, Kansas, with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production and sales of natural gas, natural gas liquids and helium on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout and whether it should attempt to extend the time period before it has to drill additional wells in Hugoton Gas Field per the farm-out agreement.

 

The Company performed the ceiling test to assess potential impairment of the capitalized costs relative to its Hugoton Gas Field Project. The ceiling test indicated an impairment charge of $192,762 was required to reduce the total capitalized costs to $88,687 as of December 31, 2022. Accordingly, the Company has recorded an impairment charge of $192,762 to reduce the capitalized tangible and intangible costs related to its Hugoton Gas Field properties to $88,687 as of December 31, 2022. The Company recorded an addition to depreciation and amortization expense of $3,411 during the three months ended June 30, 2023.

 

39
 

 

Investment in GMDOC, LLC - On May 3, 2022, the Company entered into an operating agreement (the “Operating Agreement”) pursuant to which the Company acquired 17 (or 60.7143%) of 28 limited liability membership interests (the “Interests”) in GMDOC, LLC, a Kansas limited liability company (“GMDOC”), for an aggregate purchase price of $4,037,500, and was subsequently admitted as a member of GMDOC.

 

The Company paid the cash contribution for the membership interests of $850,000, during May 2022. The remainder of the Company’s capital contribution, or $3,187,500, was financed by the Bank Loan (as defined below).

 

GMDOC had previously acquired 70% of the working interests (the “Acquisition”) in certain oil and gas leases (the “GMDOC Leases”) from Castelli Energy, L.L.C., an Oklahoma limited liability company (“Castelli”). The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC Leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis.

 

GMDOC is managed by two members: Darrah Oil Company, LLC, and Grand Mesa Operating Company, (collectively the “Managing Members”), which also serve as the operating companies under the GMDOC Leases.

 

2023 Operational and Financial Objectives

 

Corporate Activities

 

The Company’s 2023 operating objectives are focused on: 1) raising the necessary funds to finance exploration and development of the Hugoton Gas Field through the Hugoton JV, 2) raising the necessary funds for repayment of obligations that become due, or are in default and/or past due, 3) raising the funds necessary to explore and develop the Properties, including testing and evaluation of noble gas reserves in additional to the oil and gas producing zones, 4) raising the funds necessary to allow the Company to compete for new oil and gas properties that become available for acquisition purposes, and 5) funding our daily operations and the repayment of other obligations that become due, or are in default and/or past due.

 

Recent financings –

 

Issuance of Series B Convertible Preferred Stock

 

May 2023 Issuance - On May 4, 2023, the Company entered into a securities purchase agreement with three (3) accredited investors providing for an aggregate investment of $750,000 by the investors for the issuance by the Company to them of (i) 7,500 shares of Series B Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “May 2023 Series B Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 15,000,000 shares of Common Stock at an exercise price of five ($0.05) cents per share, subject to customary adjustments thereunder. The 7,500 shares of May 2023 Series B Convertible Preferred Stock are convertible into an aggregate of up to 15,000,000 shares of Common Stock. Holders of the warrants may exercise the warrants by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. The Company intends to use the proceeds of the May 2023 Series B Convertible Preferred Stock offering for development of Hugoton Gas Field and Central Kansas Uplift Properties and for general working capital purposes.

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the May 2023 Series B Convertible Preferred Stock transaction, to register the shares of Common Stock issuable upon the conversion of the May 2023 Series B Convertible Preferred Stock and the common stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the closing of the issuance of the May 2023 Series B Convertible Preferred Stock.

 

40
 

 

Refinancing and extensions of Convertible Notes Payable

 

8% Convertible Notes Payable due September 30, 2023 - The Company did not pay the $500,000 principal balances due on the October 8% Notes upon their original maturity on October 29, 2022 and the remaining balance remained due and payable and was therefore in technical default as of December 31, 2022. The Company reached an agreement with the two October 8% Note Investors on January 10, 2023. On January 10, 2023, the Company and the October 8% Note Holders amended each of the notes by entering into a Letter Agreement between the October 8% Note Investors and the Company. The Letter Agreement modifies the terms of the October 8% Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes. The conversion price of the October 8% Note and the related warrant exercise price were further adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023.

 

8% Convertible Notes Payable due September 30, 2023 - On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000, which the Company did not pay by their respective maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

 

8% Convertible Notes Payable due September 30, 2023 (the “May 22 Notes”) - The Company and the two May 2022 Note Holders reached an agreement on January 10, 2023. On January 10, 2023, the Company amended each of those notes by entering into a Letter Agreement between the investors and the Company. The Letter Agreement modifies the terms of the May 2022 Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes. The conversion rate on the May 22 Notes were further reduced to $0.05 per share as a result of the dilutive issuance of the Series B Convertible Preferred Stock that occurred on May 4, 2023.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet debt, nor did we have any transactions, arrangements, obligations (including contingent obligations) or other relationships with any unconsolidated entities or other persons that may have a material current or future effect on our financial conditions, changes in our financial conditions, or our results of operations, liquidity, capital expenditures, capital resources, or significant components of revenue or expenses except as follows:

 

Investment in Unconsolidated Subsidiary – GMDOC - On May 3, 2022, the Company entered into the Operating Agreement pursuant to which the Company acquired 17 (or 60.7143%) of 28 limited liability membership Interests in GMDOC, for an aggregate purchase price of $4,037,500, and was subsequently admitted as a member of GMDOC.

 

The Company paid the cash contribution for the membership interests of $850,000, in May 2022. The remainder of the Company’s capital contribution, or $3,187,500, was financed by the Bank Loan (as defined below).

 

GMDOC had previously acquired 70% of the working interests in the GMDOC Leases from Castelli Energy, L.L.C, an Oklahoma limited liability company. The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC Leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis.

 

Pursuant to the terms of the Operating Agreement, each member agreed to pay GMDOC, as its capital contribution, $50,000 in cash per Interest, with the remainder to be financed, in part, by a loan to GMDOC from a commercial bank, secured by GMDOC’s property, in the aggregate amount of $6,045,000 (the “Bank Loan”). The principal of the Bank Loan is to be repaid in 84 varying monthly installments, ranging from $170,000 at the beginning to $40,500 at the end of the loan term, with the first installment on July 1, 2022. The Bank Loan bears a variable interest beginning at an initial rate of 6% per annum with one rate adjustment after 36 months subject to a 6% minimum interest rate.

 

41
 

 

For the Three Months Ended June 30, 2023 and 2022

 

Results of Operations

 

Revenue

 

Revenues totaled $4,041 and $43,563 for the three months ended June 30, 2023 and 2022, respectively. The $39,522 or 91% decrease in revenues during the three months ended June 30, 2023 as compared to the same period in 2022 reflects the reduction in oil and gas sales from our Central Kansas Uplift properties due to the wells being down awaiting necessary rework/maintenance.

 

During late 2022, the Company changed its strategy regarding the Central Kansas Uplift properties considering its reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of June 30, 2023 and December 31, 2022 and has reworked one of the conventional wells on the property to produce crude oil from a deeper producing zone. Accordingly, revenues during the three months ended June 30, 2023 was substantially less than the comparable period in 2022.

 

Oil and Gas Lease Operating Expenses

 

Total oil and gas lease operating expenses totaled $133,687 and $56,178 for the three months ended June 30, 2023 and 2022, respectively. The increase in oil and gas lease operating expenses during the three months ended June 30, 2023 as compared to the same period in 2022 is attributable to significant repairs and rework performed in the three months ended June 30, 2023 that did not occur during the three months ended June 30, 2023. The Company has shut down the horizontal production wells as of June 30, 2023 and December 31, 2022 and has reworked one of the conventional wells on the property to produce crude oil from a deeper producing zone. In addition, the Company incurred a $40,000 extension fee relative to the Hugoton Participation Agreement during the three months ended June 30, 2023 to extend the time period to drill additional wells. Accordingly, oil and gas lease operating expenses during the three months ended June 30, 2023 were substantially higher than the comparable period in 2022.

 

Depreciation, Depletion and Impairment

 

Depreciation, depletion and amortization expense totaled $3,411 and $30,834 during the three months ended June 30, 2023 and 2022, respectively.

 

During late 2022, the Company changed its strategy regarding the Central Kansas Uplift properties considering its reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of June 30, 2023 and December 31, 2022 and has deepened one of the conventional wells on the property to produce crude oil known to be present in deeper producing zones. Accordingly, the Company recorded an impairment charge of $712,812 to reduce the capitalized tangible and intangible costs related to its Central Kansas Uplift properties to zero as of December 31, 2022 which remains in place at June 30, 2023. Depreciation, depletion and impairment expense was reduced substantially during the three months ended June 30, 2023 compared to the three months ended June 30, 2022 as a result of the impairment recognized at December 31, 2022.

 

Accretion of Asset Retirement Obligation

 

Total expense for the accretion of asset retirement obligations was $1,218 and $302 for the three months ended June 30, 2023 and 2022, respectively. The Company recognized additional expenses for its asset retirement obligations relative to both the Central Kansas Uplift and Hugoton Gas Field properties. The Company commenced production from the Hugoton Gas Field well in late 2022 which began the accretion of its related asset retirement obligations. The obligation relates to legal requirements associated with the retirement of long-lived assets that result from the acquisitions, construction, development, or normal use of the asset. The obligation relates primarily to the requirement to plug and abandon oil and natural gas wells and support wells at the conclusion of their useful lives.

 

42
 

 

Oil and Gas Production Related Taxes

 

Oil and gas production related taxes totaled $-0- and $82 for the three months ended June 30, 2023 and 2022, respectively. Such taxes are deducted from gross oil and gas revenue by the crude oil purchaser upon payment to the Company and include primarily severance taxes imposed by the State of Kansas, and Kansas conservation assessment fees. Revenues totaled $4,041 for the three months ended June 30, 2023, which resulted in the deduction of $-0- in production related taxes due to the shut-down of crude oil production from the Central Kansas Uplift properties in late 2022..

 

Other General and Administrative Expenses

 

Other general and administrative expenses were $119,644 for the three months ended June 30, 2023, a decrease of $359,793, or 75%, from other general and administrative expenses of $479,437 for the three months ended June 30, 2022. The decrease in other general and administrative expenses is primarily attributable to a decrease of $306,625 in stock-based compensation due to the noncash compensation awarded to the Company’s executives, members of the Board of Directors became fully vested in 2023 and therefore no related compensation expense was recorded during the three months ended June 30, 2023 as compared to $306,625 of stock based compensation expense recorded during the three months ended June 30, 2022.

 

Equity in earnings of unconsolidated subsidiary – GMDOC

 

The Company reported equity in earnings (loss) of unconsolidated subsidiary of $(10,346) for the three months ended June 30, 2023, compared to earnings of $114,336 for the three months ended June 30, 2022. Such income (loss) resulted from the Company acquiring a 60.7143% membership interest in GMDOC in May 2022. The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

 

GMDOC had previously acquired 70% of the working interests in the GMDOC Leases from Castelli Energy, L.L.C., an Oklahoma limited liability company. The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis. GMDOC, LLC generated $65,575 of net income on $630,215 of oil and gas revenues during the three months ended June 30, 2023. The Company owns a 60.7143% membership interest in such net income or $39,813 which it has reported as equity in earnings of unconsolidated subsidiary – GMDOC during the three months ended June 30, 2023.

 

Interest Expense

 

Interest expense increased to $22,927 for the three months ended June 30, 2023, compared to $332,234 for the three months ended June 30, 2022. The decrease in interest expense during the three months ended June 30, 2023 compared to the same period in 2022 was attributable to $308,984 of amortization of discount on convertible notes payable recorded during the three months ended June 30, 2022. There was no similar amortization of discount on convertible notes payable recorded during the three months ended June 30, 2023.

 

Gain on Extinguishment of Liabilities

 

The Company reported a gain on extinguishment of convertible notes payable of $24,190 and $-0- during the three months ended June 30, 2023 and 2022, respectively.

 

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $100,000 outstanding principal balance of the 8% Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable was cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable. The Company treated the refinancing of the $100,000 8% Note Payable as an extinguishment of the old note which resulted in a gain on extinguishment of $24,190 during the three months ended June 30, 2023.

 

43
 

 

Change in Warrant Derivative Fair Value

 

The change in warrant derivative liability was a loss of $292 during the three months ended June 30, 2023, as compared to a gain of $-0- during the three months ended June 30, 2022. The estimated fair value of the Company’s derivative liabilities, all of which were related to the detachable warrants issued in connection with the issuance of Series A Convertible Preferred Stock, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates. The detachable warrants issued in connection with the issuance of certain Series A Convertible Preferred Stock contained a provision allowing the holder to require cash settlement in certain situations were fundamental transaction, as defined in the warrant agreements have occurred. An event occurred on December 31, 2022 that activated the Holder’s ability to utilize such provisions, therefore the derivative liability was recognized on December 31, 2022 and June 30, 2023. Management estimated the fair value of the underlying derivative utilizing the black-scholes methodology as of June 30, 2023 and December 31, 2023 with the change in fair value being recognized as the change in warrant derivative fair value for the three months ended June 30, 2023.

 

Income Tax

 

The Company recorded no income tax benefit (expense) in the three months ended June 30, 2023 and 2022. The Company has been in a cumulative tax loss position and has substantial net operating loss carryforwards available for its utilization at June 30, 2023. The Company has continued to carry a 100% reserve on its net deferred tax assets and therefore recorded no income tax expense or benefit on its income (loss) before income taxes during the three months ended June 30, 2023 and 2022.

 

Net Income (Loss)

 

The Company reported a net loss of $263,294 for the three months ended June 30, 2023, compared to a net loss of $741,168 for the three months ended June 30, 2022. This represents an improvement of $477,874 for the three months ended June 30, 2023 compared to the three months ended June 30, 2022.

 

Convertible Preferred Stock Dividends

 

The Company recorded $73,116 and $52,289 in Series A and Series B Convertible Preferred Stock dividends in the three months ended June 30, 2023 and 2022, respectively. On March 26, 2021, the Company issued and classified its Series A Convertible Preferred Stock as equity securities on its balance sheet. During 2022, the Company issued additional shares of Series A Convertible Preferred Stock, therefore, there were more shares of Series A Convertible Preferred Stock outstanding during the three months ended June 30, 2023 as compared to the three months ended June 30, 2022. On March 4, 2023, the Company issued and classified its Series B Convertible Preferred Stock as equity securities on its balance sheet.

 

Series A Convertible Preferred Stock bear a cumulative dividend at a 10% rate based on its stated/liquidation value. Series B Convertible Preferred Stock bear a cumulative dividend at a 8% rate based on its stated/liquidation value.

 

Net Income (Loss) Applicable to Common Stockholders

 

The Series A and Series B Convertible Preferred Stock issued have dividend and/or distribution preferences over our Common Stock and, therefore, such accrued dividend amounts have been deducted from net income (loss) to report net income (loss) applicable to common stockholders of $(336,410) and $(793,457) for the three months ended June 30, 2023 and 2022, respectively.

 

Basic and Diluted Net Income (Loss) Attributable to Common Stockholders per Share

 

Basic net income (loss) attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net income (loss) attributable to common stockholders per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of shares of Common Stock and dilutive Common Stock Equivalents outstanding during the period. Common Stock Equivalents included in the diluted net income (loss) attributable to common stockholders per share computation represent shares of Common Stock issuable upon the assumed conversion of convertible notes payable, Series A Convertible Preferred Stock and the assumed exercise of stock options and warrants using the treasury stock and “if converted” method. For periods in which net losses attributable to common stockholders are incurred, weighted average shares outstanding is the same for basic and diluted loss per share calculations, as the inclusion of Common Stock Equivalents would have an anti-dilutive effect.

 

44
 

 

The Company incurred a net loss attributable to common stockholders during the three months ended June 30, 2023, and therefore all Common Stock Equivalents were considered antidilutive for fully diluted net loss per share purposes. All of the outstanding convertible notes payable, all of the Series A Convertible Preferred Stock, and all of the outstanding stock options and common stock purchase warrants were determined to be antidilutive and therefore were also excluded from the diluted loss per share calculation. The basic and diluted net income (loss) attributable to common stockholders per share was $(0.01) for the three months ended June 30, 2023.

 

The Company incurred a net loss attributable to common stockholders during the three months ended June 30, 2022, therefore all Common Stock Equivalents were considered anti-dilutive and excluded from diluted net loss attributable to common stockholders per share computations. The basic and diluted net loss attributable to common stockholders per share were $(0.04) for the three months ended June 30, 2022, respectively.

 

Potential Common Stock Equivalents as of June 30, 2023 totaled 119,929,187 shares of Common Stock, which included 17,506,404 shares of Common Stock underlying the convertible notes payable, 65,552,000 shares of Common Stock underlying the conversion of Series A and Series B Convertible Preferred Stock, 35,430,783 shares of Common Stock underlying outstanding warrants and 1,440,000 shares of Common Stock underlying outstanding stock options.

 

For the Six Months Ended June 30, 2023 and 2022

 

Results of Operations

 

Revenue

 

Revenues totaled $12,965 and $68,868 for the six months ended June 30, 2023 and 2022, respectively. The $55,903 or 81% decrease in revenues during the six months ended June 30, 2023 as compared to the same period in 2022 reflects the reduction in oil and gas sales from our Central Kansas Uplift properties due to the wells being down awaiting necessary rework/maintenance.

 

During late 2022, the Company changed its strategy regarding the Central Kansas Uplift properties considering its reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of June 30, 2023 and December 31, 2022 and has reworked one of the conventional wells on the property to produce crude oil from a deeper producing zone. Accordingly, revenues during the six months ended June 30, 2023 was substantially less than the comparable period in 2022.

 

Oil and Gas Lease Operating Expenses

 

Total oil and gas lease operating expenses totaled $163,292 and $142,714 for the six months ended June 30, 2023 and 2022, respectively. The increase in oil and gas lease operating expenses during the six months ended June 30, 2023 as compared to the same period in 2022 is attributable to significant repairs and rework performed in the six months ended June 30, 2023 that did not occur during the six months ended June 30, 2023. The Company has shut down the horizontal production wells on the Central Kansas Uplift Properties as of June 30, 2023 and December 31, 2022 and has reworked one of the conventional wells on the property to produce crude oil from a deeper producing zone. In addition, the Company incurred a $40,000 extension fee relative to the Hugoton Participation Agreement to extend the time period to drill additional wells. Accordingly, oil and gas lease operating expenses during the six months ended June 30, 2023 were substantially higher than the comparable period in 2022.

 

45
 

 

Depreciation, Depletion and Impairment

 

Depreciation, depletion and amortization expense totaled $6,822 and $61,668 during the six months ended June 30, 2023 and 2022, respectively.

 

During late 2022, the Company changed its strategy regarding the Central Kansas Uplift properties considering its reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of June 30, 2023 and December 31, 2022 and has deepened one of the conventional wells on the property to produce crude oil known to be present in deeper producing zones. Accordingly, the Company recorded an impairment charge of $712,812 to reduce the capitalized tangible and intangible costs related to its Central Kansas Uplift properties to zero as of December 31, 2022 which remains in place at June 30, 2023. Depreciation, depletion and impairment expense was reduced substantially during the six months ended June 30, 2023 compared to the six months ended June 30, 2022 as a result of the impairment recognized at December 31, 2022.

 

Accretion of Asset Retirement Obligation

 

Total expense for the accretion of asset retirement obligations was $2,436 and $580 for the six months ended June 30, 2023 and 2022, respectively. The Company recognized additional expenses for its asset retirement obligations relative to both the Central Kansas Uplift and Hugoton Gas Field properties during the six months ended June 30, 2023 as compared to the same period in 2022. The Company commenced production from the Hugoton Gas Field well in late 2022 which began the accretion of its related asset retirement obligations. The obligation relates to legal requirements associated with the retirement of long-lived assets that result from the acquisitions, construction, development, or normal use of the asset. The obligation relates primarily to the requirement to plug and abandon oil and natural gas wells and support wells at the conclusion of their useful lives.

 

Oil and Gas Production Related Taxes

 

Oil and gas production related taxes totaled $-0- and $110 for the six months ended June 30, 2023 and 2022, respectively. Such taxes are deducted from gross oil and gas revenue by the crude oil purchaser upon payment to the Company and include primarily severance taxes imposed by the State of Kansas, and Kansas conservation assessment fees. Revenues totaled $12,965 for the six months ended June 30, 2023, which resulted in the deduction of $-0- in production related taxes due to the shut-down of crude oil production from the Central Kansas Uplift properties in late 2022..

 

Other General and Administrative Expenses

 

Other general and administrative expenses were $531,492 for the six months ended June 30, 2023, a decrease of $316,652, or 37%, from other general and administrative expenses of $848,144 for the six months ended June 30, 2022. The decrease in other general and administrative expenses is primarily attributable to a decrease of $290,440 in stock-based compensation due to the noncash compensation awarded to the Company’s executives, members of the Board of Directors became fully vested in 2023 and therefore a lesser amount of related compensation expense was recorded during the six months ended June 30, 2023 as compared to $608,247 of stock based compensation expense recorded during the six months ended June 30, 2022.

 

Equity in earnings of unconsolidated subsidiary – GMDOC

 

The Company reported equity in earnings of unconsolidated subsidiary of $29,467 for the six months ended June 30, 2023, compared to $114,336 for the six months ended June 30, 2022. Such income resulted from the Company acquiring a 60.7143% membership interest in GMDOC in May 2022. The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

 

GMDOC had previously acquired 70% of the working interests in the GMDOC Leases from Castelli Energy, L.L.C., an Oklahoma limited liability company. The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis. GMDOC, LLC generated $65,575 of net income on $630,215 of oil and gas revenues during the three months ended June 30, 2023. The Company owns a 60.7143% membership interest in such net income or $39,813 which it has reported as equity in earnings of unconsolidated subsidiary – GMDOC during the six months ended June 30, 2023.

 

46
 

 

Interest Expense

 

Interest expense increased to $60,339 for the six months ended June 30, 2023, compared to $425,790 for the six months ended June 30, 2022. The decrease in interest expense during the six months ended June 30, 2023 compared to the same period in 2022 was attributable to $389,651 of amortization of discount on convertible notes payable recorded during the six months ended June 30, 2022. There was no similar amortization of discount on convertible notes payable recorded during the six months ended June 30, 2023.

 

Gain on Extinguishment of Liabilities

 

The Company reported a gain on extinguishment of convertible notes payable of $193,152 and $-0- during the six months ended June 30, 2023 and 2022, respectively.

 

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $100,000 outstanding principal balance of the 8% Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable was cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable. The Company treated the refinancing of the $100,000 8% Note Payable as an extinguishment of the old note which resulted in a gain on extinguishment of $24,190 during the six months ended June 30, 2023.

 

On January 10, 2023, the Company and the holders of the October 8% Notes reached an agreement with respect to the modification/extension of the $500,000 of aggregate outstanding principal balance on its convertible notes payable. On January 10, 2023, the Company and the October 8% Note Holders amended each of the notes by entering into a Letter Agreement between the October 8% Note Investors and the Company. The Letter Agreement modifies the terms of the October 8% Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes. The Company treated the refinancing as an extinguishment of the old notes which resulted in a gain on extinguishment of $103,977 during the six months ended June 30, 2023.

 

On January 10, 2023, the Company and the two May 2022 Note Holders reached an agreement with respect to the modification/extension of the $312,500 of aggregate outstanding principal balance on its convertible notes payable. On January 10, 2023, the Company amended each of those notes by entering into a Letter Agreement between the investors and the Company. The Letter Agreement modifies the terms of the May 2022 Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes. The Company treated the refinancing as an extinguishment of the old notes which resulted in a gain on extinguishment of $64,985 during the six months ended June 30, 2023.

 

Change in Warrant Derivative Fair Value

 

The change in warrant derivative liability was a gain of $367,175 during the six months ended June 30, 2023, as compared to a gain of $-0- during the six months ended June 30, 2022. The estimated fair value of the Company’s derivative liabilities, all of which were related to the detachable warrants issued in connection with the issuance of Series A Convertible Preferred Stock, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates. The detachable warrants issued in connection with the issuance of certain Series A Convertible Preferred Stock contained a provision allowing the holder to require cash settlement in certain situations were fundamental transaction, as defined in the warrant agreements have occurred. An event occurred on December 31, 2022 that activated the Holder’s ability to utilize such provisions, therefore the derivative liability was recognized on December 31, 2022 and June 30, 2023. Management estimated the fair value of the underlying derivative utilizing the black-scholes methodology as of June 30, 2023 and December 31, 2023 with the change in fair value being recognized as the change in warrant derivative fair value for the six months ended June 30, 2023.

 

47
 

 

Income Tax

 

The Company recorded no income tax benefit (expense) in the six months ended June 30, 2023 and 2022. The Company has been in a cumulative tax loss position and has substantial net operating loss carryforwards available for its utilization at June 30, 2023. The Company has continued to carry a 100% reserve on its net deferred tax assets and therefore recorded no income tax expense or benefit on its income (loss) before income taxes during the six months ended June 30, 2023 and 2022.

 

Net Income (Loss)

 

The Company reported net loss of $161,622 for the six months ended June 30, 2023, compared to a net loss of $1,295,802 for the six months ended June 30, 2022. This represents an improvement of $1,134,180 for the six months ended June 30, 2023 compared to the six months ended June 30, 2022.

 

Convertible Preferred Stock Dividends

 

The Company recorded $136,057 and $105,150 in Series A and Series B Convertible Preferred Stock dividends in the six months ended June 30, 2023 and 2022, respectively. On March 26, 2021, the Company issued and classified its Series A Convertible Preferred Stock as equity securities on its balance sheet. During 2022, the Company issued additional shares of Series A Convertible Preferred Stock, therefore, there were more shares of Series A Convertible Preferred Stock outstanding during the three months ended June 30, 2023 as compared to the three months ended June 30, 2022. On March 4, 2023, the Company issued and classified its Series B Convertible Preferred Stock as equity securities on its balance sheet.

 

Series A Convertible Preferred Stock bear a cumulative dividend at a 10% rate based on its stated/liquidation value. Series B Convertible Preferred Stock bear a cumulative dividend at a 8% rate based on its stated/liquidation value.

 

Net Income (Loss) Applicable to Common Stockholders

 

The Series A and Series B Convertible Preferred Stock issued have dividend and/or distribution preferences over our Common Stock and, therefore, such accrued dividend amounts have been deducted from net income (loss) to report net income (loss) applicable to common stockholders of $(297,679) and $(1,400,952) for the six months ended June 30, 2023 and 2022, respectively.

 

Basic and Diluted Net Income (Loss) Attributable to Common Stockholders per Share

 

Basic net income (loss) attributable to common stockholders per share is computed by dividing the net loss attributable to common stockholders by the weighted-average number of shares of Common Stock outstanding during the period. Diluted net income (loss) attributable to common stockholders per share is computed by dividing the net income (loss) attributable to common stockholders by the weighted-average number of shares of Common Stock and dilutive Common Stock Equivalents outstanding during the period. Common Stock Equivalents included in the diluted net income (loss) attributable to common stockholders per share computation represent shares of Common Stock issuable upon the assumed conversion of convertible notes payable, Series A Convertible Preferred Stock and the assumed exercise of stock options and warrants using the treasury stock and “if converted” method. For periods in which net losses attributable to common stockholders are incurred, weighted average shares outstanding is the same for basic and diluted loss per share calculations, as the inclusion of Common Stock Equivalents would have an anti-dilutive effect.

 

The Company incurred a net loss attributable to common stockholders during the six months ended June 30, 2023, and therefore all Common Stock Equivalents were considered antidilutive for fully diluted net loss per share purposes. All of the outstanding convertible notes payable, all of the Series A Convertible Preferred Stock, and all of the outstanding stock options and common stock purchase warrants were determined to be antidilutive and therefore were also excluded from the diluted loss per share calculation. The basic and diluted net income (loss) attributable to common stockholders per share was $(0.01) for the six months ended June 30, 2023.

 

The Company incurred a net loss attributable to common stockholders during the six months ended June 30, 2022, therefore all Common Stock Equivalents were considered anti-dilutive and excluded from diluted net loss attributable to common stockholders per share computations. The basic and diluted net loss attributable to common stockholders per share were $(0.07) for the six months ended June 30, 2022, respectively.

 

48
 

 

Potential Common Stock Equivalents as of June 30, 2023 totaled 119,929,187 shares of Common Stock, which included 17,506,404 shares of Common Stock underlying the convertible notes payable, 65,552,000 shares of Common Stock underlying the conversion of Series A and Series B Convertible Preferred Stock, 35,430,783 shares of Common Stock underlying outstanding warrants and 1,440,000 shares of Common Stock underlying outstanding stock options.

 

Liquidity and Capital Resources; Going Concern–

 

We have had a history of losses and have generated little or no operating revenues for a number of years. In 2020, we began assessing various opportunities and strategic alternatives involving the acquisition, exploration and development of gas and oil properties in the United States, including the possibility of acquiring businesses or assets that provide support services for the production of oil and gas in the United States. As a result, we: 1) acquired the Properties, 2) entered into the Hugoton JV and 3) entered into the GMDOC venture.

 

The planned development of the development projects previously identified will require us to raise additional capital to accomplish our operating plan, which cannot be assured. Historically, we financed our operations through the issuance of equity and various short and long-term debt financing that contained some level of detachable warrants to provide the holders with a level of equity participation.

 

At the present time, we do not have arrangements to raise additional capital, and we may need to identify potential investors and negotiate appropriate arrangements with them. We may not be able to arrange enough investment within the time the investment is required or that if it is arranged, that it will be on favorable terms. If we cannot obtain the needed capital, we may not be able to become profitable and may have to curtail or cease our operations. Additional equity financing, if available, may be dilutive to the holders of our capital stock. Debt financing may involve significant cash payment obligations, covenants and financial ratios that may restrict our ability to operate and grow our business.

 

Capital Raised

 

Historically, we have raised funds through various equity and debt instruments through private transactions. The Company was able to raise liquidity during 2022 through the issuance of debt and equity in private transactions with accredited investors. These financial instruments generally require the Company to register the Common Stock underlying the conversion of the Series A Convertible Preferred Stock, the Common Stock purchase warrants and the convertible notes payable. These issuances generally provide the holders with a right to participate in future capital raises and require their approval for the future issuance of securities at rates less than their purchase price. The holders have also agreed that the conversion of the Series A Convertible Preferred Stock, the convertible notes payable and the exercise of the underlying warrants are generally subject to beneficial ownership limitations such that each holder of the financial instruments individually may not convert the underlying Series A Convertible Preferred Stock, convertible notes payable or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the holders individually being the beneficial owner in excess of 4.99% (or, upon election of the holders, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

Designation of Series B Convertible Preferred Stock

 

On May 3, 2023, the Company filed the Certificate of Designation (the “Certificate of Designation”) with the Secretary of State of the State of Nevada (the “Nevada Secretary of State”), establishing the rights, preferences, privileges, qualifications, restrictions, and limitations relating to the Series B Convertible Preferred Stock, par value $0.0001 per share (the “Series B Convertible Preferred Stock”). The Certificate of Designation became effective upon filing with the Nevada Secretary of State.

 

Pursuant to the provisions of the Certificate of Designation of Preferences, Rights and Limitations of the Series B Preferred Stock (the “Certificate of Designation”) the Company is authorized to issue up to 50,000 shares of Series B Preferred from time to time with a Stated Value/Liquidation Value of $100 per share. Each share of Series B Preferred Stock is convertible, at the option of the holders thereof, at any time, subject to certain beneficial ownership limitations, into shares of Common Stock determined on a per share basis by dividing the Stated Value of such share of Preferred Stock (as such term is defined in the Certificate of Designation) by the Conversion Price (as such term is defined in the Certificate of Designation), which Conversion Price is subject to certain adjustments. In addition, the Certificate of Designation also provides for the payment of dividends, in (I) cash, or (ii) shares of Common Stock, to the holders of the Series B Preferred Stock, of 8% per annum, based on the Stated Value, until the earlier of (i) the date on which the shares of Series B Preferred Stock are converted to Common Stock or (ii) date the Company’s obligations under the Certificate of Designation have been satisfied in full. The shares of Series B Preferred Stock also (i) vote on an as-converted to Common Stock basis, subject to certain beneficial ownership limitations, (ii) are redeemable at the option of the Company at any time, (iii) rank senior to the Common Stock and any class or series of capital stock created after the Series B Preferred Stock and (iv) have a special preference upon the liquidation of the Company.

 

49
 

 

Issuance of Series B Convertible Preferred Stock

 

May 2023 Issuance - On May 4, 2023, the Company entered into a securities purchase agreement with three (3) accredited investors providing for an aggregate investment of $750,000 by the investors for the issuance by the Company to them of (i) 7,500 shares of Series B Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “May 2023 Series B Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 15,000,000 shares of Common Stock at an exercise price of five ($0.05) cents per share, subject to customary adjustments thereunder. The 7,500 shares of May 2023 Series B Convertible Preferred Stock are convertible into an aggregate of up to 15,000,000 shares of Common Stock. Holders of the warrants may exercise the warrants by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. The Company used the proceeds of the May 2023 Series B Convertible Preferred Stock offering for general working capital purposes.

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the May 2023 Series B Convertible Preferred Stock transaction, to register the shares of Common Stock issuable upon the conversion of the May 2023 Series B Convertible Preferred Stock and the common stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the issuance of the May 2023 Series B Convertible Preferred Stock.

 

The holders of the May 2023 Series B Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its May 2023 Series B Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

The Securities Purchase Agreement also contains customary representations, warranties and agreements of the Company and the Investors and customary indemnification rights and obligations of the parties thereto.

 

We will likely continue to issue such convertible preferred stock and convertible notes payable with detachable warrants to acquire Common Stock to fund our operational and capital expenditure plans for the remainder of 2023.

 

Capital Expenditures

 

As of June 30, 2023, we had: 1) acquired the Properties, 2) entered into the Hugoton JV and 3) entered into the GMDOC venture as more fully described elsewhere in this Quarterly Report on Form 10-Q.

 

Going Concern

 

The Company has incurred losses from operations, has a stockholders’ deficit, incurred net cash used in operating activities and has a significant working capital deficit as of and for the three and six months ended June 30, 2023 and as of and for the year ended December 31, 2022. The Company must raise substantial amounts of debt and equity capital from other sources in the future in order to fund (i) the development of the Properties acquired on April 1, 2021; (ii) our obligations for exploration and development under the Hugoton Farmout Agreement; (iii) normal day-to-day operations and corporate overhead; and (iv) outstanding debt and other financial obligations as they become due, as described below. Most of the Company’s outstanding debt and other financial obligations are currently past due and the Company must negotiate forbearance and/or restructuring agreements with the holders of such debt. These are substantial operational and financial issues that must be successfully addressed during 2023 and beyond.

 

50
 

 

The Company has made substantial progress in resolving many of its existing financial obligations and acquiring oil and gas producing properties to deploy its new operational strategy during the period through June 30, 2023.

 

The Company will have significant financial commitments executing its planned exploration and development of the Properties and the Hugoton Gas Field. The Company may find it necessary to raise substantial amounts of debt or equity capital to fund such exploration and development activities and may seek offers from industry operators and other third parties for interests in the Properties in exchange for cash and a carried interest in exploration and development operations or other joint venture arrangement. There can be no assurance that it will be able to obtain such new funding or be able to reach agreements with industry operators and other third parties or on what terms.

 

Due to the uncertainties related to the foregoing matters, there exists substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financials are issued. The unaudited condensed financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

 

Cash and cash equivalents balances-

 

As of June 30, 2023, we had cash and cash equivalents with an aggregate balance of $412,793, an increase from a balance of $10,163 as of December 31, 2022. Summarized immediately below and discussed in more detail in the subsequent subsections are the main elements of the $402,630 net increase in cash during the six months ended June 30, 2023:

 

  Operating activities: $281,605 of net cash used in operating activities. Net cash used in operating activities was $281,605 and $143,253 for the six months ended June 30, 2023 and 2022, respectively, a deterioration in net cash used in operating activities of $138,352. The improvement in net cash used in operating activities was primarily the result of our improvement in net income (loss) in 2023 compared to 2022. Our net loss reported for 2023 was offset by increases in non-cash income including the change in warrant derivative liability and the gain on extinguishment of convertible notes payable as reflected in our cash flows from operating activities for the six months ended June 30, 2023 compared to the same period in 2022.

 

  Investing activities: $-0- of net cash used in investing activities. Cash used in investing activities was $-0- for the six months ended June 30, 2023 compared to $1,179,977 for the six months ended June 30, 2022. We utilized funds during 2022 to acquire our $850,000 investment in unconsolidated subsidiary – GMDOC, LLC, our $314,753 investment in the Hugoton Gas Field participation agreement and our purchase of equipment for our Central Kansas Uplift properties.
       
  Financing activities: $684,235 of net cash provided by financing activities. Cash provided by financing activities for the six months ended June 30, 2023 was $684,235 compared to cash provided by financing activities of $1,169,850 for the six months ended June 30, 2022. We raised $750,000 through the issuance of Series B Convertible Preferred Stock in 2023 and $500,000 through the issuance of Series A Convertible Preferred Stock in 2022. We raised $1,200,000 through the issuance of convertible notes in 2022 and also paid-off $425,000 in convertible notes in 2022. We paid cash dividends of $65,765 and $105,150 on our Series A and Series B Convertible Preferred Stock during the six months ended June 30, 2023 and 2022, respectively.

 

The net result of these activities was a $402,630 increase in cash and cash equivalents from $10,163 as of December 31, 2022 to $412,793 as of June 30, 2023.

 

51
 

 

Commitments:

 

Capital Expenditures. We had no material commitments for capital expenditures at June 30, 2023. However, we are required by the Hugoton Gas Field Farmout Agreement to drill at least three additional gas production wells in 2023 and 2024 in order to maintain the Hugoton JV. We drilled and completed the first Hugoton Gas Field production well in May 2022, which was connected to the pipeline and commenced production on August 17, 2022. We estimate that the expenses related to the drilling program to be approximately $350,000 for drilling and completion of each additional exploratory well. The Company is considering paying $40,000 to extend the time period under which it is required to drill the additional three exploratory wells pursuant to the Hugoton Gas Field Participation Agreement.

 

Repayment of Debt. Debt obligations are comprised of the following at June 30, 2023:

 

   June 30, 2023 
Notes payable:     
      
3% convertible notes payable due March 30, 2026 (the 3% Notes)  $28,665 
8% convertible notes payable due September 30, 2023 (the October 8% Notes)   500,000 
8% convertible note payable due September 30, 2023 (the 8% Note)   100,000 
8% convertible note payable due October 29, 2022 (the Second 8% Note) (in default)   50,000 
8% Convertible promissory notes payable due September 30 2023 (the June 2022 Note)   350,000 
8% Convertible promissory notes payable due September 30, 2023 (the May 2022 Notes)   266,204 
      
Total notes payable   1,294,869 
Less: Long-term portion   28,665 
Notes payable, short-term  $1,266,204 

 

Debt obligations become due and payable as follows:

 

Years ended 

Principal

balance due

 
     
2023 (Ju1y 1, 2023 through December 31, 2023)  $1,266,204 
2024    
2025    
2026   28,665 
2027    
2028    
Total  $1,294,869 

 

With respect to the 8% convertible note payable due October 29, 2022 (the Second 8% Note) which is currently in default, the parties are negotiating a forbearance/resolution to such technical defaults which include several alternatives. Such negotiations include i) a reduction in the conversion price of the underlying convertible notes, ii) an extension and a roll-over of the principal into other Company securities, and iii) a combination of the alternatives. The Company can provide no assurance that the parties will reach a mutually agreeable resolution.

 

Open Litigation.

 

The nature of the Company’s business exposes its properties, the Company, the Hugoton JV and its interest in GMDOC to the risk of claims and litigation in the normal course of business. Other than as noted elsewhere in this Quarterly Report on Form 10-Q, in our Notes to the Unaudited condensed Financial Statements or routine litigation arising out of the ordinary course of business, the Company is not presently subject to any material litigation nor, to its knowledge, is any material litigation threatened against the Company.

 

52
 

 

Contractual Obligations

 

USNG Letter Agreement - Pursuant to the USNG Letter Agreement, the Company is required to pay USNG a $8,000 monthly cash fee beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore, there has been no payment or accrual liability relative to this cash fee provision through June 30, 2023.

 

Farmout Agreement to Explore and Develop Unconventional Gas and Brine Materials in the Hugoton Gas Field - On April 4, 2022, the Company acquired a 40% interest in a Farm-Out Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Farmout Agreement covers drilling and completion of up to 50 wells and the Company has joined three other entities in the Hugoton JV to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement Farm-Out Agreement.

 

The Hugoton JV will utilize Scout Energy Partner’s existing infrastructure assets, including water disposal, gas gathering and helium processing. In addition, the Farmout Agreement provides the Hugoton JV with rights to take in-kind and market its share of helium at the tailgate of Jayhawk Gas Plant, located in Grant County, Kansas, which will enable the Hugoton JV to market and sell the helium produced at prevailing market prices. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout and whether it should attempt to extend the time period before it has to drill additional wells in Hugoton Gas Field per the farm-out agreement.

 

Inflation and Seasonality

 

Inflation in general has had a material effect on us during the six months ended June 30, 2023 and we do believe that inflation will continue to significantly impact our business during the remainder of 2023 and perhaps beyond. We do not believe that our business is seasonal in nature.

 

In addition, our oil and gas lease operating expenses have been substantially impacted by the COVID-19 pandemic and the Russian war in Ukraine, which has restricted the supply of production pipe and other materials used in the drilling and rework of oil and gas wells. In addition, experienced oil and gas service professionals have been in high demand in the oil and gas service sector and thereby increasing the cost of oil and gas well services. We expect this trend to continue during 2023 and perhaps beyond.

 

Critical Accounting Policies

 

A critical accounting policy is defined as one that is both material to the presentation of our financial statements and requires management to make difficult, subjective, or complex judgments that could have a material effect on our financial condition and results of operations. Specifically, critical accounting estimates have the following attributes: 1) we are required to make assumptions about matters that are highly uncertain at the time of the estimate; and 2) different estimates we could reasonably have used, or changes in the estimate that are reasonably likely to occur, would have a material effect on our financial condition or results of operations.

 

Estimates and assumptions about future events and their effects cannot be determined with certainty. We base our estimates on historical experience and on various other assumptions believed to be applicable and reasonable under the circumstances. These estimates may change as new events occur, as additional information is obtained and as our operating environment changes. These changes have historically been minor and have been included in the financial statements as soon as they became known. Based on a critical assessment of our accounting policies and the underlying judgments and uncertainties affecting the application of those policies, management believes that our financial statements are fairly stated in accordance with accounting principles generally accepted in the United States and present a meaningful presentation of our financial condition and results of operations. We believe the following critical accounting policies reflect our more significant estimates and assumptions used in the preparation of our financial statements:

 

53
 

 

Note 1 – Going Concern Analysis - In accordance with Accounting Standards Update (“ASU”) 2014-15, Presentation of Financial Statements- Going Concern (Subtopic 205-40) – Disclosure of Uncertainties about an Entity’s Ability to Continue as a Going Concern, we are required to evaluate whether there are conditions or events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that our financials are issued. When management identifies conditions or events that raise substantial doubt about their ability to continue as a going concern it should consider whether its plans to mitigate those relevant conditions or events will alleviate the substantial doubt. If conditions or events raise substantial doubt about an entity’s ability to continue as a going concern, but the substantial doubt is alleviated as a result of management’s plans, the entity should disclose information that enables user of financial statements to understand the principal events that raised the substantial doubt, management’s evaluation of the significance of those conditions or events, and management’s plans that alleviated substantial doubt about the entity’s ability to continue as a going concern.

 

We performed the analysis and our overall assessment was there were conditions or events, considered in the aggregate, which raised substantial doubt about our ability to continue as a going concern within the next year, but such doubt was not adequately mitigated by our plans to address the substantial doubt as disclosed in Note 1 of the Notes to the Financial Statements.

 

Note 2 – Oil and Gas Properties and Equipment – The Company was required to perform an allocation of the purchase price for the acquisition of the Properties and to provide the estimated useful lives assigned to the related equipment purchased.

 

In addition, the accounting for, and disclosure of, oil and gas producing activities require that we choose between two alternatives under accounting principles generally accepted in the United States (“GAAP”): the full cost method or the successful efforts method. We adopted and use the full cost method of accounting, which involves capitalizing all exploration, exploitation, development and acquisition costs. Once we incur costs, they are recorded in the depletable pool of proved properties or in unproved properties, collectively, the full cost pool. Our unproved property costs, which include unproved oil and gas properties, properties under development, and major development projects, were zero through June 30, 2023 and December 31, 2022, and are not subject to depletion. We review our unproved oil and gas property costs on a quarterly basis to assess for impairment and transfer unproved costs to proved properties as a result of extensions or discoveries from drilling operations or determination that no proved reserves are attributable to such costs. We expect these costs to be evaluated in one to seven years and transferred to the depletable portion of the full cost pool during that time. The full cost pool is comprised of intangible drilling costs, lease and well equipment and exploration and development costs incurred plus acquired proved and unproved leaseholds.

 

Note 3 – Investment in unconsolidated subsidiary – GMDOC - The Company’s investment in its unconsolidated subsidiary - GMDOC requires that the Company assess its control over the operations of GMDOC.

 

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

 

Note 4 – Debt Obligations – The Company has issued various debt and equity securities that require the Company to estimate the fair value of the debt, its embedded features and any related detachable warrants or other equity-related securities issued. Management must make significant assumption/estimates in order to allocate the proceeds of the issuance of the convertible debt securities between its debt and equity components.

 

Note 6 – Stock Options - The Company follows the fair value recognition provisions of Accounting Standards Codification (“ASC”) 718. Stock-based compensation expense is recognized in the financial statements for granted, modified, or settled stock options based on estimated fair values. The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the expected term of the option award, expected stock price volatility and expected dividends. These estimates involve inherent uncertainties and the application of management judgment.

 

Note 7 – Warrants - The Company has issued various debt and equity securities (including detachable warrants) that require the Company to estimate the fair value of the debt, its embedded features and any related detachable warrants or other equity-related securities issued. Management must make significant assumption/estimates in order to allocate the proceeds of the issuance of the convertible debt securities between its debt and equity components.

 

54
 

 

Note 8 – Income Taxes - Accounting for income taxes requires significant estimates and judgments on the part of management. Such estimates and judgments include, but are not limited to, the effective tax rate anticipated to apply to tax differences that are expected to reverse in the future, the sufficiency of taxable income in future periods to realize the benefits of net deferred tax assets and net operating losses currently recorded and the likelihood that tax positions taken in tax returns will be sustained on audit.

 

Note 11 – Warrant Derivative Liabilities - Accounting for warrant derivative liabilities requires significant estimates and judgments on the part of management. The estimated fair value of the Company’s warrant derivative liabilities, all of which were related to the detachable warrants issued in connection with various notes payable, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates.

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

Not Applicable.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures to provide reasonable assurance of achieving the control objectives, as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Based on their evaluation as of June 30, 2023, the end of the period covered by this Quarterly Report on Form 10-Q, our principal executive officer and principal financial officer concluded that the Company’s disclosure controls and procedures are not effective in assuring that financial statement presentation and disclosure are in conformity with those which are required to be included in our periodic SEC filings.

 

Changes in Internal Control Over Financial Reporting

 

There have been no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that have materially affected or are reasonably likely to materially affect our internal control over financial reporting.

 

Internal control systems, no matter how well designed and operated, have inherent limitations. Therefore, even a system which is determined to be effective cannot provide absolute assurance that all control issues have been detected or prevented. Our systems of internal controls are designed to provide reasonable assurance with respect to financial statement preparation and presentation.

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

The information regarding certain legal proceedings in which the Company is involved is set forth in Note 12, Commitments and Contingencies – Litigation of the Notes to the Unaudited condensed Financial Statements (Part I, Item 1 of this Quarterly Report on Form 10-Q), and such information is incorporated by reference into this Item 1.

 

In addition to such legal proceedings, we may become involved in various other claims and threatened legal proceedings arising in the normal course of our businesses. At this time, we do not believe any material losses under such other claims and threatened proceedings to be probable. While the ultimate outcome of such legal proceedings cannot be predicted with certainty, it is in the opinion of management, after consultation with legal counsel, that the final outcome in such proceedings, in the aggregate, would not have a material adverse effect on our financial condition, results of operations or cash flows.

 

ITEM 1A. RISK FACTORS

 

As a smaller reporting company, we are not required to provide the information required by this Item.

 

55
 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

There were no sales of unregistered securities during the quarter that were not previously reported on a Current Report on Form 8-K except as set forth below.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

8% Convertible Notes Payable due October 29, 2022 (the Second 8% Note)

 

The Company did not pay the principal balance due on this Convertible Note with an outstanding principal balance of $50,000 upon its maturity on October 29, 2022 and the remaining balance remains due and payable and is therefore in technical default. The parties are negotiating a resolution to such technical default including an extension and a roll-over of the principal into other Company securities, although there can be no assurance that the parties will reach a mutually agreeable resolution.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

None.

 

ITEM 5. OTHER INFORMATION

 

None.

 

ITEM 6. EXHIBITS

 

(c) Exhibits.

 

Exhibit Number   Description
3.1   Articles of Incorporation filed with the Secretary of State of the State of Nevada on November 23, 2021 (Incorporated by reference to Exhibit 3.3 of the Current Report on Form 8-K filed by American Noble Gas Inc on December 13, 2021.)
     
3.2   Bylaws of American Noble Gas Inc., adopted effective October 22, 2021 (Incorporated by reference to Exhibit 3.4 of the Current Report on Form 8-K filed by American Noble Gas Inc on December 13, 2021.)
     
10.1   Letter Agreement dated January 10, 2023 (Incorporated by reference to Exhibit 10.1 of the Current Report on Form 8-K filed by American Noble Gas Inc on January 13, 2023.)
     
31.1   Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
     
31.2   Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
     
32.1*   Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. (Filed herewith.)
     
101.INS   Inline XBRL Instance Document.
     
101.SCH   Inline XBRL Taxonomy Extension Schema Document. (Filed herewith.)
     
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document. (Filed herewith.)
     
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document. (Filed herewith.)
     
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document. (Filed herewith.)
     
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document. (Filed herewith.)
     
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
    * This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended.

 

56
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: August 11, 2023

 

  AMERICAN NOBLE GAS INC,
  a Nevada corporation
     
  By: /s/ Thomas J. Heckman
    Thomas J. Heckman
    Chief Executive Officer and Chief Financial Officer

 

57

 

 

EXHIBIT 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)

 

I, Thomas J. Heckman, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of American Noble Gas Inc.;

 

2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period(s) in which this Report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting

 

/s/ Thomas J. Heckman  
Thomas J. Heckman  

Chief Executive Officer

(Principal Executive Officer)

 
August 11, 2023  

 

 

 

EXHIBIT 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO EXCHANGE ACT RULES 13a-14(a) AND 15d-14(a)

 

I, Thomas J. Heckman, certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of American Noble Gas Inc.;

 

2. Based on my knowledge, this Report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3. Based on my knowledge, the financial statements, and other financial information included in this Report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its subsidiaries, is made known to us by others within those entities, particularly during the period(s) in which this Report is being prepared;

 

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an Annual Report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

 

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting

 

/s/ Thomas J. Heckman  
Thomas J. Heckman  

Chief Financial Officer

(Principal Financial Officer)

 
August 11, 2023  

 

 

 

EXHIBIT 32.1

 

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

 

In connection with the Quarterly Report of American Noble Gas Inc. (the “Company”) on Form 10-Q for the period ended June 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned hereby certifies, pursuant to 18 U.S.C. §1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

/s/ Thomas J. Heckman  
Thomas J. Heckman  

Chief Executive Officer

(Principal Executive Officer)

 

Chief Financial Officer

(Principal Financial Officer)

 
August 11, 2023  

 

 

v3.23.2
Cover - shares
6 Months Ended
Jun. 30, 2023
Aug. 10, 2023
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Jun. 30, 2023  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2023  
Current Fiscal Year End Date --12-31  
Entity File Number 000-17204  
Entity Registrant Name AMERICAN NOBLE GAS INC  
Entity Central Index Key 0000822746  
Entity Tax Identification Number 87-3574612  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One 15612 College Blvd  
Entity Address, City or Town Lenexa  
Entity Address, State or Province KS  
Entity Address, Postal Zip Code 66219  
City Area Code (913)  
Local Phone Number 955-0532  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   22,924,515
v3.23.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 412,793 $ 10,163
Accrued receivable 24,086 47,423
Prepaid expenses 20,506 12,617
Total current assets 457,385 70,203
Oil and gas properties and equipment:    
Oil and gas properties and equipment 1,217,016 1,217,026
Accumulated depreciation, depletion and impairment (1,135,151) (1,128,339)
Property and equipment, net 81,865 88,687
Investment in unconsolidated subsidiary – GMDOC, LLC 1,130,928 1,101,461
Total assets 1,670,178 1,260,351
Current liabilities:    
Accounts payable 1,447,764 1,387,893
Accrued liabilities 1,201,037 1,159,403
Accrued interest - $1,925 and $1,501 to related parties as of June 30, 2023 and December 31, 2022, respectively 72,975 244,038
Accrued dividends 147,416 77,124
Warrant derivative liability 210,094 577,269
Convertible notes payable, net of unamortized discount 1,266,204 1,312,500
Total current liabilities 4,345,490 4,758,227
Asset retirement obligations 1,734,922 1,732,486
Convertible promissory notes, net of unamortized discount - related parties 28,665 28,665
Total liabilities 6,109,077 6,519,378
Commitments and contingencies (Note 12)
Stockholders’ deficit:    
Common Stock, par value $0.0001 per share, 500,000,000 shares authorized, 22,924,515 shares issued and outstanding at June 30, 2023 and 21,924,515 shares issued and outstanding at December 31, 2022 2,292 2,192
Additional paid-in capital 118,350,847 117,369,198
Accumulated deficit (122,792,042) (122,630,420)
Total stockholders’ deficit (4,438,899) (5,259,027)
Total liabilities and stockholders’ deficit 1,670,178 1,260,351
Series A Convertible Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred stock, value 3 3
Series B Convertible Preferred Stock [Member]    
Stockholders’ deficit:    
Preferred stock, value $ 1
v3.23.2
Condensed Balance Sheets (Parenthetical) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 10,000,000 10,000,000
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 500,000,000 500,000,000
Common stock, shares issued 22,924,515 21,924,515
Common stock, shares outstanding 22,924,515 21,924,515
Series A Convertible Preferred Stock [Member]    
Preferred stock, shares authorized 27,778 27,778
Preferred stock liquidation preference, per share value $ 100 $ 100
Preferred stock, shares issued 25,276 25,526
Preferred stock, shares outstanding 25,276 25,526
Series B Convertible Preferred Stock [Member]    
Preferred stock, shares authorized 50,000 50,000
Preferred stock liquidation preference, per share value $ 100 $ 100
Preferred stock, shares issued 7,500 0
Preferred stock, shares outstanding 7,500 0
Related Party [Member]    
Accrued liabilities due to related party $ 1,925 $ 1,501
v3.23.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Income Statement [Abstract]        
Revenues $ 4,041 $ 43,563 $ 12,965 $ 68,868
Operating expenses:        
Oil and gas lease operating expense 133,687 56,178 163,292 142,714
Depreciation, depletion and amortization 3,411 30,834 6,822 61,668
Accretion of asset retirement obligation 1,218 302 2,436 580
Oil and gas production related taxes 82 110
Other general and administrative expenses 119,644 479,437 531,492 848,144
Total operating expenses 257,960 566,833 704,042 1,053,216
Operating loss (253,919) (523,270) (691,077) (984,348)
Other income (expense):        
Equity in earnings of unconsolidated subsidiary – GMDOC, LLC (10,346) 114,336 29,467 114,336
Interest expense (22,927) (332,234) (60,339) (425,790)
Gain on exchange and extinguishment of liabilities 24,190 193,152
Change in warrant derivative fair value (292) 367,175
Total other income (expense) (9,375) (217,898) 529,455 (311,454)
Loss before income taxes (263,294) (741,168) (161,622) (1,295,802)
Income tax (expense) benefit
Net loss (263,294) (741,168) (161,622) (1,295,802)
Convertible preferred stock dividends (73,116) (52,289) (136,057) (105,150)
Net loss attributable to common stockholders $ (336,410) $ (793,457) $ (297,679) $ (1,400,952)
Basic and diluted net loss per share:        
Basic $ (0.01) $ (0.04) $ (0.01) $ (0.07)
Diluted $ (0.01) $ (0.04) $ (0.01) $ (0.07)
Weighted Average Number of Shares Outstanding, Basic 22,524,515 20,550,904 22,441,182 19,882,501
Weighted Average Number of Shares Outstanding, Diluted 22,524,515 20,550,904 22,441,182 19,882,501
v3.23.2
Condensed Statements of Changes in Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Preferred Stock [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2021 $ 2 $ 1,901 $ 115,522,952 $ (118,690,345) $ (3,165,490)
Balance, shares at Dec. 31, 2021 22,076 19,012,015      
Stock-based compensation 229,906 229,906
Issuance of common stock pursuant to conversion of convertible preferred stock $ 25 (25)
Issuance of common stock pursuant to conversion of convertible preferred stock, shares (800)   250,000      
Accrual of preferred stock dividends (52,861) (52,861)
Net income (loss) (554,634) (554,634)
Balance at Mar. 31, 2022 $ 2 $ 1,926 115,699,972 (119,244,979) (3,543,079)
Balance, shares at Mar. 31, 2022 21,276 19,262,015      
Balance at Dec. 31, 2021 $ 2 $ 1,901 115,522,952 (118,690,345) (3,165,490)
Balance, shares at Dec. 31, 2021 22,076 19,012,015      
Net income (loss)           (1,295,802)
Balance at Jun. 30, 2022 $ 2 $ 2,183 116,858,495 (119,986,147) (3,125,467)
Balance, shares at Jun. 30, 2022 24,376 21,830,765      
Balance at Mar. 31, 2022 $ 2 $ 1,926 115,699,972 (119,244,979) (3,543,079)
Balance, shares at Mar. 31, 2022 21,276 19,262,015      
Stock-based compensation 378,341 378,341
Accrual of preferred stock dividends (52,289) (52,289)
Net income (loss) (741,168) (741,168)
Issuance of common stock in association with the issuance of convertible bridge notes payable $ 42 196,112 196,154
Issuance of common stock in association with the issuance of convertible bridge notes payable, shares     425,000      
Issuance of restricted common stock as compensation $ 155 (155)
Issuance of restricted common stock as compensation, shares     1,550,000      
Issuance of detachable warrants to purchase common stock in association with issuance of convertible bridge note payable 136,574 136,574
Issuance of Series A preferred stock with detachable common stock purchase warrants $ 1 499,999 500,000
Issuance of Series A preferred stock with detachable common stock purchase warrants, shares 5,000          
Issuance of common stock upon conversion Series A Convertible Preferred Stock $ (1) $ 60 (59)
Issuance of common stock upon conversion, shares (1,900)   593,750      
Balance at Jun. 30, 2022 $ 2 $ 2,183 116,858,495 (119,986,147) (3,125,467)
Balance, shares at Jun. 30, 2022 24,376 21,830,765      
Balance at Dec. 31, 2022 $ 3 $ 2,192 117,369,198 (122,630,420) (5,259,027)
Balance, shares at Dec. 31, 2022 25,526 21,924,515      
Stock-based compensation 246,091 246,091
Accrual of preferred stock dividends (62,941) (62,941)
Net income (loss) 101,672 101,672
Issuance of common stock upon conversion convertible notes payable and accrued interest $ 50 49,950 50,000
Issuance of common stock upon conversion, shares     500,000      
Balance at Mar. 31, 2023 $ 3 $ 2,242 117,602,298 (122,528,748) (4,924,205)
Balance, shares at Mar. 31, 2023 25,526 22,424,515      
Balance at Dec. 31, 2022 $ 3 $ 2,192 117,369,198 (122,630,420) (5,259,027)
Balance, shares at Dec. 31, 2022 25,526 21,924,515      
Net income (loss)           (161,622)
Balance at Jun. 30, 2023 $ 3 $ 1 $ 2,292 118,350,847 (122,792,042) (4,438,899)
Balance, shares at Jun. 30, 2023 25,276 7,500 22,924,515      
Balance at Mar. 31, 2023 $ 3 $ 2,242 117,602,298 (122,528,748) (4,924,205)
Balance, shares at Mar. 31, 2023 25,526 22,424,515      
Stock-based compensation 71,716 71,716
Accrual of preferred stock dividends (73,116) (73,116)
Net income (loss) (263,294) (263,294)
Issuance of common stock upon conversion Series A Convertible Preferred Stock 50 (50)
Issuance of common stock upon conversion, shares (250)         500,000
Issuance of Series B Convertible Preferred stock with detachable common stock purchase warrants for cash $ 1 749,999   $ 750,000
Issuance of Series B Convertible Preferred stock with detachable common stock purchase warrants for cash, shares 7,500        
Balance at Jun. 30, 2023 $ 3 $ 1 $ 2,292 $ 118,350,847 $ (122,792,042) $ (4,438,899)
Balance, shares at Jun. 30, 2023 25,276 7,500 22,924,515      
v3.23.2
Condensed Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Cash flows from operating activities:    
Net loss $ (161,622) $ (1,295,802)
Adjustments to reconcile net loss to net cash used in operating activities:    
Equity in earnings of unconsolidated subsidiary – GMDOC, LLC (29,467) (114,336)
Change in warrant derivative fair value (367,175)
Stock-based compensation 317,807 608,247
Gain on extinguishment of convertible notes payable (193,152)
Depreciation, depletion and amortization 6,822 61,668
Accretion of asset retirement obligations 2,436 580
Amortization of discount on convertible notes payable 389,651
Change in operating assets and liabilities:    
Decrease (increase) in accounts receivable 23,337 (8,729)
Increase in prepaid expenses (7,889) (1,967)
Increase in accounts payable 59,871 214,956
Increase (decrease) in accrued liabilities 41,634 2,055
Increase in accrued interest 25,793 424
Net cash used in operating activities (281,605) (143,253)
Cash flows from investing activities:    
Investment in unconsolidated subsidiary – GMDOC, LLC (850,000)
Investment in Hugoton Gas Field participation agreement (314,753)
Investment in oil and gas properties and equipment (15,224)
Net cash used in investing activities (1,179,977)
Cash flows from financing activities:    
Net proceeds from issuance of convertible notes payable 1,200,000
Repayment of convertible note payable (425,000)
Net proceeds from issuance of convertible preferred stock with detachable common stock purchase warrants 750,000 500,000
Cash dividends paid on preferred stock (65,765) (105,150)
Net cash provided by financing activities 684,235 1,169,850
Net increase (decrease) in cash and cash equivalents 402,630 (153,380)
Cash and cash equivalents:    
Beginning 10,163 260,590
Ending 412,793 107,210
Supplemental cash flow information:    
Cash paid for interest 34,547 34,027
Cash paid for taxes
Supplemental disclosure of non-cash investing and financing activities:    
Accrual of dividends on Series A and Series B Convertible Preferred Stock 70,292
Issuance of common stock upon conversion of convertible notes payable and accrued interest 50,000
Conversion of Series A Convertible Preferred Stock to Common Stock 50 85
Modification of warrant exercise price pursuant to dilutive issuance of Series B Preferred Stock 126
Issuance of restricted common stock attributable to issuance of notes payable 196,154
Issuance of detachable common stock purchase warrants attributable to issuance of convertible notes payable 136,574
Issuance of restricted common stock as compensation $ 155
v3.23.2
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies

Note 1 – Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies

 

Unaudited Interim Financial Information

 

American Noble Gas, Inc. has prepared the accompanying condensed financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These financial statements are unaudited and, in our opinion, include all adjustments consisting of normal recurring adjustments and accruals necessary for a fair presentation of our condensed balance sheets, statements of operations, statements of stockholders’ deficit and cash flows for the periods presented. Operating results for the periods presented are not necessarily indicative of the results that may be expected for the remainder of 2023 due to various factors. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been omitted in accordance with the rules and regulations of the SEC. These condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes in Item 8, “Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC.

 

Nature of Operations

 

The Company has assessed various opportunities and strategic alternatives involving the acquisition, exploration and development of oil and gas oil producing properties in the United States, including the possibility of acquiring businesses or assets that provide support services for the production of oil and gas in the United States.

 

As a result, we are now involved with the following oil and gas producing properties:

 

Central Kansas Uplift - On April 1, 2021, we completed the acquisition of the Central Kansas Uplift Properties, for a purchase price of $900,000. The Central Kansas Uplift Properties include the production and mineral rights/leasehold for oil and gas properties, subject to overriding royalties to third parties, in the Central Kansas Uplift geological formation covering over 11,000 contiguous acres (the “Properties”). The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

 

We commenced rework of the existing production wells after completion of the acquisition of the Properties and have performed testing and evaluation of the existence of noble gas reserves on the Properties including helium, argon and other rare earth minerals/gases. Testing of the Properties for noble gas reserves has provided encouraging but not conclusive results and the Company has yet to determine the possibility of commercializing the noble gas reserves on the Properties. The Company plans to assess the Properties’ existing oil and gas reserves while continuing the evaluation of the existence of new oil and gas zones and other mineral reserves and specifically the noble gas reserves that the Properties may hold.

 

During the year ended December 31, 2022, the Company changed its strategy regarding the Central Kansas Uplift considering the reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of June 30, 2023 and December 31, 2022 and is considering the reworking the conventional wells on the property to emphasize crude oil production that may be present behind casing pipe in the deeper producing zones. Accordingly, the Company has recorded an impairment charge of $712,812 to reduce the capitalized tangible and intangible costs related to its Central Kansas Uplift properties to zero as of June 30, 2023 and December 31, 2022.

 

 

Hugoton Gas Field Farm-Out - On April 4, 2022, the Company acquired a 40% participation in a Farmout Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor (“Scout”) with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Company has joined three other parties to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement (collectively the “Hugoton JV”).

 

The Farmout Agreement covers drilling and completion of up to 50 wells, with the first exploratory well spudded on May 7, 2022. The Hugoton JV will utilize Scout’s existing infrastructure assets including water disposal, gas gathering and helium processing. The Farmout Agreement provides the Hugoton JV with rights to take in-kind and market its share of helium at the tailgate of Jayhawk Gas Plant, which will enable the Hugoton JV to market and sell the helium produced at prevailing market prices.

 

The Hugoton JV also acquired the right to all brine minerals subject to a ten percent (10%) royalty to Scout, across Finney and Haskell Counties. Brine minerals are harvested from the formation water produced from active, and to be drilled, oil and gas wells and may include a variety of dissolved minerals including bromine and iodine. The Hugoton JV plans to target brine minerals with commercial quantities of bromine and iodine. The Company through the Hugoton JV is currently developing proprietary technology to recover brine minerals, particularly with respect to bromine, which is well underway and has demonstrated recovery efficiency and is expected to be available for use in existing and future development wells.

 

The Hugoton JV believes that its unconventional theory has not previously been targeted for exploration by historical operations in the field. The initial exploratory well was spud on May 7, 2022 near Garden City, Kansas, with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production and sales of natural gas, natural gas liquids and helium on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout and whether it should attempt to extend the time period before it has to drill additional wells in Hugoton Gas Field per the farm-out agreement.

 

The Company performed the ceiling test to assess potential impairment of the capitalized costs relative to its Hugoton Gas Field Project. The ceiling test indicated an impairment charge of $192,762 was required to reduce the total capitalized costs to $88,687 as of December 31, 2022. Accordingly, the Company has recorded an impairment charge of $192,762 to reduce the capitalized tangible and intangible costs related to its Hugoton Gas Field properties to $88,687 as of December 31, 2022. The Company recorded an addition to depreciation and amortization expense of $3,411 during the three months ended June 30, 2023.

 

Investment in GMDOC, LLC - On May 3, 2022, the Company entered into an operating agreement (the “Operating Agreement”) pursuant to which the Company acquired 17 (or 60.7143%) of 28 limited liability membership interests (the “Interests”) in GMDOC, LLC, a Kansas limited liability company (“GMDOC”), for an aggregate purchase price of $4,037,500, and was subsequently admitted as a member of GMDOC.

 

The Company paid the cash contribution for the membership interests of $850,000, during May 2022. The remainder of the Company’s capital contribution, or $3,187,500, was financed by the Bank Loan (as defined below).

 

GMDOC had previously acquired 70% of the working interests (the “Acquisition”) in certain oil and gas leases (the “GMDOC Leases”) from Castelli Energy, L.L.C., an Oklahoma limited liability company (“Castelli”). The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC Leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis.

 

GMDOC is managed by two members: Darrah Oil Company, LLC, and Grand Mesa Operating Company, (collectively the “Managing Members”), which also serve as the operating companies under the GMDOC Leases.

 

 

Going Concern

 

The Company has incurred losses from operations, has a stockholders’ deficit, incurred net cash used in operating activities and has a significant working capital deficit as of and for the three and six months ended June 30, 2023 and as of and for the year ended December 31, 2022. The Company must raise substantial amounts of debt and equity capital from other sources in the future in order to fund (i) the development of the Properties acquired on April 1, 2021; (ii) our obligations for exploration and development under the Hugoton Farmout Agreement; (iii) normal day-to-day operations and corporate overhead; and (iv) outstanding debt and other financial obligations as they become due, as described below. Most of the Company’s outstanding debt and other financial obligations are currently past due and the Company must negotiate forbearance and/or restructuring agreements with the holders of such debt. These are substantial operational and financial issues that must be successfully addressed during 2023 and beyond.

 

The Company has made substantial progress in resolving many of its existing financial obligations and acquiring oil and gas producing properties to deploy its new operational strategy during the period through June 30, 2023.

 

The Company will have significant financial commitments executing its planned exploration and development of the Properties and the Hugoton Gas Field. The Company may find it necessary to raise substantial amounts of debt or equity capital to fund such exploration and development activities and may seek offers from industry operators and other third parties for interests in the Properties in exchange for cash and a carried interest in exploration and development operations or other joint venture arrangement. There can be no assurance that it will be able to obtain such new funding or be able to reach agreements with industry operators and other third parties or on what terms.

 

Due to the uncertainties related to the foregoing matters, there exists substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financials are issued. The unaudited condensed financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

 

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” and the series of related accounting standard updates that followed, using the modified retrospective method of adoption. Adoption of the ASU did not require an adjustment to the opening balance of equity and did not change the Company’s amount and timing of revenues.

 

The Company’s revenues are primarily derived from its interests in the sale of oil and natural gas production. To date, such revenues have only included the sale of oil and natural gas however the Company expects to begin generating more substantial revenues from the sale of noble gases in the future. The Company recognizes revenue from its interests in the sales of oil and gas in the period that its performance obligations are satisfied. Performance obligations are satisfied when the customer obtains control of product, when the Company has no further obligations to perform related to the sale, when the transaction price has been determined and when collectability is probable. The sales of oil and gas are made under contracts which the third-party operators of the wells have negotiated with customers, which typically include variable consideration that is based on pricing tied to local indices and volumes delivered in the current month. The Company receives payment from the sale of oil and gas production from one to three months after delivery. At the end of each month when the performance obligation is satisfied, the variable consideration can be reasonably estimated and amounts due from customers are accrued in trade receivables, net in the balance sheets. Variances between the Company’s estimated revenue and actual payments are recorded in the month the payment is received, however, differences have been and are insignificant. The Company’s oil is typically sold at delivery points under contracts terms that are common in our industry.

 

Cash and Cash Equivalents

 

For purposes of reporting cash flows, cash consists of cash on hand and demand deposits with financial institutions. The Company’s policy is that all highly liquid investments with an original maturity of three months or less when purchased would be cash equivalents and would be included along with cash as cash and equivalents.

 

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with several financial institutions if necessary to remain below the federally insured limit of $250,000 per bank. At June 30, 2023 and December 31, 2022, the uninsured balance amounted to $152,630 and $-0-, respectively.

 

 

Convertible Instruments

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)” which is intended to reduce complexity in applying GAAP to certain financial instruments with characteristics of liabilities and equity. The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in Accounting Standards Codification (“ASC”) 470-20, Debt: Debt with Conversion and Other Options that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. The amendments in ASU 2020-06 further revise the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares.

 

The Company early adopted ASU 2020-06 effective January 1, 2021 and applied ASU 2020-06 to all outstanding financial instruments as of January 1, 2021.

 

Conversion options that contain variable settlement features such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract generally result in their bifurcation from the host instrument.

 

Derivative Instruments

 

The Company accounts for derivative instruments or hedging activities under the provisions of ASC 815 Derivatives and Hedging. ASC 815 requires the Company to record derivative instruments at their fair value. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in other comprehensive earnings (loss) and are recognized in the statement of earnings when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized in earnings. Changes in the fair value of derivatives that do not qualify for hedge treatment are recognized in earnings.

 

The purpose of hedging is to provide a measure of stability to the Company’s cash flows in an environment of volatile oil and gas prices and to manage the exposure to commodity price risk. As of June 30, 2023 and December 31, 2022 and during the periods then ended, the Company had no oil and natural gas derivative arrangements outstanding.

 

As a result of certain terms, conditions and features included in certain common stock purchase warrants issued by the Company (Notes 4 and 11), those warrants were required to be accounted for as derivatives at estimated fair value, with changes in fair value recognized in operations.

 

Fair Value of Financial Instruments

 

The carrying values of the Company’s accounts payable, accrued liabilities and short-term notes represent the estimated fair value due to the short-term nature of the accounts.

 

In accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.

 

 

ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

 

  Level 1 — Quoted prices in active markets for identical assets and liabilities.
       
  Level 2 — Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities).
       
  Level 3 — Significant unobservable inputs (including the Company’s own assumptions in determining the fair value.

 

The estimated fair value of warrant derivative liabilities, which are related to detachable warrants issued in connection with the Series A Convertible Preferred Stock, par value $0.001 per share (the “Series A Convertible Preferred Stock”) were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock, par value $0.001 per Share (the “Common Stock”) and current interest rates. The fair values for the warrant derivatives as of June 30, 2023 and December 31, 2022 were classified under the fair value hierarchy as Level 3.

 

The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022:

 

June 30, 2023  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $210,094   $210,094 
   $   $   $210,094   $210,094 

 

December 31, 2022  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $577,269   $577,269 
   $   $   $577,269   $577,269 

 

There were no changes in valuation techniques or reclassifications of fair value measurements between Levels 1, 2 or 3 during the three and six months ended June 30, 2023 and 2022.

 

Management Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include, but are not limited to, oil and gas reserves; depreciation, depletion and amortization of proved oil and gas properties; future cash flows from oil and gas properties; impairment of long-lived assets; fair value of derivatives; asset retirement obligations, our control over equity method investments, fair value of equity compensation; warrants issued in connection with convertible debt; the realization of deferred tax assets; fair values of assets acquired and liabilities assumed in business combinations.

 

Oil and gas properties

 

Central Kansas Uplift Properties - On April 1, 2021, we completed the acquisition of the Properties, under the terms of the Asset Purchase Agreement, for a purchase price of $900,000. The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

 

 

The Company has performed workovers of the wells subsequent to the Properties purchase which was necessary to put the lease back into production status. Therefore, these tangible and intangible workover costs were expensed as lease operating expenses rather than capitalized in the full cost pool through December 31, 2022. In addition, the Company is currently evaluating the Properties for oil and gas reserves and specifically the potential for noble gas reserves such as helium, argon and krypton. Based on these evaluations, the Company may redirect its efforts to the production of noble gases rather than crude oil on the Properties. These noble gas evaluation costs have also been expensed as lease operating costs through June 30, 2023.

 

Hugoton Gas Field Farm-Out -The first exploratory well commenced on May 7, 2022 near Garden City, Kansas with a goal to evaluate its unconventional theory of where substantial oil, natural gas and noble gases may be present in the Hugoton Gas Field. The initial well in which the Company has acquired a 40% participation together with three other venture partners was spud on May 7, 2022 with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves.

 

The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout and whether it should attempt to extend the time period before it has to drill additional wells in Hugoton Gas Field per the farm-out agreement.

 

Full Cost Accounting

 

The accounting for, and disclosure of, oil and gas producing activities require that we choose between two GAAP alternatives: the full cost method or the successful efforts method. We adopted and use the full cost method of accounting, which involves capitalizing all exploration, exploitation, development and acquisition costs. Once we incur costs, they are recorded in the depletable pool of proved properties or in unproved properties, collectively, the full cost pool. Our unproved property costs, which include unproved oil and gas properties, properties under development, and major development projects, were zero as of June 30, 2023 and December 31, 2022, and are not subject to depletion. We review our unproved oil and gas property costs on a quarterly basis to assess for impairment and transfer unproved costs to proved properties as a result of extensions or discoveries from drilling operations or determination that no proved reserves are attributable to such costs. We expect these costs to be evaluated in one to seven years and transferred to the depletable portion of the full cost pool during that time. The full cost pool is comprised of intangible drilling costs, lease and well equipment and exploration and development costs incurred plus acquired proved and unproved leaseholds.

 

When we acquire significant amounts of undeveloped acreage, we capitalize interest on the acquisition costs in accordance with FASB ASC Subtopic 835-20 for Capitalization of Interest. When the unproved property costs are moved to proved developed and undeveloped oil and gas properties, or the properties are sold, we cease capitalizing interest.

 

Capitalized costs to acquire oil and natural gas properties are depreciated and depleted on a units-of-production basis based on estimated proved reserves. Capitalized costs of exploratory wells and development costs are depreciated and depleted on a units-of-production basis based on estimated proved developed reserves. Under this method, the sum of the full cost pool, excluding the book value of unproved properties, and all estimated future development costs are divided by the total estimated quantities of proved reserves. This rate is applied to our total production for the quarter, and the appropriate expense is recorded. Support equipment and other property, plant and equipment related to oil and gas producing activities, as well as property, plant and equipment unrelated to oil and gas producing activities, are recorded at cost and depreciated on a straight-line basis over the estimated useful lives of the assets.

 

Sales, dispositions and other oil and gas property retirements are accounted for as adjustments to the full cost pool, with no recognition of gain or loss, unless the disposition would significantly alter the amortization rate and/or the relationship between capitalized costs and Proved Reserves.

 

Pursuant to Rule 4-10(c)(4) of Regulation S-X, at the end of each quarterly period, companies that use the full cost method of accounting for their oil and gas properties must compute a limitation on capitalized costs, or ceiling test. The ceiling test involves comparing the net book value of the full cost pool, after taxes, to the full cost ceiling limitation defined below. In the event the full cost ceiling is less than the full cost pool, we must record a ceiling test write-down of our oil and gas properties to the value of the full cost ceiling. The full cost ceiling limitation is computed as the sum of the present value of estimated future net revenues from our proved reserves by applying average prices as prescribed by the SEC Release No. 33-8995, less estimated future expenditures (based on current costs) to develop and produce the proved reserves, discounted at 10%, plus the cost of properties not being amortized and the lower of cost or estimated fair value of unproved properties included in the costs being amortized, net of income tax effects.

 

 

The ceiling test is computed using the simple average spot price for the trailing twelve-month period using the first day of each month. The trailing twelve-month reference price was $94.14 per barrel for the West Texas Intermediate oil at Cushing, Oklahoma through December 31, 2022. This reference price for oil is further adjusted for quality factors and regional differentials to derive estimated future net revenues. Under full cost accounting rules, any ceiling test write-downs of oil and gas properties may not be reversed in subsequent periods. We recognized an impairment charge of $905,574 as of June 30, 2023 and December 31, 2022 which is attributable to changing our strategy to exploring for noble gases and away from crude oil production at our Central Kansas Uplift properties which resulted in a large decrease in estimated future cash flows.

 

The ceiling test calculation is based upon estimates of proved reserves. There are numerous uncertainties inherent in estimating quantities of proved reserves, in projecting the future rates of production and in the timing of development activities. The accuracy of any reserve estimate is a function of the quality of available data and of engineering and geological interpretation and judgment. Results of drilling, testing and production subsequent to the date of the estimate may justify revision of such estimate. Accordingly, reserve estimates are often different from the quantities of oil and gas that are ultimately recovered.

 

Equity Method Investments

 

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of the net income or loss of these investees is included in our Statements of Operations. Judgment regarding the level of influence over each equity method investment includes considering key factors such as the Company’s ownership interest, legal form of the investee, representation on the board of directors, participation in policy-making decisions and material intra-entity transactions.

 

The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when reviewing an equity method investment for impairment include the length of time and the extent to which the fair value of the equity method investment has been less than cost, the investee’s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than temporary is recognized in the period identified.

 

The Company accounts for distributions received from equity method investees under the “nature of the distribution” approach. Under this approach, distributions received from equity method investees are classified on the basis of the nature of the activity or activities of the investee that generated the distribution as either a return on investment (classified as cash inflows from operating activities) or a return of investment (classified as cash inflows from investing activities).

 

Issuance of Debt Instruments With Detachable Stock Purchase Warrants

 

Proceeds from the issuance of a debt instrument with stock purchase warrants (detachable call options) are allocated to the two elements based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portion of the proceeds allocated to the warrants are recorded as additional paid-in capital. The remainder of the proceeds are allocated to the debt instrument portion of the transaction. Such issuances generally result in a discount (or, occasionally, a reduced premium) relative to the debt instrument, which is amortized to interest expense using the effective interest rate method.

 

Asset Retirement Obligations

 

The Company records estimated future asset retirement obligations pursuant to the provisions of ASC 410. ASC 410 requires entities to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred with a corresponding increase in the carrying amount of the related long-lived asset. Subsequent to its initial measurement, the asset retirement liability is required to be accreted each period. The Company’s asset retirement obligations consist of costs related to the plugging of wells, the removal of facilities and equipment, and site restoration on oil and gas properties.

 

 

During April 2021, the Company acquired the Properties and assumed the related asset retirement obligation existing at the date of acquisition. The asset retirement obligation assumed for the Properties relates to the plug and abandonment costs when the wells acquired are no longer useful. The Company determined the value of the liability by obtaining quotes for this service and estimated the increased costs that the Company will face in the future. We then discounted the future value based on an intrinsic interest rate that is appropriate for us. If costs rise more than what we have expected there could be additional charges in the future; however, we monitor the costs of the abandoned wells and we will adjust this liability if necessary.

 

As of December 31, 2012, the Company had divested all of its domestic oil properties that contained operating and abandoned wells in Texas, Colorado and Wyoming. The Company may have obligations related to the divestiture of certain abandoned non-producing domestic leasehold properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. Management believes the Company has been relieved from asset retirement obligation related to Infinity-Texas because of the sale of its Texas oil and gas properties in 2011 and its sale of 100% of the stock in Infinity-Texas in 2012. The Company has recognized an additional liability of $734,897 related to its former Texas oil and gas producing properties (included in asset retirement obligations) to recognize the potential personal liability of the Company and its officers for the Infinity-Texas oil and gas properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. In addition, management believes the Company has been relieved from asset retirement obligations related to Infinity-Wyoming because of the sale of its Wyoming and Colorado oil and gas properties in 2008; however, the Company has recognized since 2012 an additional liability of $981,106 related to its former Wyoming and Colorado oil and gas producing properties (included in asset retirement obligations) to recognize the potential liability of the Company and its officers should the new owner not perform its obligations to reclaim abandoned wells in a timely manner.

 

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes. This method requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between financial accounting bases and tax bases of assets and liabilities. The tax benefits of tax loss carryforwards and other deferred taxes are recorded as an asset to the extent that management assesses the utilization of such assets to be more likely than not. Management routinely assesses the realizability of the Company’s deferred income tax assets, and a valuation allowance is recognized if it is determined that deferred income tax assets may not be fully utilized in future periods. Management considers future taxable earnings in making such assessments. Numerous judgments and assumptions are inherent in the determination of future taxable earnings, including such factors as future operating conditions. When the future utilization of some portion of the deferred tax asset is determined not to be more likely than not, a valuation allowance is provided to reduce the recorded deferred tax asset. When the Company can project that a portion of the deferred tax asset can be realized through application of a portion of tax loss carryforward, the Company will record that utilization as a deferred tax benefit and recognize a deferred tax asset in the same amount. There can be no assurance that facts and circumstances will not materially change and require the Company to adjust its deferred income tax asset valuation allowance in a future period. The Company recognized a deferred tax asset, net of valuation allowance, of $-0- at June 30, 2023 and December 31, 2022.

 

The Company is potentially subject to taxation in many jurisdictions, and the calculation of income tax liabilities (if any) involves dealing with uncertainties in the application of complex income tax laws and regulations in various taxing jurisdictions. It recognizes certain income tax positions that meet a more-likely-than not recognition threshold. If the Company ultimately determines that the payment of these liabilities will be unnecessary, it will reverse the liability and recognize an income tax benefit. No liability for unrecognized tax benefit was recorded as of June 30, 2023 and December 31, 2022.

 

Stock-based compensation

 

The Company applies ASC 718, Stock Compensation, which requires companies to recognize compensation expense for share-based payments based on the estimated fair value of the awards. ASC 718 also requires tax benefits relating to the deductibility of increases in the value of equity instruments issued under share-based compensation arrangements to be presented as financing cash inflows in the statement of cash flows. Compensation cost is recognized based on the grant-date fair value for all share-based payments granted and is estimated in accordance with the provisions of ASC 718.

 

 

Related Party Transactions

 

The Company’s financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances and similar items in the ordinary course of business. Disclosure of related party transactions include: 1) the nature of the relationships involved, 2) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements, 3) the dollar amounts of the transactions for each periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period, and 4) amounts due from or to related parties as of the date of each balance sheet presented and if not otherwise apparent,5) the terms of settlement.

 

Basic and Diluted Income (Loss) Per Share

 

Net income (loss) per share is calculated in accordance with FASB ASC 260, Earnings Per Share, for the periods presented. Basic net loss per share is based upon the weighted average number of shares of Common Stock outstanding. Diluted net earnings (loss) per share is based on the assumption that all dilutive convertible shares, warrants and stock options were converted or exercised or excluded from the calculations if their inclusion would be antidilutive. Dilution is computed by applying the if-converted/treasury stock method. Under this method, options and warrants are assumed exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase shares of Common Stock at the average market price during the period. The Company has outstanding convertible notes payable, Series A Convertible Preferred Stock and Series B Convertible Preferred Stock all of which are potentially dilutive. Such potential dilutive effect is included in diluted earnings (loss) per share at the beginning of the period (or at the time of issuance, if later) if they have a dilutive effect or such potentially dilutive securities are excluded from the calculations if their inclusion would be antidilutive.

 

The adoption of ASU 2020-06 requires the Company to assume share settlement when an instrument can be settled in cash or shares at the entity’s option. This applies both to convertible instruments and freestanding arrangements that could result in cash or share settlement. ASU 2020-06 also stipulates that an average market price for the period should be used in the computation of the diluted earnings (loss) per share denominator in cases when the exercise price of an instrument may change based on an entity’s share price or changes in the entity’s share price may affect the number of shares that would be used to settle a financial instrument. Lastly, an entity should use the weighted-average share count from each quarter when calculating the year-to-date weighted average share count for all potentially dilutive securities.

 

During the three and six months ended June 30, 2023 and 2022, the Company had outstanding the following securities that were potentially dilutive: i) Series A and Series B Convertible Preferred Stock, ii) various convertible notes payable, iii) warrants to purchase Common Stock and iv) options to purchase Common Stock. All potentially dilutive securities were considered for inclusion or exclusion from the calculation of diluted income (loss) per share for the three and six months ended June 30, 2023 and 2022. Any potentially dilutive security that were considered anti-dilutive were excluded from the net income (loss) per share reported for the three and six months ended June 30, 2023 and 2022.

 

Debt – Modifications and Extinguishments / Troubled Debt Restructuring:

 

In accordance with ASC 470, the Company assesses restructuring of debt as troubled debt restructuring if the creditor for economic or legal reasons related to the debtor’s financial difficulties grant a concession to the debtor that it would not otherwise consider. The Company records a gain on restructuring of payables when it transfers its assets to a creditor to fully settle a payable. The gain is measured by the excess of the carrying amount of the payable over the fair value of the assets transferred or fair value of equity interest granted.

 

 

The Company follows ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), which requires the Company to assess whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires the Company to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different based on an analysis of the present value of the future cash flows under the terms of the new debt instrument compared to the present value of the remaining cash flows under the terms of the original instrument. The accounting treatment is different depending on whether such difference in the present value of future cash flows is greater than or less than 10 percent as follows:

 

  Difference is less than 10% - If the modification results in a difference in present value of future cash flows for the new and old debt instruments is less than 10% then it is considered to be not significant and is treated as a modification of the existing debt. Under a modification of debt, no gain or loss is recognized at the date of the modification. Rather a new effective interest rate is calculated, and interest expenses are accounted for under the interest method using the new effective interest rate on a prospective basis.
     
  Difference is more than 10% - If the modification results in a difference in present value of future cash flows for the new and old debt instruments is more than 10% then it is considered as significant and is treated as an extinguishment of the old debt instrument and issuance of the new debt instrument. Under extinguishment accounting, the old debt instrument is extinguished, and the new debt instrument is recorded at fair value. The difference in the carrying amount of the old debt instrument compared to the fair value of the new debt instrument is recognized as a gain or loss from extinguishment of debt as of the date of modification. Interest expense is accounted for under the interest method using the new effective rate.

 

Recent Accounting Pronouncements

 

Business Combinations - In October 2021, FASB issued ASU 2021-08 Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities were recognized by the acquirer at fair value on the acquisition date. The Company adopted this ASU on January 1, 2023 and its adoption did not have a material impact on our financial statements.

 

Other accounting standards that have been issued by the FASB or other standards-setting bodies are not expected to have a material impact on the Company’s financial position, results of operations and cash flows.

 

v3.23.2
Oil and Gas Properties and Equipment
6 Months Ended
Jun. 30, 2023
Extractive Industries [Abstract]  
Oil and Gas Properties and Equipment

Note 2 – Oil and Gas Properties and Equipment

 

Oil and gas properties and equipment is comprised of the following at June 30, 2023 and December 31, 2022:

 

 

   June 30, 2023   December 31, 2022 
Central Kansas Uplift - Oil and gas production equipment  $913,425   $913,425 
Hugoton Gas Field - Oil and gas production equipment   96,831    96,831 
Central Kansas Uplift – Leasehold costs   15,225    15,225 
Hugoton Gas Field – Leasehold costs   191,535    191,535 
           
Subtotal   1,217,016    1,217,016 
Less: Accumulated impairment   (905,574)   (905,574)
Less: Accumulated depreciation, depletion and amortization   (229,577)   (222,755)
Oil and gas properties and equipment, net  $81,865   $88,687 

 

v3.23.2
Investment in unconsolidated subsidiary – GMDOC
6 Months Ended
Jun. 30, 2023
Investments, All Other Investments [Abstract]  
Investment in unconsolidated subsidiary – GMDOC

Note 3 – Investment in unconsolidated subsidiary – GMDOC

 

A summary of the Company’s investment in unconsolidated subsidiary-GMDOC during the three and six months ended June 30, 2023 and 2022 follows:

 

    2023     2022     2023     2022  
    Three months ended
June 30,
    Six months ended
June 30,
 
    2023     2022     2023     2022  
                         

Investment in unconsolidated subsidiary-GMDOC, at beginning of period

  $ 1,141,274     $     $ 1,101,461     $  
Purchase of membership units in GMDOC, LLC           850,000             850,000  
Equity in earnings (loss) of GMDOC     (10,346 )     114,336       29,467       114,336  
Distributions during period                        
                                 
Investment in unconsolidated subsidiary-GMDOC at end of period   $ 1,130,928     $ 964,336     $ 1,130,928     $ 964,336  

 

 

The following table presents summarized balance sheet financial information of the Company’s unconsolidated subsidiary – GMDOC as of June 30, 2023 and December 31, 2022:

 

   June 30, 2023   December 31, 2022 
ASSETS          
Assets:          
Cash  $103,061   $208,450 
Accrued revenue & prepaid expenses   173,625    320,212 
Oil and gas properties and equipment, net   7,042,620    7,359,905 
           
Total assets  $7,319,306   $7,888,567 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Accounts payable and accrued liabilities  $97,188   $207,244 
General managing members advances   150,000     
Mortgage note payable, net   4,328,036    4,984,821 
Asset Retirement Obligations   916,211    882,331 
Member’s equity   1,827,871    1,814,171 
           
Total liabilities and member’s equity  $7,319,306   $7,888,567 

 

The following table presents summarized income statement financial information of the Company’s unconsolidated subsidiary – GMDOC for the three and six months ended June 30, 2023 and 2022:

 

   2023   2022   2023   2022 
   Three months ended
June 30,
   Six months ended
June 30,
 
   2023   2022   2023   2022 
                 
Oil and gas revenues  $433,998   $788,964   $1,064,213   $788,964 
Lease operating expenses   (216,023)   (244,276)   (524,115)   (244,276)
Production related taxes   (4,888)   (22,912)   (20,777)   (22,912)
Ad valorem taxes   (5,982)   (10,755)   (16,737)   (10,755)
Depreciation expense   (134,206)   (131,514)   (268,413)   (131,514)
Accretion of asset retirement obligation   (16,940)   (16,987)   (33,880)   (16,987)
General and administrative expenses   (5,129)   (100,054)   (11,811)   (100,054)
Interest expense   (67,871)   (74,147)   (139,946)   (74,147)
                     
Net income (loss)   (17,041)   188,319    48,534    188,319 
AMGAS member’s percentage   60.7143

%

   60.7143    60.7143%   60.7143%
                     
Equity in earnings (loss) of unconsolidated subsidiary – GMDOC  $(10,346)  $114,336   $29,467   $114,336 

 

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee, GMDOC. Management’s judgment regarding its level of influence over the operations of GMDOC included considering key factors such as the Company’s ownership interest, legal form of the investee, its’ lack of participation in policy-making decisions and its’ lack of control over the day-to-day operations of GMDOC.

 

 

v3.23.2
Debt Obligations
6 Months Ended
Jun. 30, 2023
Debt Disclosure [Abstract]  
Debt Obligations

Note 4 – Debt Obligations

 

Debt obligations were comprised of the following at June 30, 2023 and December 31, 2022:

 

   June 30, 2023   December 31, 2022 
Notes payable:          
           
3% convertible notes payable due March 30, 2026 (the 3% Notes)  $28,665   $28,665 
8% convertible notes payable due September 30, 2023 (the October 8% Notes)   500,000    500,000 
8% convertible note payable due September 30, 2023 (the 8% Note)   100,000    100,000 
8% convertible note payable due October 29, 2022 (the Second 8% Note) (in default)   50,000    50000 
8% Convertible promissory notes payable due September 30, 2023 (the June 2022 Note)   350,000    350,000 
8% Convertible promissory notes payable due September 30, 2023 (the May 2022 Notes)   266,204    312,500 
           
Total notes payable   1,294,869    1,341,165 
Less: Long-term portion   28,665    28,665 
Notes payable, short-term  $1,266,204   $1,312,500 

 

Debt obligations become due and payable as follows:

 

Years ended 

Principal

balance due

 
     
2023 (Ju1y 1, 2023 through December 31, 2023)  $1,266,204 
2024    
2025    
2026   28,665 
2027    
2028    
Total  $1,294,869 

 

3% Convertible Notes Payable due March 30, 2026

 

On March 31, 2021, the Company entered into Debt Settlement Agreements with six creditors (five of which were related parties) which extinguished accounts payable and accrued liabilities totaling $2,866,497 in exchange for the issuance of $28,665 in principal balance of 3% convertible notes payable (the “3% Notes”) with detachable warrants to purchase 5,732,994 shares of Common Stock for fifty cents ($0.50) per share (the “3% Note Warrants”). The 3% Notes allow for prepayment at any time with all principal and accrued interest becoming due and payable at maturity on March 30, 2026 (the “Maturity Date”). The 3% Notes are convertible as to principal and any accrued interest, at the option of the holder, into shares of Common Stock at any time after the issue date and prior to the close of business on the business day preceding the Maturity Date at the rate of fifty cents ($0.50) per share, subject to normal and customary adjustment.

 

8% Convertible Notes Payable due September 30, 2023

 

On October 29, 2021, the Company issued to two accredited investors (the “October 8% Note Investors”) unsecured convertible notes payable due October 29, 2022 (the “October 8% Notes”), with an aggregate principal face amount of approximately $500,000. The October 8% Notes are, subject to certain conditions, convertible into an aggregate of 1,000,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued five and one half-year Common Stock purchase warrants to purchase up to 1,500,000 shares of Common Stock at an exercise price of $0.50 per share, subject to customary adjustments (the “October 8% Note Warrants”) which are immediately exercisable. The conversion price of the October 8% Note and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The October 8% Note Investors purchased the October 8% Notes and October 8% Note Warrants from the Company for an aggregate purchase price of $500,000 and the proceeds were used for general working capital purposes. The Company also granted the October 8% Note Investors certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the October 8% Note Warrants and the conversion of the October 8% Notes unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

 

The October 8% Notes all bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note and the October 8% Notes shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the October 8% Notes, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the October 8% Note Investor.

 

The conversion of the October 8% Notes and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the October 8% Note Investors may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

The Company and the October 8% Note Investors have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

 

The Company did not pay the principal balance due on the October 8% Notes upon their original maturity on October 29, 2022 and the remaining balance remained due and payable and was therefore in technical default as of December 31, 2022. The Company reached an agreement with the two October 8% Note Investors on January 10, 2023. On January 10, 2023, the Company and the October 8% Note Holders amended each of the notes by entering into a Letter Agreement between the October 8% Note Investors and the Company. The Letter Agreement modifies the terms of the October 8% Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes.

 

The Company evaluated the terms of the January 10, 2023 Letter Agreement which amended the October 8% Notes. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The amendment of the Fixed Conversion Price to $0.10 from $0.50 per share, as provided for in the Letter Agreement, would be considered substantive based on the likelihood of the conversion option being exercised in the future. Accordingly, the Company accounted for the amendment of the Notes as an extinguishment of the original Bridge Notes.

 

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

 

  

As of

January 10, 2023

 
Carrying value of the original convertible notes payable     
Principal balance  $500,000 
Accrued interest   120,753 
Total carrying value of original convertible note payable   620,753 
      
Less: Net present value of future cash flows on amended convertible notes payable   (516,776)
      
Gain on extinguishment of convertible notes payable  $103,977 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $103,977 during the six months ended June 30, 2023.

 

The conversion rate on the October 8% Notes was reduced to $0.05 per share as a result of the dilutive issuance of the Series B Convertible Preferred Stock that occurred on May 4, 2023 (See Note 13).

 

8% Convertible Note Payable due September 30, 2023

 

On August 30, 2021, the Company issued to an accredited investor (the “8% Note Investor”) an unsecured convertible note due October 29, 2022 (the “8% Note”), with an aggregate principal face amount of approximately $100,000. The 8% Note is, subject to certain conditions, convertible into an aggregate of 200,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five and one half-year Common Stock purchase warrant to purchase up to 200,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “8% Note Warrant”) which are immediately exercisable. The conversion price of the 8% Note and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023.The 8% Note Investor purchased the 8% Note and 8% Note Warrant from the Company for an aggregate purchase price of $100,000 and the proceeds were used for general working capital purposes. The Company also granted the 8% Note Investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the 8% Note Warrant and the conversion of the 8% Note unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

The 8% Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the 8% Note, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the 8% Note Investor.

 

The conversion of the 8% Note and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

 

The Company and the 8% Note Investor have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

 

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

 

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including $100,000 outstanding principal balance of the 8% Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable was cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable. The Company treated the refinancing of the $100,000 8% Note Payable as an extinguishment of the old note which resulted in a gain on extinguishment of $24,190 during the three months ended June 30, 2023.

 

The Company evaluated the modification of the 8% Note that occurred on May 5, 2023. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The analysis of the present value of future cash flows under the new debt instrument compared to the old debt instrument resulted in a difference in excess of 10%. Accordingly, the Company accounted for the amendment of the Note as an extinguishment of the original 8% Note.

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment:

 

  

As of

May 5, 2023

 
Carrying value of the original convertible note payable     
Principal balance  $100,000 
Accrued interest   28,877 
Total carrying value of original convertible note payable   128,877 
      
Less: Net present value of future cash flows on amended convertible note payable   (104,687)
      
Gain on extinguishment of convertible notes payable  $24,190 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $24,290 during the three and six months ended June 30, 2023.

 

 

8% Convertible Notes Payable due October 29, 2022 (in default)

 

On October 29, 2021, the Company issued to an accredited investor (the “Second 8% Note Investor”) an unsecured convertible note payable due October 29, 2022 (the “Second 8% Notes”), with an aggregate principal face amount of approximately $50,000. The Second 8% Note is, subject to certain conditions, convertible into an aggregate of 100,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued five and one half-year Common Stock purchase warrants to purchase up to 150,000 shares of Common Stock at an exercise price of $0.50 per share, subject to customary adjustments (the “Second 8% Note Warrants”) which are immediately exercisable. The conversion price of the Second 8% Notes and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023.The Second 8% Note Investor purchased the Second 8% Note and the Second 8% Warrants from the Company for an aggregate purchase price of $50,000 and the proceeds were used for general working capital purposes. The Company also granted the Second 8% Note Investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the Second 8% Note Warrants and the conversion of the Second 8% Note unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

The Second 8% Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the Second 8% Note shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the Second 8% Note, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the Second 8% Note Investor.

 

The conversion of the Second 8% Note and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

The Company, the Second 8% Note Investor have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.

 

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

 

The Company has accrued default interest aggregating $12,349 and $10,668 as of June 30, 2023 and December 31, 2022, respectively related to the repayment default on this note.

 

The conversion rate on the Second 8% Note was reduced to $0.05 per share as a result of the dilutive issuance of the Series B Convertible Preferred Stock that occurred on May 4, 2023 (See Note 13).

 

8% Convertible Notes Payable due September 30, 2023

 

On June 8, 2022, the Company issued to an accredited investor an unsecured convertible note due September 15, 2022 (the “June 2022 Note”), with an aggregate principal face amount of $350,000. The June 2022 Note is, subject to certain conditions, convertible into an aggregate of 700,000 shares of Common Stock, at a price of fifty cents ($0.50) per share. The Company also issued a five-year Common Stock purchase warrant to purchase up to 700,000 shares of Common Stock at an exercise price of fifty cents ($0.50) per share, subject to customary adjustments (the “June 2022 Warrants”) which are immediately exercisable. The investor purchased the June 2022 Note and June 2022 Warrant from the Company for an aggregate purchase price of $350,000 and the proceeds were used for drilling and completion costs on the initial well drilled under the Hugoton Gas Field participation agreement and general working capital purposes. The Company also granted the investor certain piggy-back registration rights whereby the Company has agreed to register for resale the shares of Common Stock underlying the June 2022 Warrant and the conversion of the June 2022 Note unless the shares of the Company commence to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.

 

 

The June 2022 Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to the remaining principal amount of the underlying note and any accrued and unpaid interest.

 

The underlying notes and warrants contain customary events of default, representations, warranties, agreements of the Company and the investors and customary indemnification rights and obligations of the parties thereto, as applicable.

 

On May 5, 2023, the Company reached an agreement with the holder of two separate convertible notes payable in the aggregate principal face amount of approximately $450,000 (including the June 2022 Note), which the Company did not pay by their maturity dates. The Company and the holder of the two convertible notes payable entered into a new convertible promissory note (the “New Note”), exchanging the outstanding principal amount of the old convertible notes payable into the New Note, with a maturity date of September 30, 2023. Upon issuance of the New Note, the old convertible notes payable were cancelled and the repayment defaults under the prior convertible notes payable were cured with the entry into the New Note. The conversion price of the New Note was reduced from $0.50 per share to $0.40 per share however, the interest rate and other significant terms of the New Note are the same as those of the prior convertible notes payable.

 

The Company evaluated the modification of the 8% Note that occurred on May 5, 2023. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The analysis of the present value of future cash flows under the new debt instrument compared to old debt instrument resulted in a difference less than 10%. Accordingly, the Company accounted for the amendment of the Note as a modification of the original 8% Note resulting in no gain or loss on the date of modification. Rather a new effective interest rate is calculated, and interest expenses are accounted for under the interest method using the new effective interest rate on a prospective basis.

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment:

 

  

As of

May 5, 2023

 
Carrying value of the original convertible note payable     
Principal balance  $350,000 
Accrued interest   35,595 
Total carrying value of original convertible note payable   385,595 
      
Less: Net present value of future cash flows on amended convertible note payable   (366,400)
      
Difference  $19,195 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment was less than 10%. As a result, the Company did not record a gain on extinguishment of convertible notes payable.

 

 

8% Convertible Notes Payable due September 30, 2023 (the “May 22 Notes”)

 

The Company entered into a securities purchase agreement with two accredited investors for the Company’s 8% convertible notes payable due June 29, 2022 (the “May 2022 Notes”), with an aggregate principal amount of $850,000. The May 2022 Notes are, subject to certain conditions, convertible into an aggregate of 2,125,000 shares of Common Stock, at a price of forty cents ($0.40) per share. The conversion price of the May 22 Notes and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The Company also issued an aggregate of 425,000 shares of Common Stock as commitment shares (“Commitment Shares” and, together with the May 2022 Notes and Conversion Shares, the “Securities”) to the investors as additional consideration for the purchase of the May 2022 Notes. The closing of the offering of the Securities occurred on May 13, 2022, when the investors purchased the Securities for an aggregate purchase price of $850,000. The Company has also granted the Investors certain automatic and piggy-back registration rights whereby the Company has agreed to register the resale by the Investors of the Conversion Shares. The proceeds of this offering of Securities were used to purchase the Company’s membership interests in GMDOC.

 

The May 2022 Notes bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time (subject to the occurrence of an event of default) in an amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest, and shall be mandatorily repaid in cash in an amount equal to a) fifty percent (50%) of the then outstanding principal amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 but not greater than $3,000,000; or b) one hundred percent (100%) of the then outstanding principal amount equal to 120% of the principal amount of a May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of in excess of $3,000,000. In addition, pursuant to the May 2022 Notes, so long as such May 2022 Notes remain outstanding, the Company shall not enter into any financing transactions pursuant to which the Company sells its securities at a price lower than the $0.40 per share conversion price, subject to certain adjustments, without the written consent of the investors.

 

The conversion of the May 2022 Notes are each subject to beneficial ownership limitations such that the investors may not convert the May 2022 Notes to the extent that such conversion or exercise would result in an investor being the beneficial owner in excess of 4.99% (or, upon election of the Investor, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.

 

Pursuant to the purchase agreement for the Securities, for a period of twelve (12) months after the closing date, the investors have a right to participate in any issuance of the Company’s Common Stock, Common Stock equivalents, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of the subsequent financing.

 

The Company also entered into that certain registration rights side letter, pursuant to which, in the event the Company’s shares of Common Stock have not commenced trading on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date, and, thereafter, the Company agreed to file a registration statement under the Securities Act to register the offer and sale, by the Company, of Common Stock underlying the May 2022 Notes in the event that such notes are not repaid prior to such 120-day period.

 

The Company paid half of the May 2022 Notes principal balance upon its maturity on June 29, 2022 and an additional $112,500 in September 2022 and the remaining balance remains due and payable and was therefore in technical default as of December 31, 2022.

 

The Company and the two May 2022 Note Holders reached an agreement on January 10, 2023. On January 10, 2023, the Company amended each of those notes by entering into a Letter Agreement between the investors and the Company. The Letter Agreement modifies the terms of the May 2022 Notes by extending each note’s respective maturity date to September 30, 2023. In consideration for the extension, the Company amended the Fixed Conversion Price (as defined in each note) to $0.10, subject to any future adjustments as provided in each of the notes.

 

 

The Company evaluated the terms of the January 10, 2023 Letter Agreement which amended the May 2022 Notes. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the May 2022 Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The amendment of the Fixed Conversion Price to $0.10 from $0.50 per share, as provided for in the Letter Agreement, would be considered substantive based on the likelihood of the conversion option being exercised in the future. Accordingly, the Company accounted for the amendment of the Notes as an extinguishment of the original Bridge Notes.

 

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

 

  

As of

January 10, 2023

 
Carrying value of the original convertible notes payable     
Principal balance  $312,500 
Accrued interest   75,471 
Total carrying value of original convertible note payable   387,971 
      
Less: Net present value of future cash flows on amended convertible notes payable   (322,986)
      
Gain on extinguishment of convertible notes payable  $64,985 

 

The difference between estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment exceeded 10%. As a result, the Company recorded a gain on extinguishment of convertible notes payable totaling $64,985 during the six months ended June 30, 2023.

 

On January 13, 2023, one of the May 22 Note holders exercised its right to convert $46,296 of principal and $3,704 accrued interest into 500,000 shares of common stock. The remaining outstanding principal balance on the two May 2022 Notes totaled $266,204 and $312,500 as of June 30, 2023 and December 31, 2022, respectively.

 

v3.23.2
Accrued liabilities
6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
Accrued liabilities

Note 5 – Accrued liabilities

 

Accrued liabilities consisted of the following at June 30, 2023 and December 31, 2022:

 

   June 30, 2023   December 31, 2022 
Accrued rent  $614,918   $614,918 
Accrued Nicaragua Concession fees   544,485    544,485 
Accrued lease operating costs   41,634     
           
Total accrued liabilities  $1,201,037   $1,159,403 

 

The accrued rent balances relate to unpaid rent for the Company’s previous headquarters in Denver, Colorado and represents unpaid rents and related costs for the period June 2006 through November 2008. The Company has not had any correspondence with the landlord for several years and will seek to settle and/or negotiate the matter when it has the financial resources to do so.

 

 

From 2009 to 2020, the Company had pursued the exploration of potential oil and gas resources in the United States and in the Perlas and Tyra concession blocks in offshore Nicaragua in the Caribbean Sea (the “Concessions”), which contain a total of approximately 1.4 million acres. In January 2020, the Company decided to cease its activities, exploration and production in the Concessions. The accrued Nicaraguan Concession fees were accrued during the time the Concessions had lapsed and the Company was attempting to negotiate extensions to the underlying concessions with the Nicaraguan government which were unsuccessful. The Company abandoned all efforts to negotiate an extension to the Concessions effective January 1, 2020 and ceased the accrual of all related fees at that time.

 

v3.23.2
Stock Options
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Stock Options

Note 6 – Stock Options

 

Total stock-based compensation is comprised of the following for the three and six months ended June 30, 2023 and 2022:

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2023   2022   2023   2022 
Stock-based compensation – stock option grants  $   $51,000   $   $127,499 
                     
Stock-based compensation – restricted stock grants       255,625    174,375    336,875 
                     
Stock-based compensation – warrants issued for services pursuant to USNG Letter Agreement   71,716    71,716    143,432    143,873 
                     
Total stock-based compensation  $71,716   $378,341   $317,807   $608,247 

 

The Company applies ASC 718, Stock Compensation, which requires companies to recognize compensation expense for share-based payments based on the estimated fair value of the awards. ASC 718 also requires tax benefits relating to the deductibility of increases in the value of equity instruments issued under share-based compensation arrangements to be presented as financing cash inflows in the statement of cash flows. Compensation cost is recognized based on the grant-date fair value for all share-based payments granted and is estimated in accordance with the provisions of ASC 718.

 

At the Company’s Annual Meeting of Stockholders held on September 25, 2015, the stockholders approved the 2015 Stock Option and Restricted Stock Plan (the “2015 Plan”) and the Company reserved 500,000 shares for issuance under the 2015 Plan. At the Company’s Annual Meeting of Stockholders held on October 13, 2021, the stockholders approved the 2021 Stock Option and Restricted Stock Plan (the “2021 Plan”) and the Company reserved 5,000,000 shares for issuance under the 2021 Plan.

 

The 2021 Plan and the 2015 Plan provide for under which both incentive and non-statutory stock options may be granted to employees, officers, non-employee directors and consultants. An aggregate of 5,500,000 shares of the Company’s Common Stock is reserved for issuance under the 2021 Plan and the 2015 Plan. Options granted under the 2021 Plan and 2015 Plan allow for the purchase of shares of Common Stock at prices not less than the fair market value of such stock at the date of grant, become exercisable immediately or as directed by the Company’s Board of Directors and generally expire ten years after the date of grant. The Company has issued stock options and restricted stock awards that are not pursuant to a formal plan with terms similar to the 2021 and 2015 Plans.

 

As of June 30, 2023, 5,500,000 shares were available for future grants under the 2021 Plan and the 2015 Plan.

 

The fair value of each option award is estimated on the date of grant using the Black-Scholes option-pricing model, which requires the input of subjective assumptions, including the expected term of the option award, expected stock price volatility and expected dividends. These estimates involve inherent uncertainties and the application of management judgment. For purposes of estimating the expected term of options granted, the Company aggregates option recipients into groups that have similar option exercise behavioral traits. Expected volatilities used in the valuation model are based on the expected volatility based on historical volatility. The risk-free rate for the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The Company’s forfeiture rate assumption used in determining its stock-based compensation expense is estimated based on historical data. The actual forfeiture rate could differ from these estimates.

 

 

Stock option grants

 

The following table summarizes stock option activity for the six months ended June 30, 2023 and 2022:

 

   Number of Options  

Weighted Average Exercise

Price Per

Share

  

Weighted

Average

Remaining
Contractual
Term

 

Aggregate

Intrinsic

Value

 
Outstanding at December 31, 2021   1,892,000   $1.93   9.07 years  $ 
Granted                
Exercised                
Forfeited   (350,000)   0.50         
Outstanding at June 30, 2022   1,542,000   $2.26   8.49 years  $ 
Outstanding and exercisable at June 30, 2022   1,542,000   $2.26   8.49 years  $ 
                   
Outstanding at December 31, 2022   1,442,000   $2.38   7.96 years  $ 
Granted                
Exercised                
Forfeited   (2,000)   30.00         
Outstanding at June 30, 2023   1,440,000   $2.34   7.47 years  $ 
Outstanding and exercisable at June 30, 2023   1,440,000   $2.34   7.47 years  $ 

 

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of June 30, 2023:

 

    Outstanding options  Exercisable options

Exercise price

per share

  

Number of

options

   Weighted average
remaining
contractual life
 

Number of

options

   Weighted average
remaining
contractual life
                   
$0.50    1,350,000   7.93 years   1,350,000   7.93 years
$30.00    90,000   0.54 years   90,000   0.54 years
                   
 Total    1,440,000   7.47 years   1,440,000   7.47 years

 

There were no stock options granted during the three and six months ended June 30, 2023 and 2022. The Company recorded stock-based compensation expense in connection with the vesting of stock options granted aggregating $-0- and $51,000 for the three months ended June 30, 2023 and 2022, respectively and $-0- and $127,499 for the three months ended June 30, 2023 and 2022, respectively.

 

The intrinsic value as of June 30, 2023 and December 31, 2022 related to the vested and unvested stock options as of that date was $-0-. There is no unrecognized compensation cost as of June 30, 2023 related to the unvested stock options as of that date.

 

Restricted stock grants.

 

During May 2022, the Board of Directors granted 1,550,000 shares of restricted stock awards to our officers, directors and consultants. In addition, during August 2020 the Board of Directors granted 5,000,000 shares of restricted stock awards to our officers, directors and a consultant. Restricted stock awards are valued on the date of grant and have no purchase price for the recipient. Restricted stock awards typically vest over a period of time generally corresponding to yearly anniversaries of the grant date. Unvested shares of restricted stock awards may be forfeited upon the termination of service of employment with the Company, depending upon the circumstances of termination. Except for restrictions placed on the transferability of restricted stock, holders of unvested restricted stock have full stockholder’s rights, including voting rights and the right to receive cash dividends.

 

 

A summary of all restricted stock activity under the equity compensation plans for the six months ended June 30, 2023 and 2022 is as follows:

 

  

Number of

restricted

shares

  

Weighted

average

grant date

fair value

 
Nonvested balance, December 31, 2021   1,250,000   $0.13 
Granted   1,550,000    0.45 
Vested   (1,637,500)   (0.21)
Forfeited        
Nonvested balance, June 30, 2022   1,162,500   $0.45 
           
Nonvested balance, December 31, 2022   387,500   $0.45 
Granted        
Vested   (387,500)   (0.45)
Forfeited        
Nonvested balance, June 30, 2023      $ 

 

The Company recorded stock-based compensation expense in connection with the issuance/vesting of restricted stock grants aggregating $-0- and $255,625 during the three months ended June 30, 2023 and 2022, respectively and $174,375 and $336,875 during the six months ended June 30, 2023 and 2022, respectively.

 

The Company estimated the fair market value of these restricted stock grants based on the closing market price on the date of grant. As of June 30, 2023, there were $-0- of total unrecognized compensation costs related to all remaining non-vested restricted stock grants as all restricted stock granted to date have fully vested.

 

v3.23.2
Warrants
6 Months Ended
Jun. 30, 2023
Warrants  
Warrants

Note 7 – Warrants

 

The following table summarizes warrant activity for the six months ended June 30, 2023 and 2022:

 

  

Number of

Warrants

  

Weighted

Average

Exercise Price

Per Share

 
Outstanding and exercisable at December 31, 2021   17,580,784   $0.47 
Issued in connection with issuance of Series A Convertible Preferred Stock (See Note 13)   1,666,667    .30 

Issued in connection with issuance of 8% Convertible Promissory Note (See Note 4)

   700,000    .50 
Exercised        
Forfeited/expired        
Outstanding and exercisable at June 30, 2022   19,947,451   $0.45 
           
Outstanding and exercisable at December 31, 2022   20,430,783   $0.45 
Issued   15,000,000    .05 
Exercised        
Forfeited/expired        
           
Outstanding and exercisable at June 30, 2023   35,430,783   $0.19 

 

The weighted average term of all outstanding Common Stock purchase warrants was 4.2 years as of June 30, 2023. The intrinsic value of all outstanding Common Stock purchase warrants and the intrinsic value of all vested Common Stock purchase warrants was zero as of June 30, 2023 and 2022.

 

The warrant exercise price on warrants to acquire 9,056,409 shares of common stock were adjusted from their original exercise price (ranging from $0.30 per share to $0.50 per share) to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. A total of 3,799,999 of the total warrants effected by the dilutive issuance are treated as equity-based warrants and 5,256,410 of the total were treated as derivative-liability-based warrants. The modification in warrant exercise prices resulted in a total increase in their fair value as of May 4, 2023 (the modification date) totaling $793. The portion of the fair market value increase attributable to warrants treated as equity-based totaled $126 and recorded as an issuance cost of the Series B Convertible Preferred Stock (as a charge to additional paid-in capital) and an increase to additional paid-in capital. The portion of the fair market value increase attributable to warrants treated as derivative-liability-based totaled $667 and was included in the Change in warrant derivative fair value for the three and six months ended June 30, 2023. The following is a summary of the assumptions used in calculating estimated fair value of such warrants as of the May 4, 2023:

 

  

As of

May 4, 2023 with original exercise price

  

As of

May 4, 2023 with new exercise price

 
         
Volatility – range   345.8%   345.8%
Risk-free rate   3.41%   3.41%
Contractual term   3.4 to 4.8 years    3.4 to 4.8 years 
Exercise price  $0.30 to 0.50    $0.05 
Number of warrants in aggregate   9,056,409    9,056,409 

 

 

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase common shares as of June 30, 2023:

 

 

    Outstanding and exercisable warrants

Exercise price

per share

  

Number of

warrants

  

Weighted average

remaining contractual life

$0.05    24,056,409   4.7 years
$0.50    11,374,374   3.0 years
           
 Total    35,430,783   4.2 years

 

Warrants issued pursuant to USNG Letter Agreement

 

On November 9, 2021, the Company entered into a letter agreement (the “USNG Letter Agreement”) with U.S. Noble Gas, LLC (“USNG”), pursuant to which USNG provides consulting services to the Company for exploration, testing, refining, production, marketing and distribution of various potential reserves of noble gases and rare earth element/minerals on the Company’s recently acquired 11,000-acre oil and gas properties in the Otis Albert Field located on the Properties. The USNG Letter Agreement would cover all of the noble gases, specifically including helium, and rare earth elements/minerals potentially existing on Properties and the Company’s future acquisitions, if any, including the Hugoton Gas Field.

 

The USNG Letter Agreement also provides that USNG will supply a large vessel designed for flows up to 5,000 barrels of water per day at low pressures, known as a gas extraction/separator unit. The gas extraction/separator unit is a dewatering vessel that the Company may use for multiple wells in the future.

 

The USNG Letter Agreement requires the Company to establish a four-member board of advisors (the “Board of Advisors”) comprised of various experts involved in noble gas and rare earth elements/minerals. The Board of Advisors will help attract both industry partners and financial partners for developing a large helium, noble gas and/or rare earth element/mineral resources that may exist in the region where the Company currently operates. The industry partners would include helium, noble gas and/or rare earth element/mineral purchasers and exploration and development companies from the energy industry. The financial partners may include large family offices or small institutions.

 

Pursuant to the USNG Letter Agreement, the Company will pay USNG a monthly cash fee equal to $8,000 per month beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore, there has been no payment or accrual liability relative to this cash fee provision as of June 30, 2023 and December 31, 2022.

 

The USNG Letter Agreement has an initial term of 5 years, which shall thereafter continue for successive one-year periods, provided that there is no uncured breach, unless otherwise terminated by either party upon a written notice of intent to non-renew.

 

In consideration for the consulting services to be rendered and pursuant to the terms of the USNG Letter Agreement, the Company issued warrants to purchase, in the aggregate, 2,060,000 shares of its Common Stock at an exercise price of fifty cents ($0.50) to three of USNG’s principal consultants and four third-party service providers. The Company issued warrants to purchase, in the aggregate, 1,200,000 shares of Common Stock at fifty cents ($0.50) per share exercise price to three members of the Board of Advisors. The Company granted a total of 3,260,000 warrants to purchase its Common Stock with an exercise price of fifty cents ($0.50) per share in connection with the USNG Letter Agreement and the arrangements described therein. The warrants expire five years after the date of the USNG Letter Agreement.

 

The fair value of the warrants to purchase Common Stock in consideration for services to be rendered under the USNG Letter Agreement with USNG is estimated on the date of grant using the Black-Scholes option-pricing model.

 

 

The Company recognized $71,716 and $71,716 of compensation expense relative to the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement during the three months ended June 30, 2023 and 2022, respectively $143,432 and $143,873 during the six months ended June 30, 2023 and 2022, respectively. There have been no exercises or forfeitures of the warrants to purchase Common Stock relative to the USNG Letter during the three and six months ended June 30, 2023 and 2022.

 

The total grant date fair value of the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement on November 9, 2021 was $1,434,313 in total or $0.44 per share. Total unrecognized compensation costs related to the 3,260,000 warrants to purchase Common Stock issued pursuant to the USNG Letter Agreement, as of June 30, 2023 was $956,207 which will be amortized over the next forty months.

 

v3.23.2
Income Taxes
6 Months Ended
Jun. 30, 2023
Income Tax Disclosure [Abstract]  
Income Taxes

Note 8 – Income Taxes

 

The effective income tax rate on income (loss) before income tax benefit varies from the statutory federal income tax rate primarily due to the net operating loss history of the Company maintaining a full reserve on all net deferred tax assets during the three and six months ended June 30, 2023 and 2022.

 

The Company has incurred operating losses in recent years, and it continues to be in a three-year cumulative loss position at June 30, 2023. Accordingly, the Company determined there was not sufficient positive evidence regarding its potential for future profits to outweigh the negative evidence of our three-year cumulative loss position under the guidance provided in ASC 740. Therefore, it determined to continue to provide a 100% valuation allowance on its net deferred tax assets. The Company expects to continue to maintain a full valuation allowance until it determines that it can sustain a level of profitability that demonstrates its ability to realize these assets. To the extent the Company determines that the realization of some or all of these benefits is more likely than not based upon expected future taxable income, a portion or all of the valuation allowance will be reversed.

 

For income tax purposes, the Company has net operating loss carry-forwards of approximately $64,710,000 in accordance with its 2021 Federal Income tax return as filed. Approximately $61,045,000 of such net operating loss carry-forwards expire from 2028 through 2037 while $1,935,000 of such net operating loss carry-forwards have an indefinite carryforward period in accordance with the Tax Cuts and Jobs Act. In addition, the Tax Cuts and Jobs Act limits the usage of net operating loss carryforwards to 80% of taxable income per year.

 

The Company has recently completed the filing of its tax returns for the tax years 2012 through 2021. Therefore, all such tax returns are open to examination by the Internal Revenue Service.

 

The Internal Revenue Code contains provisions under Section 382 which limit a company’s ability to utilize net operating loss carry-forwards in the event that it has experienced a more than 50% change in ownership over a three-year period. Management has completed its review of whether such ownership changes have occurred, and based upon such review, management believes that the Company is not currently subject to an annual limitation or the possibility of the complete elimination of the net operating loss carry- forwards. In addition, the Company may be limited by additional ownership changes which may occur in the future.

 

 

v3.23.2
Gain on Extinguishment of Convertible Notes Payable
6 Months Ended
Jun. 30, 2023
Gain On Extinguishment Of Convertible Notes Payable  
Gain on Extinguishment of Convertible Notes Payable

Note 9 – Gain on Extinguishment of Convertible Notes Payable

 

During the three and six months ended June 30, 2023 and 2022, the Company recorded gains on the extinguishment of convertible notes payable through negotiation and settlements with certain creditors as follows:

 

   2023   2022   2023   2022 
   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2023   2022   2023   2022 
Gain on extinguishment of convertible notes payable:                    
Gain on extinguishment of convertible notes
payable – the May 22 Notes (see Note 4)
  $24,190   $   $24,190   $ 
Gain on extinguishment of convertible notes
payable – the October 8% Notes (See Note 4)
           103,977     
Gain on extinguishment of convertible notes
payable – the May 22 Notes (see Note 4)
           64,985     
                     
Total gain on exchange and extinguishment of liabilities  $24,190   $   $193,152   $ 

 

v3.23.2
Asset Retirement Obligations
6 Months Ended
Jun. 30, 2023
Asset Retirement Obligation Disclosure [Abstract]  
Asset Retirement Obligations

Note 10 – Asset Retirement Obligations

 

The Company’s asset retirement obligations primarily relate to the Company’s portion of future plugging and abandonment costs for wells and related facilities. The following table presents the changes in the asset retirement obligations for the six months ended June 30, 2023 and 2022:

 

   Amount 
     
Asset retirement obligation at December 31, 2021  $1,730,264 
Additions    
Accretion expense during the period   580 
      
Asset retirement obligation at June 30, 2022  $1,730,844 
      
Asset retirement obligation at December 31, 2022  $1,732,486 
Additions    
Accretion expense during the period   2,436 
      
Asset retirement obligation at June 30, 2023  $1,734,922 

 

Approximately $1,716,003 of the total asset retirement obligation existing at June 30, 2023 and December 31, 2022 represent the remaining potential liability for oil and gas wells the Company had owned in Texas and Wyoming prior to their sales/disposal in 2012. The Company was not in compliance with then existing federal, state and local laws, rules and regulations for its previously owned Texas and Wyoming domestic oil and gas properties. All domestic oil and gas properties held by Infinity-Wyoming and Infinity-Texas were disposed of in 2012 and in years prior to 2012; however, the Company may remain liable for certain asset retirement costs should the new owners not complete their asset retirement obligations. Management believes the total asset retirement obligations recorded relative to all the Company wells including these Texas and Wyoming wells of $1,733,704 and $1,732,486 as of June 30, 2023 and December 31, 2022, respectively are sufficient to cover any potential noncompliance liabilities relative to the plugging of abandoned wells, the removal of facilities and equipment, and site restoration on oil and gas properties for its current and former oil and gas properties.

 

 

v3.23.2
Warrant Derivative Liability
6 Months Ended
Jun. 30, 2023
Warrant Derivative Liability  
Warrant Derivative Liability

Note 11 – Warrant Derivative Liability

 

The estimated fair value of the Company’s derivative liabilities, all of which were related to the detachable warrants issued in connection with Series A Convertible Preferred Stock, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates. The detachable warrants issued in connection with the issuance of certain Series A Convertible Preferred Stock (See Note 13 - March 2021 Issuance) contained a provision allowing the holder to require cash settlement in certain situations were fundamental transaction, as defined in the warrant agreements have occurred. An event occurred on December 31, 2022 that activated the Holder’s ability to utilize such provisions therefore the related derivative liability was recognized on December 31, 2022 and also at June 30, 2023.

 

The following is a summary of the assumptions used in calculating estimated fair value of such derivative liabilities as of the June 30, 2023 and December 31, 2022:

 

  

As of

June 30, 2023

  

As of

December 31, 2022

 
         
Volatility – range   347.2%   342.2%
Risk-free rate   4.13%   3.99%
Contractual term   3.24 years    3.74 years 
Exercise price  $0.05   $0.39 
Number of warrants in aggregate   5,256,410    5,256,410 

 

The following table provides a summary of the changes in fair value, including net transfers in and/or out, of the derivative financial instruments, measured at fair value on a recurring basis using significant unobservable inputs for both open and closed derivatives:

 

 

   Amount 
Balance at December 31, 2021  $ 
Unrealized derivative gains included in other income/expense for the period    
Balance at June 30, 2022  $ 
      
Balance at December 31, 2022  $577,269 
      
Unrealized derivative gains included in other income/expense for the period   (367,175)
      
Balance at June 30, 2023  $210,094 

 

The warrant exercise price on warrants to acquire 5,256,410 shares of common stock treated as derivative liability-based were adjusted from their original exercise price of $0.39 per share to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The modification in warrant exercise prices resulted in an increase in their fair value as of May 4, 2023 (the modification date) totaling $667 was included in the unrealized derivative gains included in other income/expense for the three and six months ended June 30, 2023. The following is a summary of the assumptions used in calculating estimated fair value of such derivative warrants as of the May 4, 2023:

 

  

As of

May 4, 2023 with original exercise price

  

As of

May 4, 2023 with new exercise price

 
         
Volatility – range   345.8%   345.8%
Risk-free rate   3.41%   3.41%
Contractual term   3.4 years    3.4 years 
Exercise price  $0.39   $0.05 
Number of warrants in aggregate   5,256,410    5,256,410 

 

v3.23.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 12 – Commitments and Contingencies

 

Lack of Compliance with Law Regarding Domestic Properties

 

The Company was not in compliance with then existing federal, state and local laws, rules and regulations for domestic oil and gas properties owned and disposed of in 2012 and in years prior to 2012 and could have a material or significantly adverse effect upon the liquidity, capital expenditures, earnings or competitive position of the Company. All domestic oil and gas properties held by Infinity-Wyoming and Infinity-Texas were disposed of in 2012 and in years prior to 2012; however, the Company may remain liable for certain asset retirement costs should the new owners not complete their obligations. Management believes the total asset retirement obligations recorded for these prior matters of $1,716,003 as of June 30, 2023 and December 31, 2022 are sufficient to cover any potential noncompliance liabilities relative to the plugging of abandoned wells, the removal of facilities and equipment, and site restoration on oil and gas properties for its former oil and gas properties.

 

USNG Letter Agreement commitment

 

Pursuant to the USNG Letter Agreement (see Note 7), the Company will pay USNG a monthly cash fee equal to $8,000 per month beginning at the onset of commercial helium or minerals production and sales, subject to certain thresholds. Such monthly fees will become due and payable for any month that the Company receives cash receipts in excess of $25,000 derived from the sale of noble gases and/or rare earth elements/minerals. The Company has not yet achieved the $25,000 cash receipts threshold, therefore there has been no payment or accrual liability relative to this cash fee provision as of June 30, 2023 and December 31, 2022.

 

 

The USNG Letter Agreement has an initial term of 5 years, which shall thereafter continue for successive one-year periods, provided that there is no uncured breach, unless otherwise terminated by either party upon a written notice of intent to non-renew.

 

Litigation

 

The Company is subject to various claims and legal actions in which vendors are claiming breach of contract due to the Company’s failure to pay amounts due. The Company believes that it has made adequate provision for these claims in the accompanying financial statements.

 

The Company is currently involved in litigation as follows:

 

In October 2012, the State of Texas filed a lawsuit naming Infinity-Texas, the Company and the corporate officers of Infinity-Texas, seeking $30,000 of reclamation costs associated with a single well, in addition to administrative expenses and penalties. The Company engaged in negotiations with the State of Texas in late 2012 and early 2013 and reached a settlement agreement that would reduce the aggregate liability, in this action and any extension of this action to other Texas wells, to $45,103, which amount has been paid. Certain performance obligations remain which must be satisfied in order to finally settle and dismiss the matter.
   
  Pending satisfactory performance of the performance obligations and their acceptance by the State of Texas, the Company’s officers have potential liability regarding the above matter, and the Company’s officers are held personally harmless by indemnification provisions of the Company. Therefore, to the extent they might actually occur, these liabilities are the obligations of the Company. Management estimates that the liabilities associated with this matter will not exceed $780,000, calculated as $30,000 for each of the 26 Infinity-Texas operated wells. This related liability, less the payment made to the State of Texas in 2012 in the amount of $45,103, is included in the asset retirement obligation on the accompanying balance sheets, which management believes is sufficient to provide for the ultimate resolution of this dispute.

 

Cambrian Consultants America, Inc. (“Cambrian”) filed an action in the District Court of Harris County, Texas, number CV2014-55719, on September 26, 2014 against the Company resulting from certain professional consulting services provided for quality control and management of seismic operations during November and December 2013 on the Nicaraguan Concessions. Cambrian provided these services pursuant to a Master Consulting Agreement with the Company, dated November 20, 2013, and has claimed breach of contract for failure to pay amounts due. On December 8, 2014, a default judgment was entered against the Company in the amount of $96,877 plus interest and attorney fees. The Company has included the impact of this litigation as a liability in its accounts payable, which management believes is sufficient to provide for the ultimate resolution of this dispute.

 

Torrey Hills Capital, Inc. (“Torrey”) notified the Company by letter, dated August 15, 2014, of its demand for the payment of $56,000, which it alleged was unpaid and owed under a consulting agreement dated October 18, 2013. The parties entered into a consulting agreement under which Torrey agreed to provide investor relations services in exchange for payment of $7,000 per month and the issuance of 15,000 shares of Common Stock. The agreement was for an initial three month-term with automatic renewals unless terminated upon 30 days’ written notice by either party. The Company made payments totaling $14,000 and issued 15,000 shares of Common Stock during 2013. The Company contends that Torrey breached the agreement by not performing the required services and that it had provided proper notice of termination to Torrey. Furthermore, the Company contends that the parties agreed to settle the dispute on or about June 19, 2014 under which it would issue 2,800 shares of Common Stock in full settlement of any balance then owed and final termination of the agreement. Torrey disputed the Company’s contentions and submitted the dispute to binding arbitration. The Company was unable to defend itself and the arbitration panel awarded Torrey a total of $79,594 in damages. The Company has accrued this amount in accounts payable as of June 30, 2023 and December 31, 2022, which management believes is sufficient to provide for the ultimate resolution of this dispute.

 

 

v3.23.2
Stockholder’s Deficit
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Stockholder’s Deficit

Note 13 – Stockholder’s Deficit

 

Conversion of 8% Convertible Notes Payable to Common Stock.

 

On January 13, 2023, a holder of 8% Convertible Notes Payable exercised its right to convert $46,296 of principal and $3,704 of accrued interest into 500,000 shares of common stock.

 

Convertible Preferred Stock

 

As of June 30, 2023 and December 31, 2022, the Company is authorized to issue up to 10,000,000 shares of preferred stock, par value $0.0001 per share.

 

Series A Convertible Preferred Stock Authorization - On March 16, 2021, the Company approved and filed a Certificate of Designation of Preferences, Rights and Limitations of the Series A Convertible Preferred Stock (“COD”) with the Secretary of State of the State of Delaware. The COD provides for the issuance of up to 27,778 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share. Pursuant to the provisions of the COD, the Series A Convertible Preferred Stock is convertible, at the option of the holders thereof, at any time, subject to certain beneficial ownership limitations, into shares of Common Stock determined on a per share basis by dividing the $100 stated/liquidation value of such share of Series A Convertible Preferred Stock by the $0.32 per share conversion price, which conversion price is subject to certain adjustments. The conversion price of the Series A Convertible Preferred Stock was adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. In addition, the COD provides for the payment of 10% per annum cumulative dividends, in (i) cash, or (ii) shares of Common Stock, to the holders of the Series A Convertible Preferred Stock based on the stated/liquidation value, until the earlier of (i) the date on which the shares of Series A Convertible Preferred Stock are converted to Common Stock or (ii) date the Company’s obligations under the COD have been satisfied in full. The shares of Series A Convertible Preferred Stock also (i) vote on an as-converted to Common Stock basis, subject to certain beneficial ownership limitations, (ii) are subject to mandatory conversion into Common Stock upon the closing of any equity financing transaction consummated after the original issue date, pursuant to which the Company raises gross proceeds of not less than $5,000,000, (iii) rank senior to the Common Stock and any class or series of capital stock created after the Series A Convertible Preferred Stock and (iv) have a special preference upon the liquidation of the Company.

 

Series B Convertible Preferred Stock Authorization - On May 3, 2023, the Company approved and filed a COD of the Series B Convertible Preferred Stock with the Secretary of State of the State of Delaware. The COD provides for the issuance of up to 50,000 shares of Series B Convertible Preferred Stock with a stated/liquidation value of $100 per share. Pursuant to the provisions of the COD, the Series B Convertible Preferred Stock is convertible, at the option of the holders thereof, at any time, subject to certain beneficial ownership limitations, into shares of Common Stock determined on a per share basis by dividing the $100 stated/liquidation value of such share of Series A Convertible Preferred Stock by the $0.05 per share conversion price, which conversion price is subject to certain adjustments. In addition, the COD provides for the payment of 8% per annum cumulative dividends, in (i) cash, or (ii) shares of Common Stock, to the holders of the Series A Convertible Preferred Stock based on the stated/liquidation value, until the earlier of (i) the date on which the shares of Series A Convertible Preferred Stock are converted to Common Stock or (ii) date the Company’s obligations under the COD have been satisfied in full. The shares of Series A Convertible Preferred Stock also (i) vote on an as-converted to Common Stock basis, subject to certain beneficial ownership limitations, (ii) are subject to mandatory conversion into Common Stock upon the closing of any equity financing transaction consummated after the original issue date, pursuant to which the Company raises gross proceeds of not less than $5,000,000, (iii) rank senior to the Common Stock and any class or series of capital stock created after the Series B Convertible Preferred Stock and (iv) have a special preference upon the liquidation of the Company.

 

The following summarizes the activity in the Series A and Series B Convertible Preferred Stock for the three months ended June 30, 2023 and 2022:

 

   Six months ended
June 30, 2023
   Six months ended
June 30, 2022
 
   Series A   Series B   Series A   Series B 
                 
Outstanding at beginning of period:   25,526        22,076     
Issued       7,500    5,000     
Converted to common stock   (250)       (2,700)    
Redeemed                 
                     
Outstanding at end of period   25,276    7,500    24,376     

 

 

Series A - March 2021 Issuance - On March 26, 2021, the Company entered into a securities purchase agreement with five (5) accredited investors providing for an aggregate investment of $2,050,000 by the investors for the issuance by the Company to them of (i) 22,776 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “March 2021 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 5,256,410 shares of Common Stock at an exercise price of thirty-nine ($0.39) per share, subject to customary adjustments thereunder. The conversion price of the March 2021 Series A Convertible Preferred Stock and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. Holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. Net proceeds from the issuance of March 2021 Series A Convertible Preferred Stock totaled $1,929,089 after deducting the placement agent fee and other expenses of the offering. The Company used the proceeds of the March 2021 Series A Convertible Preferred Stock offering to complete the acquisition and development of the Properties, to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the acquisition of the Properties, which occurred on April 1, 2021, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the closing of the acquisition of the Properties, which occurred on April 1, 2021. The Company completed the required registration of these shares on Form S-1, which the Securities and Exchange Commission declared effective on August 4, 2021.

 

The holders of March 2021 Series A Convertible Preferred Stock exercised their right to convert 250 shares of the March 2021 Series A Convertible Preferred Stock into 500,000 shares of Common Stock during the six months ended June 30, 2023. The holders exercised their rights to convert a total of 2,700 shares of March 2021 Series A Convertible Preferred Stock into 843,750 shares of Common Stock during the six months ended June 30, 2022.

 

On March 26, 2021, Ozark Capital, LLC (“Ozark”) acquired 1,111 shares of March 2021 Series A Convertible Preferred Stock (convertible into 2,222,000 shares of Common Stock), together with warrants to acquire 256,410 shares of Common Stock at five cents ($0.05) per share for a total cash of $100,000. Ozark and its affiliates hold over 10% of the shares of the Company’s Common Stock as of June 30, 2023 and December 31, 2022.

 

All holders of the March 2021 Series A Convertible Preferred Stock, including Ozark, have agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days’ advance notice to the Company.

 

Series A - June 2022 Issuance - On June 15, 2022, the Company entered into a securities purchase agreement with an accredited investor providing for an aggregate investment of $500,000 by the investor for the issuance by the Company of (i) 5,000 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “June 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 1,666,667 shares of Common Stock at an exercise price of thirty cents ($0.30) per share, subject to customary adjustments thereunder. The conversion price of the June 2021 Series A Convertible Preferred Stock and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The holder of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the June 2022 Series A Convertible Preferred Stock totaled $500,000. The Company used the proceeds of the June 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

 

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the of the June 2022 Series A Preferred Stock, which occurred on June 15, 2022, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof, but in any event no later than the ninetieth (90th) calendar day following the closing of the offering, which occurred on June 15, 2022.

 

The holder of the June 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its June 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

Series A - August/September 2022 Issuances – During August and September 2022, the Company entered into a securities purchase agreement with three accredited investors providing for an aggregate investment of $145,000 by the investors for the issuance by the Company of (i) 1,450 shares of Series A Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “August/September 2022 Series A Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 483,332 shares of Common Stock at an exercise price of thirty ($0.30) per share, subject to customary adjustments thereunder. The conversion price of the August/September 2021 Series A Convertible Preferred Stock and the related warrant exercise price were adjusted to $0.05 per share due to the dilutive issuance of the Series B Convertible Preferred Stock on May 4, 2023. The holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrant. Net proceeds from the issuance of the August/September 2022 Series A Convertible Preferred Stock totaled $145,000. The Company used the proceeds of the August/September 2022 Series A Convertible Preferred Stock offering to pay-off certain outstanding convertible notes payable (see Note 4) and for general working capital purposes.

 

The holders of the August/September 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its August/September 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

Series B - May 2023 Issuance - On May 4, 2023, the Company entered into a securities purchase agreement with three (3) accredited investors providing for an aggregate investment of $750,000 by the investors for the issuance by the Company to them of (i) 7,500 shares of Series B Convertible Preferred Stock with a stated/liquidation value of $100 per share (the “May 2023 Series B Convertible Preferred Stock”); and (ii) warrants, with a term of five and a half (5.5) years, exercisable six (6) months after issuance, to purchase an aggregate of up to 15,000,000 shares of Common Stock at an exercise price of five ($0.05) per share, subject to customary adjustments thereunder. The May 2023 Series B Convertible Preferred Stock is convertible into an aggregate of up to 15,000,000 shares of Common Stock. Holders of the warrants may exercise them by paying the applicable cash exercise price or, if there is not an effective registration statement for the sale of the shares of Common Stock underlying the warrants within six (6) months following the closing date, as defined in the warrants, by exercising on a cashless basis pursuant to the formula provided in the warrants. Net proceeds from the issuance of May 2023 Series B Convertible Preferred Stock totaled $750,000 which was used for general working capital purposes.

 

The Company also entered into that certain registration rights agreement, pursuant to which the Company agreed to file a registration statement within forty-five (45) days following the closing of the acquisition of the Properties, to register the shares of Common Stock underlying the warrants. The Company is to use its best efforts to cause such registration statement to be declared effective within forty-five (45) days after the filing thereof.

 

The holders of the May 2023 Series B Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its May 2023 Series B Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.

 

The holders of May 2023 Series B Convertible Preferred Stock did not exercise their rights to convert any of the May 2023 Series B Convertible Preferred Stock into shares of Common Stock during the three and six months ended June 30, 2023 and 2022.

 

 

On April 27, 2023 and May 4, 2023, Ozark Capital, LLC (“Ozark”) acquired 2,500 shares of May 2023 Series B Convertible Preferred Stock (convertible into 5,000,000 shares of Common Stock), together with warrants to acquire 5,000,000 shares of Common Stock at five cents ($0.05) per share for a total cash of $250,000. Ozark and its affiliates hold over 10% of the shares of the Company’s Common Stock as of June 30, 2023 and December 31, 2022.

 

The estimated fair value of the detachable warrants issued in connection with Series B Convertible Preferred Stock, were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock and current interest rates.

 

Such warrants are equity-classified with an estimated fair value of $899,963 as of the date of their issuance. The following is a summary of the assumptions used in calculating estimated fair value of the detachable warrants issued in relation to the Series B Convertible Preferred Stock issuance as of the May 4, 2023, their issuance date:

 

  

As of

May 4, 2023

 
      
Volatility – range   345.8%
Risk-free rate   3.41%
Contractual term   5.5 years 
Exercise price  $0.05 
Number of warrants in aggregate   15,000,000 

 

Series A Convertible Preferred Stock Dividends – The Company has accrued preferred dividends totaling $63,516 and $126,457 relative to the Series A Convertible Preferred Stock which was charged to additional paid in capital during the three and six months ended June 30, 2023, respectively and $52,289 and $105,150 relative to the Series A Convertible Preferred Stock during the three and six months ended June 30, 2022, respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $137,816 and $77,124 relative to the Series A Convertible Preferred Stock as of June 30, 2023 and December 31, 2022, respectively.

 

Accrued dividends on Series A Convertible Preferred Stock attributable to Ozark were $2,770 and $5,509 for the three and six months ended June 30, 2023, respectively and $2,739 and $5,479 for the three and six months ended June 30, 2022. The Company has outstanding accrued and unpaid preferred dividends totaling $2,770 and $2,800 relative to the Ozark’s Series A Convertible Preferred Stock as of June 30, 2023 and December 31, 2022, respectively.

 

Series B Convertible Preferred Stock Dividends - The Company has accrued preferred dividends totaling $9,600 and $9,600 relative to the Series B Convertible Preferred Stock which was charged to additional paid in capital during the three and six months ended June 30, 2023, respectively and there was no Series B Convertible Preferred Stock Series outstanding during the three and six months ended June 30, 2022. The Company has outstanding accrued and unpaid preferred dividends totaling $9,600 and $-0- relative to the May 2023 Series B Convertible Preferred Stock as of June 30, 2023 and December 31, 2022, respectively.

 

Accrued dividends on Series B Convertible Preferred Stock attributable to Ozark were $3,353 and $3,353 for the three and six months ended June 30, 2023 and $-0- and $-0- for the three and six months ended June 30, 2022 respectively. The Company has outstanding accrued and unpaid preferred dividends totaling $3,353 and $-0- relative to the Ozark’s Series B Convertible Preferred Stock as of June 30, 2023 and December 31, 2022, respectively.

 

v3.23.2
Related Party Transactions
6 Months Ended
Jun. 30, 2023
Related Party Transactions [Abstract]  
Related Party Transactions

Note 14 – Related Party Transactions

 

The Company does not have any employees other than its Chief Executive Officer, Chief Operating Officer and Chief Financial Officer. In previous years, certain general and administrative services (for which payment is deferred) had been provided by the Company’s Chief Financial Officer’s accounting firm at its standard billing rates plus out-of-pocket expenses consisting primarily of accounting, tax and other administrative fees. The Company no longer utilizes its Chief Financial Officer’s accounting firm for such support services and was not billed for any such services during the years ended December 31, 2022 and 2021. On March 31, 2021, the parties entered into a Debt Settlement Agreement whereby all amounts due to such firm for services totaling $762,407 were extinguished upon the issuance of $7,624 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Note 4. Total amounts due to this related party was $-0- as of June 30, 2023 and December 31, 2022.

 

The Company had accrued compensation to its officers and directors in years prior to 2018. The Board of Directors authorized the Company to cease the accrual of compensation for its officers and directors, effective January 1, 2018. On March 31, 2021, the parties entered into Debt Settlement Agreements whereby all accrued amounts due for such services totaling $1,789,208 were extinguished upon the issuance of $17,892 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Note 4. Total amounts due to the officers and directors related to accrued compensation was $-0- as of June 30, 2023 and December 31, 2022.

 

Offshore Finance, LLC was owed financing costs in connection with a subordinated loan to the Company which was converted to common shares in 2014. The managing partner of Offshore and the Company’s Chief Financial Officer are partners in the accounting firm which the Company used for general corporate purposes in the past. On March 31, 2021, the parties entered into a Debt Settlement Agreement whereby all amounts due for such services totaling $26,113 were extinguished upon the issuance of $261 principal balance of the 3% Notes and the issuance of the 3% Note Warrants as further described in Note 4. Total amounts due to this related party was $-0- as of June 30, 2023 and December 31, 2022.

 

In connection with the Hugoton Gas Field Farmout Agreement, John Loeffelbein, the Company’s previous Chief Operating Officer, was granted a 3% carried interest through drilling in the Hugoton JV. Such carried interest was burdened only to the three other partners in the Hugoton JV and not the Company’s interest. On April 18, 2022, John Loeffelbein resigned from his position as Chief Operating Officer with the Company.

 

v3.23.2
Subsequent Events
6 Months Ended
Jun. 30, 2023
Subsequent Events [Abstract]  
Subsequent Events

Note 15 – Subsequent Events

 

On August 2, 2023 the Company’s Board of Directors granted stock purchase options to acquire a total of 10,000,000 shares of common stock to its newly-appointed Chief Executive Officer/Chief Financial Officer, its independent board members and a consultant. The options have an exercise price of $0.05 per share and vest ratably on a quarterly basis over the next two years beginning September 30, 2023. The stock options have a term of ten years.

 

**********************

v3.23.2
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Unaudited Interim Financial Information

Unaudited Interim Financial Information

 

American Noble Gas, Inc. has prepared the accompanying condensed financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial reporting. These financial statements are unaudited and, in our opinion, include all adjustments consisting of normal recurring adjustments and accruals necessary for a fair presentation of our condensed balance sheets, statements of operations, statements of stockholders’ deficit and cash flows for the periods presented. Operating results for the periods presented are not necessarily indicative of the results that may be expected for the remainder of 2023 due to various factors. Certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) have been omitted in accordance with the rules and regulations of the SEC. These condensed financial statements should be read in conjunction with the audited financial statements and accompanying notes in Item 8, “Financial Statements and Supplementary Data,” of our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC.

 

Nature of Operations

Nature of Operations

 

The Company has assessed various opportunities and strategic alternatives involving the acquisition, exploration and development of oil and gas oil producing properties in the United States, including the possibility of acquiring businesses or assets that provide support services for the production of oil and gas in the United States.

 

As a result, we are now involved with the following oil and gas producing properties:

 

Central Kansas Uplift - On April 1, 2021, we completed the acquisition of the Central Kansas Uplift Properties, for a purchase price of $900,000. The Central Kansas Uplift Properties include the production and mineral rights/leasehold for oil and gas properties, subject to overriding royalties to third parties, in the Central Kansas Uplift geological formation covering over 11,000 contiguous acres (the “Properties”). The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

 

We commenced rework of the existing production wells after completion of the acquisition of the Properties and have performed testing and evaluation of the existence of noble gas reserves on the Properties including helium, argon and other rare earth minerals/gases. Testing of the Properties for noble gas reserves has provided encouraging but not conclusive results and the Company has yet to determine the possibility of commercializing the noble gas reserves on the Properties. The Company plans to assess the Properties’ existing oil and gas reserves while continuing the evaluation of the existence of new oil and gas zones and other mineral reserves and specifically the noble gas reserves that the Properties may hold.

 

During the year ended December 31, 2022, the Company changed its strategy regarding the Central Kansas Uplift considering the reduced net cash flows from the sale of crude oil production. The reduction in net cash flows was attributable to lower spot crude oil prices during 2022 compared to 2021 and higher than anticipated operating costs related to the operation of the horizontal wells on the Properties. The Company has shut down the horizontal production wells as of June 30, 2023 and December 31, 2022 and is considering the reworking the conventional wells on the property to emphasize crude oil production that may be present behind casing pipe in the deeper producing zones. Accordingly, the Company has recorded an impairment charge of $712,812 to reduce the capitalized tangible and intangible costs related to its Central Kansas Uplift properties to zero as of June 30, 2023 and December 31, 2022.

 

 

Hugoton Gas Field Farm-Out - On April 4, 2022, the Company acquired a 40% participation in a Farmout Agreement by and between Sunflower Exploration, LLC as the Farmee and Scout Energy Partners as Farmor (“Scout”) with regards to its oil and gas interests in the Hugoton Gas Field, located in Haskell and Finney Counties, Kansas. The Company has joined three other parties to explore for and develop potential oil, natural gas, noble gases and brine minerals on the properties underlying the Farmout Agreement (collectively the “Hugoton JV”).

 

The Farmout Agreement covers drilling and completion of up to 50 wells, with the first exploratory well spudded on May 7, 2022. The Hugoton JV will utilize Scout’s existing infrastructure assets including water disposal, gas gathering and helium processing. The Farmout Agreement provides the Hugoton JV with rights to take in-kind and market its share of helium at the tailgate of Jayhawk Gas Plant, which will enable the Hugoton JV to market and sell the helium produced at prevailing market prices.

 

The Hugoton JV also acquired the right to all brine minerals subject to a ten percent (10%) royalty to Scout, across Finney and Haskell Counties. Brine minerals are harvested from the formation water produced from active, and to be drilled, oil and gas wells and may include a variety of dissolved minerals including bromine and iodine. The Hugoton JV plans to target brine minerals with commercial quantities of bromine and iodine. The Company through the Hugoton JV is currently developing proprietary technology to recover brine minerals, particularly with respect to bromine, which is well underway and has demonstrated recovery efficiency and is expected to be available for use in existing and future development wells.

 

The Hugoton JV believes that its unconventional theory has not previously been targeted for exploration by historical operations in the field. The initial exploratory well was spud on May 7, 2022 near Garden City, Kansas, with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves. The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production and sales of natural gas, natural gas liquids and helium on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout and whether it should attempt to extend the time period before it has to drill additional wells in Hugoton Gas Field per the farm-out agreement.

 

The Company performed the ceiling test to assess potential impairment of the capitalized costs relative to its Hugoton Gas Field Project. The ceiling test indicated an impairment charge of $192,762 was required to reduce the total capitalized costs to $88,687 as of December 31, 2022. Accordingly, the Company has recorded an impairment charge of $192,762 to reduce the capitalized tangible and intangible costs related to its Hugoton Gas Field properties to $88,687 as of December 31, 2022. The Company recorded an addition to depreciation and amortization expense of $3,411 during the three months ended June 30, 2023.

 

Investment in GMDOC, LLC - On May 3, 2022, the Company entered into an operating agreement (the “Operating Agreement”) pursuant to which the Company acquired 17 (or 60.7143%) of 28 limited liability membership interests (the “Interests”) in GMDOC, LLC, a Kansas limited liability company (“GMDOC”), for an aggregate purchase price of $4,037,500, and was subsequently admitted as a member of GMDOC.

 

The Company paid the cash contribution for the membership interests of $850,000, during May 2022. The remainder of the Company’s capital contribution, or $3,187,500, was financed by the Bank Loan (as defined below).

 

GMDOC had previously acquired 70% of the working interests (the “Acquisition”) in certain oil and gas leases (the “GMDOC Leases”) from Castelli Energy, L.L.C., an Oklahoma limited liability company (“Castelli”). The GMDOC Leases cover approximately 10,000 acres located in Southern Kansas near the Oklahoma border. The GMDOC Leases currently produce approximately 100 barrels of oil per day and 1.5 million cubic feet of natural gas per day on a gross basis.

 

GMDOC is managed by two members: Darrah Oil Company, LLC, and Grand Mesa Operating Company, (collectively the “Managing Members”), which also serve as the operating companies under the GMDOC Leases.

 

 

Going Concern

Going Concern

 

The Company has incurred losses from operations, has a stockholders’ deficit, incurred net cash used in operating activities and has a significant working capital deficit as of and for the three and six months ended June 30, 2023 and as of and for the year ended December 31, 2022. The Company must raise substantial amounts of debt and equity capital from other sources in the future in order to fund (i) the development of the Properties acquired on April 1, 2021; (ii) our obligations for exploration and development under the Hugoton Farmout Agreement; (iii) normal day-to-day operations and corporate overhead; and (iv) outstanding debt and other financial obligations as they become due, as described below. Most of the Company’s outstanding debt and other financial obligations are currently past due and the Company must negotiate forbearance and/or restructuring agreements with the holders of such debt. These are substantial operational and financial issues that must be successfully addressed during 2023 and beyond.

 

The Company has made substantial progress in resolving many of its existing financial obligations and acquiring oil and gas producing properties to deploy its new operational strategy during the period through June 30, 2023.

 

The Company will have significant financial commitments executing its planned exploration and development of the Properties and the Hugoton Gas Field. The Company may find it necessary to raise substantial amounts of debt or equity capital to fund such exploration and development activities and may seek offers from industry operators and other third parties for interests in the Properties in exchange for cash and a carried interest in exploration and development operations or other joint venture arrangement. There can be no assurance that it will be able to obtain such new funding or be able to reach agreements with industry operators and other third parties or on what terms.

 

Due to the uncertainties related to the foregoing matters, there exists substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financials are issued. The unaudited condensed financial statements do not include any adjustments relating to the recoverability and classification of asset carrying amounts or the amount and classification of liabilities that might result should the Company be unable to continue as a going concern.

 

Revenue Recognition

Revenue Recognition

 

On January 1, 2018, the Company adopted Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers (Topic 606)” and the series of related accounting standard updates that followed, using the modified retrospective method of adoption. Adoption of the ASU did not require an adjustment to the opening balance of equity and did not change the Company’s amount and timing of revenues.

 

The Company’s revenues are primarily derived from its interests in the sale of oil and natural gas production. To date, such revenues have only included the sale of oil and natural gas however the Company expects to begin generating more substantial revenues from the sale of noble gases in the future. The Company recognizes revenue from its interests in the sales of oil and gas in the period that its performance obligations are satisfied. Performance obligations are satisfied when the customer obtains control of product, when the Company has no further obligations to perform related to the sale, when the transaction price has been determined and when collectability is probable. The sales of oil and gas are made under contracts which the third-party operators of the wells have negotiated with customers, which typically include variable consideration that is based on pricing tied to local indices and volumes delivered in the current month. The Company receives payment from the sale of oil and gas production from one to three months after delivery. At the end of each month when the performance obligation is satisfied, the variable consideration can be reasonably estimated and amounts due from customers are accrued in trade receivables, net in the balance sheets. Variances between the Company’s estimated revenue and actual payments are recorded in the month the payment is received, however, differences have been and are insignificant. The Company’s oil is typically sold at delivery points under contracts terms that are common in our industry.

 

Cash and Cash Equivalents

Cash and Cash Equivalents

 

For purposes of reporting cash flows, cash consists of cash on hand and demand deposits with financial institutions. The Company’s policy is that all highly liquid investments with an original maturity of three months or less when purchased would be cash equivalents and would be included along with cash as cash and equivalents.

 

The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (FDIC) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with several financial institutions if necessary to remain below the federally insured limit of $250,000 per bank. At June 30, 2023 and December 31, 2022, the uninsured balance amounted to $152,630 and $-0-, respectively.

 

 

Convertible Instruments

Convertible Instruments

 

In August 2020, the Financial Accounting Standards Board (“FASB”) issued ASU 2020-06, “Debt – Debt with Conversion and Other Options (Subtopic 470- 20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40)” which is intended to reduce complexity in applying GAAP to certain financial instruments with characteristics of liabilities and equity. The guidance in ASU 2020-06 simplifies the accounting for convertible debt instruments and convertible preferred stock by removing the existing guidance in Accounting Standards Codification (“ASC”) 470-20, Debt: Debt with Conversion and Other Options that requires entities to account for beneficial conversion features and cash conversion features in equity, separately from the host convertible debt or preferred stock. The guidance in ASC 470-20 applies to convertible instruments for which the embedded conversion features are not required to be bifurcated from the host contract and accounted for as derivatives. In addition, the amendments revise the scope exception from derivative accounting in ASC 815-40 for freestanding financial instruments and embedded features that are both indexed to the issuer’s own stock and classified in stockholders’ equity, by removing certain criteria required for equity classification. These amendments are expected to result in more freestanding financial instruments qualifying for equity classification (and, therefore, not accounted for as derivatives), as well as fewer embedded features requiring separate accounting from the host contract. The amendments in ASU 2020-06 further revise the guidance in ASC 260, Earnings Per Share, to require entities to calculate diluted earnings per share (EPS) for convertible instruments by using the if-converted method. In addition, entities must presume share settlement for purposes of calculating diluted EPS when an instrument may be settled in cash or shares.

 

The Company early adopted ASU 2020-06 effective January 1, 2021 and applied ASU 2020-06 to all outstanding financial instruments as of January 1, 2021.

 

Conversion options that contain variable settlement features such as provisions to adjust the conversion price upon subsequent issuances of equity or equity linked securities at exercise prices more favorable than that featured in the hybrid contract generally result in their bifurcation from the host instrument.

 

Derivative Instruments

Derivative Instruments

 

The Company accounts for derivative instruments or hedging activities under the provisions of ASC 815 Derivatives and Hedging. ASC 815 requires the Company to record derivative instruments at their fair value. If the derivative is designated as a fair value hedge, the changes in the fair value of the derivative and of the hedged item attributable to the hedged risk are recognized in earnings. If the derivative is designated as a cash flow hedge, the effective portions of changes in the fair value of the derivative are recorded in other comprehensive earnings (loss) and are recognized in the statement of earnings when the hedged item affects earnings. Ineffective portions of changes in the fair value of cash flow hedges, if any, are recognized in earnings. Changes in the fair value of derivatives that do not qualify for hedge treatment are recognized in earnings.

 

The purpose of hedging is to provide a measure of stability to the Company’s cash flows in an environment of volatile oil and gas prices and to manage the exposure to commodity price risk. As of June 30, 2023 and December 31, 2022 and during the periods then ended, the Company had no oil and natural gas derivative arrangements outstanding.

 

As a result of certain terms, conditions and features included in certain common stock purchase warrants issued by the Company (Notes 4 and 11), those warrants were required to be accounted for as derivatives at estimated fair value, with changes in fair value recognized in operations.

 

Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The carrying values of the Company’s accounts payable, accrued liabilities and short-term notes represent the estimated fair value due to the short-term nature of the accounts.

 

In accordance with ASC Topic 820 — Fair Value Measurements and Disclosures (“ASC 820”), the Company utilizes the market approach to measure fair value for its financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets, liabilities or a group of assets or liabilities, such as a business.

 

 

ASC 820 utilizes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The following is a brief description of those three levels:

 

  Level 1 — Quoted prices in active markets for identical assets and liabilities.
       
  Level 2 — Other significant observable inputs (including quoted prices in active markets for similar assets or liabilities).
       
  Level 3 — Significant unobservable inputs (including the Company’s own assumptions in determining the fair value.

 

The estimated fair value of warrant derivative liabilities, which are related to detachable warrants issued in connection with the Series A Convertible Preferred Stock, par value $0.001 per share (the “Series A Convertible Preferred Stock”) were estimated using a closed-ended option pricing model utilizing assumptions related to the contractual term of the instruments, estimated volatility of the price of the Company’s common stock, par value $0.001 per Share (the “Common Stock”) and current interest rates. The fair values for the warrant derivatives as of June 30, 2023 and December 31, 2022 were classified under the fair value hierarchy as Level 3.

 

The following table represents the Company’s hierarchy for its financial assets and liabilities measured at fair value on a recurring basis as of June 30, 2023 and December 31, 2022:

 

June 30, 2023  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $210,094   $210,094 
   $   $   $210,094   $210,094 

 

December 31, 2022  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $577,269   $577,269 
   $   $   $577,269   $577,269 

 

There were no changes in valuation techniques or reclassifications of fair value measurements between Levels 1, 2 or 3 during the three and six months ended June 30, 2023 and 2022.

 

Management Estimates

Management Estimates

 

The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

 

Significant estimates include, but are not limited to, oil and gas reserves; depreciation, depletion and amortization of proved oil and gas properties; future cash flows from oil and gas properties; impairment of long-lived assets; fair value of derivatives; asset retirement obligations, our control over equity method investments, fair value of equity compensation; warrants issued in connection with convertible debt; the realization of deferred tax assets; fair values of assets acquired and liabilities assumed in business combinations.

 

Oil and gas properties

Oil and gas properties

 

Central Kansas Uplift Properties - On April 1, 2021, we completed the acquisition of the Properties, under the terms of the Asset Purchase Agreement, for a purchase price of $900,000. The purchase of the Properties included the existing production equipment, infrastructure and ownership of 11 square miles of existing 3-D seismic data on the acreage. The Properties include a horizontal producing well, horizontal saltwater injection well, conventional saltwater disposal well and two conventional vertical producing wells, which currently produce from the Reagan Sand Zone with an approximate depth of 3,600 feet.

 

 

The Company has performed workovers of the wells subsequent to the Properties purchase which was necessary to put the lease back into production status. Therefore, these tangible and intangible workover costs were expensed as lease operating expenses rather than capitalized in the full cost pool through December 31, 2022. In addition, the Company is currently evaluating the Properties for oil and gas reserves and specifically the potential for noble gas reserves such as helium, argon and krypton. Based on these evaluations, the Company may redirect its efforts to the production of noble gases rather than crude oil on the Properties. These noble gas evaluation costs have also been expensed as lease operating costs through June 30, 2023.

 

Hugoton Gas Field Farm-Out -The first exploratory well commenced on May 7, 2022 near Garden City, Kansas with a goal to evaluate its unconventional theory of where substantial oil, natural gas and noble gases may be present in the Hugoton Gas Field. The initial well in which the Company has acquired a 40% participation together with three other venture partners was spud on May 7, 2022 with production casing set after testing and completion logs identified at least two potential zones with substantial gas and helium reserves.

 

The initial well was completed upon the successful perforation across two lower intervals of the Chase group of formations. The fracture stimulation was completed in two stages during June 2022. The well was connected to the pipeline and commenced commercial production on August 17, 2022. The Company is continuing to evaluate the initial flows of both natural gas and helium to determine its plan for additional wells on the farmout and whether it should attempt to extend the time period before it has to drill additional wells in Hugoton Gas Field per the farm-out agreement.

 

Full Cost Accounting

Full Cost Accounting

 

The accounting for, and disclosure of, oil and gas producing activities require that we choose between two GAAP alternatives: the full cost method or the successful efforts method. We adopted and use the full cost method of accounting, which involves capitalizing all exploration, exploitation, development and acquisition costs. Once we incur costs, they are recorded in the depletable pool of proved properties or in unproved properties, collectively, the full cost pool. Our unproved property costs, which include unproved oil and gas properties, properties under development, and major development projects, were zero as of June 30, 2023 and December 31, 2022, and are not subject to depletion. We review our unproved oil and gas property costs on a quarterly basis to assess for impairment and transfer unproved costs to proved properties as a result of extensions or discoveries from drilling operations or determination that no proved reserves are attributable to such costs. We expect these costs to be evaluated in one to seven years and transferred to the depletable portion of the full cost pool during that time. The full cost pool is comprised of intangible drilling costs, lease and well equipment and exploration and development costs incurred plus acquired proved and unproved leaseholds.

 

When we acquire significant amounts of undeveloped acreage, we capitalize interest on the acquisition costs in accordance with FASB ASC Subtopic 835-20 for Capitalization of Interest. When the unproved property costs are moved to proved developed and undeveloped oil and gas properties, or the properties are sold, we cease capitalizing interest.

 

Capitalized costs to acquire oil and natural gas properties are depreciated and depleted on a units-of-production basis based on estimated proved reserves. Capitalized costs of exploratory wells and development costs are depreciated and depleted on a units-of-production basis based on estimated proved developed reserves. Under this method, the sum of the full cost pool, excluding the book value of unproved properties, and all estimated future development costs are divided by the total estimated quantities of proved reserves. This rate is applied to our total production for the quarter, and the appropriate expense is recorded. Support equipment and other property, plant and equipment related to oil and gas producing activities, as well as property, plant and equipment unrelated to oil and gas producing activities, are recorded at cost and depreciated on a straight-line basis over the estimated useful lives of the assets.

 

Sales, dispositions and other oil and gas property retirements are accounted for as adjustments to the full cost pool, with no recognition of gain or loss, unless the disposition would significantly alter the amortization rate and/or the relationship between capitalized costs and Proved Reserves.

 

Pursuant to Rule 4-10(c)(4) of Regulation S-X, at the end of each quarterly period, companies that use the full cost method of accounting for their oil and gas properties must compute a limitation on capitalized costs, or ceiling test. The ceiling test involves comparing the net book value of the full cost pool, after taxes, to the full cost ceiling limitation defined below. In the event the full cost ceiling is less than the full cost pool, we must record a ceiling test write-down of our oil and gas properties to the value of the full cost ceiling. The full cost ceiling limitation is computed as the sum of the present value of estimated future net revenues from our proved reserves by applying average prices as prescribed by the SEC Release No. 33-8995, less estimated future expenditures (based on current costs) to develop and produce the proved reserves, discounted at 10%, plus the cost of properties not being amortized and the lower of cost or estimated fair value of unproved properties included in the costs being amortized, net of income tax effects.

 

 

The ceiling test is computed using the simple average spot price for the trailing twelve-month period using the first day of each month. The trailing twelve-month reference price was $94.14 per barrel for the West Texas Intermediate oil at Cushing, Oklahoma through December 31, 2022. This reference price for oil is further adjusted for quality factors and regional differentials to derive estimated future net revenues. Under full cost accounting rules, any ceiling test write-downs of oil and gas properties may not be reversed in subsequent periods. We recognized an impairment charge of $905,574 as of June 30, 2023 and December 31, 2022 which is attributable to changing our strategy to exploring for noble gases and away from crude oil production at our Central Kansas Uplift properties which resulted in a large decrease in estimated future cash flows.

 

The ceiling test calculation is based upon estimates of proved reserves. There are numerous uncertainties inherent in estimating quantities of proved reserves, in projecting the future rates of production and in the timing of development activities. The accuracy of any reserve estimate is a function of the quality of available data and of engineering and geological interpretation and judgment. Results of drilling, testing and production subsequent to the date of the estimate may justify revision of such estimate. Accordingly, reserve estimates are often different from the quantities of oil and gas that are ultimately recovered.

 

Equity Method Investments

Equity Method Investments

 

The Company uses the equity method of accounting for equity investments if the investment provides the ability to exercise significant influence, but not control, over operating and financial policies of the investee. The Company’s proportionate share of the net income or loss of these investees is included in our Statements of Operations. Judgment regarding the level of influence over each equity method investment includes considering key factors such as the Company’s ownership interest, legal form of the investee, representation on the board of directors, participation in policy-making decisions and material intra-entity transactions.

 

The Company evaluates equity method investments for impairment whenever events or changes in circumstances indicate that the carrying amount of the investment might not be recoverable. Factors considered by the Company when reviewing an equity method investment for impairment include the length of time and the extent to which the fair value of the equity method investment has been less than cost, the investee’s financial condition and near-term prospects and the intent and ability to hold the investment for a period of time sufficient to allow for anticipated recovery. An impairment that is other-than temporary is recognized in the period identified.

 

The Company accounts for distributions received from equity method investees under the “nature of the distribution” approach. Under this approach, distributions received from equity method investees are classified on the basis of the nature of the activity or activities of the investee that generated the distribution as either a return on investment (classified as cash inflows from operating activities) or a return of investment (classified as cash inflows from investing activities).

 

Issuance of Debt Instruments With Detachable Stock Purchase Warrants

Issuance of Debt Instruments With Detachable Stock Purchase Warrants

 

Proceeds from the issuance of a debt instrument with stock purchase warrants (detachable call options) are allocated to the two elements based on the relative fair values of the debt instrument without the warrants and of the warrants themselves at time of issuance. The portion of the proceeds allocated to the warrants are recorded as additional paid-in capital. The remainder of the proceeds are allocated to the debt instrument portion of the transaction. Such issuances generally result in a discount (or, occasionally, a reduced premium) relative to the debt instrument, which is amortized to interest expense using the effective interest rate method.

 

Asset Retirement Obligations

Asset Retirement Obligations

 

The Company records estimated future asset retirement obligations pursuant to the provisions of ASC 410. ASC 410 requires entities to record the fair value of a liability for an asset retirement obligation in the period in which it is incurred with a corresponding increase in the carrying amount of the related long-lived asset. Subsequent to its initial measurement, the asset retirement liability is required to be accreted each period. The Company’s asset retirement obligations consist of costs related to the plugging of wells, the removal of facilities and equipment, and site restoration on oil and gas properties.

 

 

During April 2021, the Company acquired the Properties and assumed the related asset retirement obligation existing at the date of acquisition. The asset retirement obligation assumed for the Properties relates to the plug and abandonment costs when the wells acquired are no longer useful. The Company determined the value of the liability by obtaining quotes for this service and estimated the increased costs that the Company will face in the future. We then discounted the future value based on an intrinsic interest rate that is appropriate for us. If costs rise more than what we have expected there could be additional charges in the future; however, we monitor the costs of the abandoned wells and we will adjust this liability if necessary.

 

As of December 31, 2012, the Company had divested all of its domestic oil properties that contained operating and abandoned wells in Texas, Colorado and Wyoming. The Company may have obligations related to the divestiture of certain abandoned non-producing domestic leasehold properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. Management believes the Company has been relieved from asset retirement obligation related to Infinity-Texas because of the sale of its Texas oil and gas properties in 2011 and its sale of 100% of the stock in Infinity-Texas in 2012. The Company has recognized an additional liability of $734,897 related to its former Texas oil and gas producing properties (included in asset retirement obligations) to recognize the potential personal liability of the Company and its officers for the Infinity-Texas oil and gas properties should the new owner not perform its obligations to reclaim abandoned wells in a timely manner. In addition, management believes the Company has been relieved from asset retirement obligations related to Infinity-Wyoming because of the sale of its Wyoming and Colorado oil and gas properties in 2008; however, the Company has recognized since 2012 an additional liability of $981,106 related to its former Wyoming and Colorado oil and gas producing properties (included in asset retirement obligations) to recognize the potential liability of the Company and its officers should the new owner not perform its obligations to reclaim abandoned wells in a timely manner.

 

Income Taxes

Income Taxes

 

The Company uses the asset and liability method of accounting for income taxes. This method requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of temporary differences between financial accounting bases and tax bases of assets and liabilities. The tax benefits of tax loss carryforwards and other deferred taxes are recorded as an asset to the extent that management assesses the utilization of such assets to be more likely than not. Management routinely assesses the realizability of the Company’s deferred income tax assets, and a valuation allowance is recognized if it is determined that deferred income tax assets may not be fully utilized in future periods. Management considers future taxable earnings in making such assessments. Numerous judgments and assumptions are inherent in the determination of future taxable earnings, including such factors as future operating conditions. When the future utilization of some portion of the deferred tax asset is determined not to be more likely than not, a valuation allowance is provided to reduce the recorded deferred tax asset. When the Company can project that a portion of the deferred tax asset can be realized through application of a portion of tax loss carryforward, the Company will record that utilization as a deferred tax benefit and recognize a deferred tax asset in the same amount. There can be no assurance that facts and circumstances will not materially change and require the Company to adjust its deferred income tax asset valuation allowance in a future period. The Company recognized a deferred tax asset, net of valuation allowance, of $-0- at June 30, 2023 and December 31, 2022.

 

The Company is potentially subject to taxation in many jurisdictions, and the calculation of income tax liabilities (if any) involves dealing with uncertainties in the application of complex income tax laws and regulations in various taxing jurisdictions. It recognizes certain income tax positions that meet a more-likely-than not recognition threshold. If the Company ultimately determines that the payment of these liabilities will be unnecessary, it will reverse the liability and recognize an income tax benefit. No liability for unrecognized tax benefit was recorded as of June 30, 2023 and December 31, 2022.

 

Stock-based compensation

Stock-based compensation

 

The Company applies ASC 718, Stock Compensation, which requires companies to recognize compensation expense for share-based payments based on the estimated fair value of the awards. ASC 718 also requires tax benefits relating to the deductibility of increases in the value of equity instruments issued under share-based compensation arrangements to be presented as financing cash inflows in the statement of cash flows. Compensation cost is recognized based on the grant-date fair value for all share-based payments granted and is estimated in accordance with the provisions of ASC 718.

 

 

Related Party Transactions

Related Party Transactions

 

The Company’s financial statements include disclosures of material related party transactions, other than compensation arrangements, expense allowances and similar items in the ordinary course of business. Disclosure of related party transactions include: 1) the nature of the relationships involved, 2) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements, 3) the dollar amounts of the transactions for each periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period, and 4) amounts due from or to related parties as of the date of each balance sheet presented and if not otherwise apparent,5) the terms of settlement.

 

Basic and Diluted Income (Loss) Per Share

Basic and Diluted Income (Loss) Per Share

 

Net income (loss) per share is calculated in accordance with FASB ASC 260, Earnings Per Share, for the periods presented. Basic net loss per share is based upon the weighted average number of shares of Common Stock outstanding. Diluted net earnings (loss) per share is based on the assumption that all dilutive convertible shares, warrants and stock options were converted or exercised or excluded from the calculations if their inclusion would be antidilutive. Dilution is computed by applying the if-converted/treasury stock method. Under this method, options and warrants are assumed exercised at the beginning of the period (or at the time of issuance, if later), and as if funds obtained thereby were used to purchase shares of Common Stock at the average market price during the period. The Company has outstanding convertible notes payable, Series A Convertible Preferred Stock and Series B Convertible Preferred Stock all of which are potentially dilutive. Such potential dilutive effect is included in diluted earnings (loss) per share at the beginning of the period (or at the time of issuance, if later) if they have a dilutive effect or such potentially dilutive securities are excluded from the calculations if their inclusion would be antidilutive.

 

The adoption of ASU 2020-06 requires the Company to assume share settlement when an instrument can be settled in cash or shares at the entity’s option. This applies both to convertible instruments and freestanding arrangements that could result in cash or share settlement. ASU 2020-06 also stipulates that an average market price for the period should be used in the computation of the diluted earnings (loss) per share denominator in cases when the exercise price of an instrument may change based on an entity’s share price or changes in the entity’s share price may affect the number of shares that would be used to settle a financial instrument. Lastly, an entity should use the weighted-average share count from each quarter when calculating the year-to-date weighted average share count for all potentially dilutive securities.

 

During the three and six months ended June 30, 2023 and 2022, the Company had outstanding the following securities that were potentially dilutive: i) Series A and Series B Convertible Preferred Stock, ii) various convertible notes payable, iii) warrants to purchase Common Stock and iv) options to purchase Common Stock. All potentially dilutive securities were considered for inclusion or exclusion from the calculation of diluted income (loss) per share for the three and six months ended June 30, 2023 and 2022. Any potentially dilutive security that were considered anti-dilutive were excluded from the net income (loss) per share reported for the three and six months ended June 30, 2023 and 2022.

 

Debt – Modifications and Extinguishments / Troubled Debt Restructuring:

Debt – Modifications and Extinguishments / Troubled Debt Restructuring:

 

In accordance with ASC 470, the Company assesses restructuring of debt as troubled debt restructuring if the creditor for economic or legal reasons related to the debtor’s financial difficulties grant a concession to the debtor that it would not otherwise consider. The Company records a gain on restructuring of payables when it transfers its assets to a creditor to fully settle a payable. The gain is measured by the excess of the carrying amount of the payable over the fair value of the assets transferred or fair value of equity interest granted.

 

 

The Company follows ASC 470-50 Debt – Modifications and Extinguishments (“ASC 470-50”), which requires the Company to assess whether the modified terms had resulted in a change that was substantial from the original agreement. ASC 470-50 requires the Company to assess if an exchange of debt instruments between or a modification of a debt instrument by a debtor and a creditor in a nontroubled debt situation is deemed to have been accomplished with debt instruments that are substantially different based on an analysis of the present value of the future cash flows under the terms of the new debt instrument compared to the present value of the remaining cash flows under the terms of the original instrument. The accounting treatment is different depending on whether such difference in the present value of future cash flows is greater than or less than 10 percent as follows:

 

  Difference is less than 10% - If the modification results in a difference in present value of future cash flows for the new and old debt instruments is less than 10% then it is considered to be not significant and is treated as a modification of the existing debt. Under a modification of debt, no gain or loss is recognized at the date of the modification. Rather a new effective interest rate is calculated, and interest expenses are accounted for under the interest method using the new effective interest rate on a prospective basis.
     
  Difference is more than 10% - If the modification results in a difference in present value of future cash flows for the new and old debt instruments is more than 10% then it is considered as significant and is treated as an extinguishment of the old debt instrument and issuance of the new debt instrument. Under extinguishment accounting, the old debt instrument is extinguished, and the new debt instrument is recorded at fair value. The difference in the carrying amount of the old debt instrument compared to the fair value of the new debt instrument is recognized as a gain or loss from extinguishment of debt as of the date of modification. Interest expense is accounted for under the interest method using the new effective rate.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

Business Combinations - In October 2021, FASB issued ASU 2021-08 Business Combinations (“Topic 805”): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. The ASU requires contract assets and contract liabilities acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606, Revenue from Contracts with Customers, as if it had originated the contracts. Under the current business combinations guidance, such assets and liabilities were recognized by the acquirer at fair value on the acquisition date. The Company adopted this ASU on January 1, 2023 and its adoption did not have a material impact on our financial statements.

 

Other accounting standards that have been issued by the FASB or other standards-setting bodies are not expected to have a material impact on the Company’s financial position, results of operations and cash flows.

v3.23.2
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

 

June 30, 2023  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $210,094   $210,094 
   $   $   $210,094   $210,094 

 

December 31, 2022  Level 1   Level 2   Level 3   Total 
Liabilities:                    
Warrant derivative liabilities  $   $   $577,269   $577,269 
   $   $   $577,269   $577,269 
v3.23.2
Oil and Gas Properties and Equipment (Tables)
6 Months Ended
Jun. 30, 2023
Extractive Industries [Abstract]  
Schedule of Oil and Gas Properties and Equipment

Oil and gas properties and equipment is comprised of the following at June 30, 2023 and December 31, 2022:

 

 

   June 30, 2023   December 31, 2022 
Central Kansas Uplift - Oil and gas production equipment  $913,425   $913,425 
Hugoton Gas Field - Oil and gas production equipment   96,831    96,831 
Central Kansas Uplift – Leasehold costs   15,225    15,225 
Hugoton Gas Field – Leasehold costs   191,535    191,535 
           
Subtotal   1,217,016    1,217,016 
Less: Accumulated impairment   (905,574)   (905,574)
Less: Accumulated depreciation, depletion and amortization   (229,577)   (222,755)
Oil and gas properties and equipment, net  $81,865   $88,687 
v3.23.2
Investment in unconsolidated subsidiary – GMDOC (Tables)
6 Months Ended
Jun. 30, 2023
Investments, All Other Investments [Abstract]  
Schedule of Investment Unconsolidated Subsidiary

A summary of the Company’s investment in unconsolidated subsidiary-GMDOC during the three and six months ended June 30, 2023 and 2022 follows:

 

    2023     2022     2023     2022  
    Three months ended
June 30,
    Six months ended
June 30,
 
    2023     2022     2023     2022  
                         

Investment in unconsolidated subsidiary-GMDOC, at beginning of period

  $ 1,141,274     $     $ 1,101,461     $  
Purchase of membership units in GMDOC, LLC           850,000             850,000  
Equity in earnings (loss) of GMDOC     (10,346 )     114,336       29,467       114,336  
Distributions during period                        
                                 
Investment in unconsolidated subsidiary-GMDOC at end of period   $ 1,130,928     $ 964,336     $ 1,130,928     $ 964,336  
Schedule of Unconsolidated Subsidairy Balance Sheet Financial Information

The following table presents summarized balance sheet financial information of the Company’s unconsolidated subsidiary – GMDOC as of June 30, 2023 and December 31, 2022:

 

   June 30, 2023   December 31, 2022 
ASSETS          
Assets:          
Cash  $103,061   $208,450 
Accrued revenue & prepaid expenses   173,625    320,212 
Oil and gas properties and equipment, net   7,042,620    7,359,905 
           
Total assets  $7,319,306   $7,888,567 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Accounts payable and accrued liabilities  $97,188   $207,244 
General managing members advances   150,000     
Mortgage note payable, net   4,328,036    4,984,821 
Asset Retirement Obligations   916,211    882,331 
Member’s equity   1,827,871    1,814,171 
           
Total liabilities and member’s equity  $7,319,306   $7,888,567 
Schedule of Unconsolidated Subsidiary Financial Information

The following table presents summarized income statement financial information of the Company’s unconsolidated subsidiary – GMDOC for the three and six months ended June 30, 2023 and 2022:

 

   2023   2022   2023   2022 
   Three months ended
June 30,
   Six months ended
June 30,
 
   2023   2022   2023   2022 
                 
Oil and gas revenues  $433,998   $788,964   $1,064,213   $788,964 
Lease operating expenses   (216,023)   (244,276)   (524,115)   (244,276)
Production related taxes   (4,888)   (22,912)   (20,777)   (22,912)
Ad valorem taxes   (5,982)   (10,755)   (16,737)   (10,755)
Depreciation expense   (134,206)   (131,514)   (268,413)   (131,514)
Accretion of asset retirement obligation   (16,940)   (16,987)   (33,880)   (16,987)
General and administrative expenses   (5,129)   (100,054)   (11,811)   (100,054)
Interest expense   (67,871)   (74,147)   (139,946)   (74,147)
                     
Net income (loss)   (17,041)   188,319    48,534    188,319 
AMGAS member’s percentage   60.7143

%

   60.7143    60.7143%   60.7143%
                     
Equity in earnings (loss) of unconsolidated subsidiary – GMDOC  $(10,346)  $114,336   $29,467   $114,336 
v3.23.2
Debt Obligations (Tables)
6 Months Ended
Jun. 30, 2023
Short-Term Debt [Line Items]  
Schedule of Debt Outstanding

Debt obligations were comprised of the following at June 30, 2023 and December 31, 2022:

 

   June 30, 2023   December 31, 2022 
Notes payable:          
           
3% convertible notes payable due March 30, 2026 (the 3% Notes)  $28,665   $28,665 
8% convertible notes payable due September 30, 2023 (the October 8% Notes)   500,000    500,000 
8% convertible note payable due September 30, 2023 (the 8% Note)   100,000    100,000 
8% convertible note payable due October 29, 2022 (the Second 8% Note) (in default)   50,000    50000 
8% Convertible promissory notes payable due September 30, 2023 (the June 2022 Note)   350,000    350,000 
8% Convertible promissory notes payable due September 30, 2023 (the May 2022 Notes)   266,204    312,500 
           
Total notes payable   1,294,869    1,341,165 
Less: Long-term portion   28,665    28,665 
Notes payable, short-term  $1,266,204   $1,312,500 
Schedule of Debt Obligations Maturities

Debt obligations become due and payable as follows:

 

Years ended 

Principal

balance due

 
     
2023 (Ju1y 1, 2023 through December 31, 2023)  $1,266,204 
2024    
2025    
2026   28,665 
2027    
2028    
Total  $1,294,869 
October 8% Notes [Member]  
Short-Term Debt [Line Items]  
Schedule of Convertible Debt

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

 

  

As of

January 10, 2023

 
Carrying value of the original convertible notes payable     
Principal balance  $500,000 
Accrued interest   120,753 
Total carrying value of original convertible note payable   620,753 
      
Less: Net present value of future cash flows on amended convertible notes payable   (516,776)
      
Gain on extinguishment of convertible notes payable  $103,977 
8% Convertible Promissory Notes Payable [Member]  
Short-Term Debt [Line Items]  
Schedule of Convertible Debt

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment:

 

  

As of

May 5, 2023

 
Carrying value of the original convertible note payable     
Principal balance  $100,000 
Accrued interest   28,877 
Total carrying value of original convertible note payable   128,877 
      
Less: Net present value of future cash flows on amended convertible note payable   (104,687)
      
Gain on extinguishment of convertible notes payable  $24,190 
June 2022 Note [Member]  
Short-Term Debt [Line Items]  
Schedule of Convertible Debt

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of May 5, 2023, the date of the amendment:

 

  

As of

May 5, 2023

 
Carrying value of the original convertible note payable     
Principal balance  $350,000 
Accrued interest   35,595 
Total carrying value of original convertible note payable   385,595 
      
Less: Net present value of future cash flows on amended convertible note payable   (366,400)
      
Difference  $19,195 
May 2022 Notes [Member]  
Short-Term Debt [Line Items]  
Schedule of Convertible Debt

Following is an analysis of estimated net present value of future cash flows of the amended notes as compared to the original notes as of January 10, 2023, the date of the amendment:

 

  

As of

January 10, 2023

 
Carrying value of the original convertible notes payable     
Principal balance  $312,500 
Accrued interest   75,471 
Total carrying value of original convertible note payable   387,971 
      
Less: Net present value of future cash flows on amended convertible notes payable   (322,986)
      
Gain on extinguishment of convertible notes payable  $64,985 
v3.23.2
Accrued liabilities (Tables)
6 Months Ended
Jun. 30, 2023
Payables and Accruals [Abstract]  
Schedule of Accrued Liabilities

Accrued liabilities consisted of the following at June 30, 2023 and December 31, 2022:

 

   June 30, 2023   December 31, 2022 
Accrued rent  $614,918   $614,918 
Accrued Nicaragua Concession fees   544,485    544,485 
Accrued lease operating costs   41,634     
           
Total accrued liabilities  $1,201,037   $1,159,403 
v3.23.2
Stock Options (Tables)
6 Months Ended
Jun. 30, 2023
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation

Total stock-based compensation is comprised of the following for the three and six months ended June 30, 2023 and 2022:

 

   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2023   2022   2023   2022 
Stock-based compensation – stock option grants  $   $51,000   $   $127,499 
                     
Stock-based compensation – restricted stock grants       255,625    174,375    336,875 
                     
Stock-based compensation – warrants issued for services pursuant to USNG Letter Agreement   71,716    71,716    143,432    143,873 
                     
Total stock-based compensation  $71,716   $378,341   $317,807   $608,247 
Summary of Stock Option Activity

The following table summarizes stock option activity for the six months ended June 30, 2023 and 2022:

 

   Number of Options  

Weighted Average Exercise

Price Per

Share

  

Weighted

Average

Remaining
Contractual
Term

 

Aggregate

Intrinsic

Value

 
Outstanding at December 31, 2021   1,892,000   $1.93   9.07 years  $ 
Granted                
Exercised                
Forfeited   (350,000)   0.50         
Outstanding at June 30, 2022   1,542,000   $2.26   8.49 years  $ 
Outstanding and exercisable at June 30, 2022   1,542,000   $2.26   8.49 years  $ 
                   
Outstanding at December 31, 2022   1,442,000   $2.38   7.96 years  $ 
Granted                
Exercised                
Forfeited   (2,000)   30.00         
Outstanding at June 30, 2023   1,440,000   $2.34   7.47 years  $ 
Outstanding and exercisable at June 30, 2023   1,440,000   $2.34   7.47 years  $ 
Summary of Exercise Price and Weighted Average Remaining Contractual Life

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable options under the Company’s option plans as of June 30, 2023:

 

    Outstanding options  Exercisable options

Exercise price

per share

  

Number of

options

   Weighted average
remaining
contractual life
 

Number of

options

   Weighted average
remaining
contractual life
                   
$0.50    1,350,000   7.93 years   1,350,000   7.93 years
$30.00    90,000   0.54 years   90,000   0.54 years
                   
 Total    1,440,000   7.47 years   1,440,000   7.47 years
Schedule of Restricted Stock Unit Activity

A summary of all restricted stock activity under the equity compensation plans for the six months ended June 30, 2023 and 2022 is as follows:

 

  

Number of

restricted

shares

  

Weighted

average

grant date

fair value

 
Nonvested balance, December 31, 2021   1,250,000   $0.13 
Granted   1,550,000    0.45 
Vested   (1,637,500)   (0.21)
Forfeited        
Nonvested balance, June 30, 2022   1,162,500   $0.45 
           
Nonvested balance, December 31, 2022   387,500   $0.45 
Granted        
Vested   (387,500)   (0.45)
Forfeited        
Nonvested balance, June 30, 2023      $ 
v3.23.2
Warrants (Tables)
6 Months Ended
Jun. 30, 2023
Warrants  
Summary of Warrant Activity

The following table summarizes warrant activity for the six months ended June 30, 2023 and 2022:

 

  

Number of

Warrants

  

Weighted

Average

Exercise Price

Per Share

 
Outstanding and exercisable at December 31, 2021   17,580,784   $0.47 
Issued in connection with issuance of Series A Convertible Preferred Stock (See Note 13)   1,666,667    .30 

Issued in connection with issuance of 8% Convertible Promissory Note (See Note 4)

   700,000    .50 
Exercised        
Forfeited/expired        
Outstanding and exercisable at June 30, 2022   19,947,451   $0.45 
           
Outstanding and exercisable at December 31, 2022   20,430,783   $0.45 
Issued   15,000,000    .05 
Exercised        
Forfeited/expired        
           
Outstanding and exercisable at June 30, 2023   35,430,783   $0.19 
Schedule of Calculating Estimated Fair Value of Warrants

 

  

As of

May 4, 2023 with original exercise price

  

As of

May 4, 2023 with new exercise price

 
         
Volatility – range   345.8%   345.8%
Risk-free rate   3.41%   3.41%
Contractual term   3.4 to 4.8 years    3.4 to 4.8 years 
Exercise price  $0.30 to 0.50    $0.05 
Number of warrants in aggregate   9,056,409    9,056,409 
Summary of Warrant Range of Exercise Prices and Weighted Average Remaining Contractual Life

The following table summarizes the range of exercise prices and weighted average remaining contractual life for outstanding and exercisable warrants to purchase common shares as of June 30, 2023:

 

 

    Outstanding and exercisable warrants

Exercise price

per share

  

Number of

warrants

  

Weighted average

remaining contractual life

$0.05    24,056,409   4.7 years
$0.50    11,374,374   3.0 years
           
 Total    35,430,783   4.2 years
v3.23.2
Gain on Extinguishment of Convertible Notes Payable (Tables)
6 Months Ended
Jun. 30, 2023
Gain On Extinguishment Of Convertible Notes Payable  
Schedule of Estimated Gain on Exchange and Extinguishment of Debt

During the three and six months ended June 30, 2023 and 2022, the Company recorded gains on the extinguishment of convertible notes payable through negotiation and settlements with certain creditors as follows:

 

   2023   2022   2023   2022 
   Three Months Ended
June 30,
   Six Months Ended
June 30,
 
   2023   2022   2023   2022 
Gain on extinguishment of convertible notes payable:                    
Gain on extinguishment of convertible notes
payable – the May 22 Notes (see Note 4)
  $24,190   $   $24,190   $ 
Gain on extinguishment of convertible notes
payable – the October 8% Notes (See Note 4)
           103,977     
Gain on extinguishment of convertible notes
payable – the May 22 Notes (see Note 4)
           64,985     
                     
Total gain on exchange and extinguishment of liabilities  $24,190   $   $193,152   $ 
v3.23.2
Asset Retirement Obligations (Tables)
6 Months Ended
Jun. 30, 2023
Asset Retirement Obligation Disclosure [Abstract]  
Schedule of Assets Retirement Obligation

 

   Amount 
     
Asset retirement obligation at December 31, 2021  $1,730,264 
Additions    
Accretion expense during the period   580 
      
Asset retirement obligation at June 30, 2022  $1,730,844 
      
Asset retirement obligation at December 31, 2022  $1,732,486 
Additions    
Accretion expense during the period   2,436 
      
Asset retirement obligation at June 30, 2023  $1,734,922 
v3.23.2
Warrant Derivative Liability (Tables)
6 Months Ended
Jun. 30, 2023
Warrant Derivative Liability  
Summary of Warrant Valuation Assumption

The following is a summary of the assumptions used in calculating estimated fair value of such derivative liabilities as of the June 30, 2023 and December 31, 2022:

 

  

As of

June 30, 2023

  

As of

December 31, 2022

 
         
Volatility – range   347.2%   342.2%
Risk-free rate   4.13%   3.99%
Contractual term   3.24 years    3.74 years 
Exercise price  $0.05   $0.39 
Number of warrants in aggregate   5,256,410    5,256,410 
 
  

As of

May 4, 2023 with original exercise price

  

As of

May 4, 2023 with new exercise price

 
         
Volatility – range   345.8%   345.8%
Risk-free rate   3.41%   3.41%
Contractual term   3.4 years    3.4 years 
Exercise price  $0.39   $0.05 
Number of warrants in aggregate   5,256,410    5,256,410 
 
Summary of Changes in Fair Value Derivative Financial Instruments

The following table provides a summary of the changes in fair value, including net transfers in and/or out, of the derivative financial instruments, measured at fair value on a recurring basis using significant unobservable inputs for both open and closed derivatives:

 

 

   Amount 
Balance at December 31, 2021  $ 
Unrealized derivative gains included in other income/expense for the period    
Balance at June 30, 2022  $ 
      
Balance at December 31, 2022  $577,269 
      
Unrealized derivative gains included in other income/expense for the period   (367,175)
      
Balance at June 30, 2023  $210,094 
v3.23.2
Stockholder’s Deficit (Tables)
6 Months Ended
Jun. 30, 2023
Equity [Abstract]  
Schedule of Series A and B Convertible Preferred Stock Activity

The following summarizes the activity in the Series A and Series B Convertible Preferred Stock for the three months ended June 30, 2023 and 2022:

 

   Six months ended
June 30, 2023
   Six months ended
June 30, 2022
 
   Series A   Series B   Series A   Series B 
                 
Outstanding at beginning of period:   25,526        22,076     
Issued       7,500    5,000     
Converted to common stock   (250)       (2,700)    
Redeemed                 
                     
Outstanding at end of period   25,276    7,500    24,376     
v3.23.2
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Platform Operator, Crypto-Asset [Line Items]    
Warrant derivative liabilities $ 210,094 $ 577,269
Fair value on liablities 210,094 577,269
Fair Value, Inputs, Level 1 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Warrant derivative liabilities
Fair value on liablities
Fair Value, Inputs, Level 2 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Warrant derivative liabilities
Fair value on liablities
Fair Value, Inputs, Level 3 [Member]    
Platform Operator, Crypto-Asset [Line Items]    
Warrant derivative liabilities 210,094 577,269
Fair value on liablities $ 210,094 $ 577,269
v3.23.2
Nature of Operations, Basis of Presentation and Summary of Significant Accounting Policies (Details Narrative)
3 Months Ended 6 Months Ended 12 Months Ended
May 16, 2022
USD ($)
May 03, 2022
USD ($)
a
Apr. 02, 2021
USD ($)
a
Jun. 30, 2023
USD ($)
a
$ / shares
Jun. 30, 2023
USD ($)
a
$ / shares
Jun. 30, 2022
USD ($)
Dec. 31, 2022
USD ($)
$ / shares
Dec. 31, 2012
USD ($)
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Payments to acquire oil and gas property and equipment     $ 900,000   $ 15,224    
Oil and Gas, developed average, gross | a     11,000          
Tangible asset impairment charges         712,812   $ 712,812  
Impairment Charge on Reclassified Assets             192,762  
Capitalized Costs, Oil and Gas Producing Activities, Gross             88,687  
Capitalized Costs, Asset Retirement Costs             192,762  
Depreciation and amortization       $ 3,411 $ 6,822 $ 61,668    
Repayments of Debt $ 850,000              
Proceeds from Bank Debt $ 3,187,500              
Area of land | a       1.4 1.4      
Cash insured limit       $ 250,000 $ 250,000      
Uninsured balance amounted       $ 152,630 $ 152,630   $ 0  
Preferred stock, par value | $ / shares       $ 0.0001 $ 0.0001   $ 0.0001  
Common stock, par value | $ / shares       $ 0.001 $ 0.001      
Oil and gas property full cost method net     $ 900,000          
Impairment charge on oil and gas properties         $ 905,574   $ 905,574  
Debt percentage               100.00%
Deferred tax asset, net of valuation allowance       $ 0 0   0  
Unrecognized tax benefits       $ 0 $ 0   $ 0  
West Texas Intermediate [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Share Price | $ / shares             $ 94.14  
Texas Oil And Gas [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Oil and gas reclamation liability               $ 734,897
Wyoming And Colorado Oil And Gas [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Oil and gas reclamation liability               $ 981,106
Series A Preferred Stock [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Preferred stock, par value | $ / shares       $ 0.001 $ 0.001      
Operating Agreement [Member] | GMDOC, LLC [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Area of land | a   10,000            
Operating Agreement [Member] | GMDOC, LLC [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Ownership percentage   60.7143%            
Aggregate purchase price of acquisition   $ 4,037,500            
Operating Agreement [Member] | GMDOC, LLC [Member] | Castelli Energy, L.L.C., [Member]                
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]                
Ownership percentage   70.00%            
v3.23.2
Schedule of Oil and Gas Properties and Equipment (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Property, Plant and Equipment [Line Items]    
Subtotal $ 1,217,016 $ 1,217,016
Less: Accumulated impairment (905,574) (905,574)
Less: Accumulated depreciation, depletion and amortization (229,577) (222,755)
Property and equipment, net 81,865 88,687
Central Kansas Uplift [Member]    
Property, Plant and Equipment [Line Items]    
Hugoton Gas Field - Oil and gas production equipment 913,425 913,425
Hugoton Gas Field – Leasehold costs 15,225 15,225
Hugoton Gas Field [Member]    
Property, Plant and Equipment [Line Items]    
Hugoton Gas Field - Oil and gas production equipment 96,831 96,831
Hugoton Gas Field – Leasehold costs $ 191,535 $ 191,535
v3.23.2
Schedule of Investment Unconsolidated Subsidiary (Details) - GMDOC, LLC [Member] - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Restructuring Cost and Reserve [Line Items]        
Investment in unconsolidated subsidiary-GMDOC, at beginning of period $ 1,141,274 $ 1,101,461
Purchase of membership units in GMDOC, LLC 850,000 850,000
Equity in earnings (loss) of GMDOC (10,346) 114,336 29,467 114,336
Distributions during period
Investment in unconsolidated subsidiary-GMDOC at end of period $ 1,130,928 $ 964,336 $ 1,130,928 $ 964,336
v3.23.2
Schedule of Unconsolidated Subsidairy Balance Sheet Financial Information (Details) - USD ($)
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Assets:            
Oil and gas properties and equipment, net $ 81,865   $ 88,687      
Total assets 1,670,178   1,260,351      
LIABILITIES AND STOCKHOLDERS’ DEFICIT            
General managing members advances 150,000        
Mortgage note payable, net 1,447,764   1,387,893      
Asset Retirement Obligations 1,734,922   1,732,486      
Member’s equity (4,438,899) $ (4,924,205) (5,259,027) $ (3,125,467) $ (3,543,079) $ (3,165,490)
Total liabilities and stockholders’ deficit 1,670,178   1,260,351      
GMDOC, LLC [Member]            
Assets:            
Cash 103,061   208,450      
Accrued revenue & prepaid expenses 173,625   320,212      
Oil and gas properties and equipment, net 7,042,620   7,359,905      
Total assets 7,319,306   7,888,567      
LIABILITIES AND STOCKHOLDERS’ DEFICIT            
Accounts payable and accrued liabilities 97,188   207,244      
Mortgage note payable, net 4,328,036   4,984,821      
Asset Retirement Obligations 916,211   882,331      
Member’s equity 1,827,871   1,814,171      
Total liabilities and stockholders’ deficit $ 7,319,306   $ 7,888,567      
v3.23.2
Schedule of Unconsolidated Subsidiary Financial Information (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Mar. 31, 2023
Jun. 30, 2022
Mar. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Restructuring Cost and Reserve [Line Items]            
Lease operating expenses $ (133,687)   $ (56,178)   $ (163,292) $ (142,714)
Production related taxes   (82)   (110)
Depreciation expense (3,411)   (30,834)   (6,822) (61,668)
Accretion of asset retirement obligation (1,218)   (302)   (2,436) (580)
Interest expense (22,927)   (332,234)   (60,339) (425,790)
Net income (loss) (263,294) $ 101,672 (741,168) $ (554,634) (161,622) (1,295,802)
GMDOC, LLC [Member]            
Restructuring Cost and Reserve [Line Items]            
Oil and gas revenues 433,998   788,964   1,064,213 788,964
Lease operating expenses (216,023)   (244,276)   (524,115) (244,276)
Production related taxes (4,888)   (22,912)   (20,777) (22,912)
Ad valorem taxes (5,982)   (10,755)   (16,737) (10,755)
Depreciation expense (134,206)   (131,514)   (268,413) (131,514)
Accretion of asset retirement obligation (16,940)   (16,987)   (33,880) (16,987)
General and administrative expenses (5,129)   (100,054)   (11,811) (100,054)
Interest expense (67,871)   (74,147)   (139,946) (74,147)
Net income (loss) $ (17,041)   $ 188,319   $ 48,534 $ 188,319
AMGAS member’s percentage 60.7143%   60.7143%   60.7143% 60.7143%
Equity in earnings (loss) of unconsolidated subsidiary – GMDOC $ (10,346)   $ 114,336   $ 29,467 $ 114,336
v3.23.2
Schedule of Debt Outstanding (Details) (Parenthetical)
6 Months Ended 12 Months Ended
Jun. 30, 2023
Dec. 31, 2022
Convertible Promissory Notes Payable [Member]    
Short-Term Debt [Line Items]    
Debt interest rate 3.00%  
Debt maturity date Mar. 30, 2026 Mar. 30, 2026
Convertible Promissory Notes Payable One [Member]    
Short-Term Debt [Line Items]    
Debt interest rate 8.00% 8.00%
Debt maturity date Sep. 30, 2023 Sep. 30, 2023
Convertible Promissory Notes Payable Two [Member]    
Short-Term Debt [Line Items]    
Debt interest rate 8.00% 8.00%
Debt maturity date Sep. 30, 2023 Sep. 30, 2023
Convertible Promissory Notes Payable Three [Member]    
Short-Term Debt [Line Items]    
Debt interest rate 8.00% 8.00%
Debt maturity date Oct. 29, 2022 Oct. 29, 2022
Convertible Promissory Notes Payable Four [Member]    
Short-Term Debt [Line Items]    
Debt interest rate 8.00% 8.00%
Debt maturity date Sep. 30, 2023 Sep. 30, 2023
Convertible Promissory Notes Payable Five [Member]    
Short-Term Debt [Line Items]    
Debt interest rate 8.00% 8.00%
Debt maturity date Sep. 30, 2023 Sep. 30, 2023
v3.23.2
Schedule of Debt Outstanding (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Short-Term Debt [Line Items]    
Notes payable $ 1,294,869 $ 1,341,165
Notes payable, noncurrent 28,665 28,665
Notes payable, current 1,266,204 1,312,500
Convertible Promissory Notes Payable [Member]    
Short-Term Debt [Line Items]    
Notes payable 28,665 28,665
Convertible Promissory Notes Payable One [Member]    
Short-Term Debt [Line Items]    
Notes payable 500,000 500,000
Convertible Promissory Notes Payable Two [Member]    
Short-Term Debt [Line Items]    
Notes payable 100,000 100,000
Convertible Promissory Notes Payable Three [Member]    
Short-Term Debt [Line Items]    
Notes payable 50,000 50,000
Convertible Promissory Notes Payable Four [Member]    
Short-Term Debt [Line Items]    
Notes payable 350,000 350,000
Convertible Promissory Notes Payable Five [Member]    
Short-Term Debt [Line Items]    
Notes payable $ 266,204 $ 312,500
v3.23.2
Schedule of Debt Obligations Maturities (Details)
Jun. 30, 2023
USD ($)
Debt Disclosure [Abstract]  
2023 (Ju1y 1, 2023 through December 31, 2023) $ 1,266,204
2024
2025
2026 28,665
2027
2028
Total $ 1,294,869
v3.23.2
Schedule of Convertible Debt (Details) - USD ($)
3 Months Ended 6 Months Ended
May 05, 2023
Jan. 10, 2023
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Short-Term Debt [Line Items]            
Gain on extinguishment of convertible notes payable     $ 24,190 $ 193,152
October 8% Notes [Member]            
Short-Term Debt [Line Items]            
Principal balance at par   $ 500,000        
Accrued interest   120,753        
Notes payable, in default   620,753        
Deferred Debt Issuance Cost, Writeoff   (516,776)        
Gain on extinguishment of convertible notes payable   103,977     103,977  
8% Convertible Promissory Notes Payable [Member]            
Short-Term Debt [Line Items]            
Principal balance at par $ 100,000          
Accrued interest 28,877          
Notes payable, in default 128,877          
Deferred Debt Issuance Cost, Writeoff (104,687)          
Gain on extinguishment of convertible notes payable 24,190   $ 24,190      
June 2022 Note [Member]            
Short-Term Debt [Line Items]            
Principal balance at par 350,000          
Accrued interest 35,595          
Notes payable, in default 385,595          
Deferred Debt Issuance Cost, Writeoff (366,400)          
Gain on extinguishment of convertible notes payable $ 19,195          
May 2022 Notes [Member]            
Short-Term Debt [Line Items]            
Principal balance at par   312,500        
Accrued interest   75,471        
Notes payable, in default   387,971        
Deferred Debt Issuance Cost, Writeoff   (322,986)        
Gain on extinguishment of convertible notes payable   $ 64,985     $ 64,985  
v3.23.2
Debt Obligations (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
May 05, 2023
May 04, 2023
May 04, 2023
Jan. 13, 2023
Jan. 10, 2023
Jun. 08, 2022
May 13, 2022
Oct. 29, 2021
Aug. 30, 2021
Mar. 31, 2021
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Jan. 09, 2023
Jun. 29, 2022
Short-Term Debt [Line Items]                                  
Debt instrument, face amount                                 $ 112,500
Conversion price         $ 0.10     $ 0.10                  
Gain on extinguishment of convertible notes payable                     $ 24,190 $ 193,152      
Accrued default interest                     72,975   $ 72,975   $ 244,038    
Series B Convertible Preferred Stock [Member]                                  
Short-Term Debt [Line Items]                                  
Warrant to purchase of common stock   15,000,000 15,000,000                            
Warrants exercise price   $ 0.05 $ 0.05                            
Conversion price   $ 0.05 $ 0.05                            
Conversion rate     8.00%                            
Stock Issued During Period, Shares, New Issues   7,500                     7,500      
8% Convertible Promissory Notes Payable [Member]                                  
Short-Term Debt [Line Items]                                  
Debt instrument, face amount $ 450,000                                
Share price $ 0.40 $ 0.50 $ 0.50                            
Proceeds from convertible debt $ 100,000                                
Debt conversion, description The Company evaluated the modification of the 8% Note that occurred on May 5, 2023. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The analysis of the present value of future cash flows under the new debt instrument compared to the old debt instrument resulted in a difference in excess of 10%. Accordingly, the Company accounted for the amendment of the Note as an extinguishment of the original 8% Note.                                
Conversion price $ 0.40 0.50 0.50                            
Gain on extinguishment of convertible notes payable $ 24,190                   24,190            
Outstanding principal balance $ 100,000                                
8% Convertible Promissory Notes Payable [Member] | Convertible Notes Payable [Member]                                  
Short-Term Debt [Line Items]                                  
Gain on extinguishment of convertible notes payable                     $ 24,290   $ 24,290        
October 8% Notes [Member]                                  
Short-Term Debt [Line Items]                                  
Conversion price   0.05 0.05   $ 0.50                     $ 0.10  
Gain on extinguishment of convertible notes payable         $ 103,977               $ 103,977        
Convertible Promissory Notes Payable Two [Member]                                  
Short-Term Debt [Line Items]                                  
Debt instrument interest rate                     8.00%   8.00%   8.00%    
Debt maturity date                         Sep. 30, 2023   Sep. 30, 2023    
Accrued default interest                     $ 12,349   $ 12,349   $ 10,668    
May 2022 Notes [Member]                                  
Short-Term Debt [Line Items]                                  
Debt instrument, face amount       $ 46,296                          
Proceeds from convertible debt       500,000                          
Conversion price         $ 0.50                     $ 0.10  
Gain on extinguishment of convertible notes payable         $ 64,985               64,985        
Outstanding principal balance                     $ 266,204   $ 266,204   $ 312,500    
Accrued default interest       $ 3,704                          
Debt Settlement Agreement [Member] | 3% Convertible Promissory Notes Payable [Member]                                  
Short-Term Debt [Line Items]                                  
Extinguishment of debt amount                   $ 2,866,497              
Debt instrument, face amount                   $ 28,665              
Debt instrument interest rate                   3.00%              
Warrant to purchase of common stock                   5,732,994              
Warrants exercise price                   $ 0.50              
Debt instrument description                   The 3% Notes allow for prepayment at any time with all principal and accrued interest becoming due and payable at maturity on March 30, 2026 (the “Maturity Date”).              
Debt maturity date                   Mar. 30, 2026              
Securities Purchase Agreement [Member] | 8% Convertible Promissory Notes Payable [Member]                                  
Short-Term Debt [Line Items]                                  
Debt instrument, face amount           $ 350,000 $ 850,000 $ 500,000 $ 100,000                
Warrant to purchase of common stock           700,000   1,500,000 200,000                
Warrants exercise price   $ 0.05 $ 0.05     $ 0.50   $ 0.50                  
Debt instrument description               The Company also granted the October 8% Note Investors certain piggy-back registration rights whereby the Company has agreed to register for resale the shares underlying the October 8% Note Warrants and the conversion of the October 8% Notes unless the shares of the Company commences to trade on the NYSE American; the Nasdaq Capital Market; the Nasdaq Global Market; the Nasdaq Global Select Market; or the New York Stock Exchange, within one hundred twenty (120) days after the closing date.                  
Debt maturity date             Jun. 29, 2022   Oct. 29, 2022                
Number of shares issued on conversion           700,000   1,000,000                  
Share price           $ 0.50 $ 0.40 $ 0.50 $ 0.50                
Proceeds from convertible debt           $ 350,000 $ 850,000 $ 500,000 $ 100,000                
Debt conversion, description The Company evaluated the modification of the 8% Note that occurred on May 5, 2023. This evaluation included analyzing whether there are significant and consequential changes to the economic substance of the October 8% Notes based on an analysis of the amended future cash flows. If the change was deemed insignificant (generally less than 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is considered a debt modification in the financial statements, whereas if the change is considered substantial (generally over 10% difference in estimated net present value of future cash flows between the amended notes and the original notes) then the change is reflected as a debt extinguishment in the financial statements. A modification or an exchange that changes the substantive conversion option as of the conversion date would generally be considered substantial and require extinguishment accounting. The analysis of the present value of future cash flows under the new debt instrument compared to old debt instrument resulted in a difference less than 10%. Accordingly, the Company accounted for the amendment of the Note as a modification of the original 8% Note resulting in no gain or loss on the date of modification.           The May 2022 Notes bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time (subject to the occurrence of an event of default) in an amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest, and shall be mandatorily repaid in cash in an amount equal to a) fifty percent (50%) of the then outstanding principal amount equal to 120% of the principal amount of each May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 but not greater than $3,000,000; or b) one hundred percent (100%) of the then outstanding principal amount equal to 120% of the principal amount of a May 2022 Note and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of in excess of $3,000,000. In addition, pursuant to the May 2022 Notes, so long as such May 2022 Notes remain outstanding, the Company shall not enter into any financing transactions pursuant to which the Company sells its securities at a price lower than the $0.40 per share conversion price, subject to certain adjustments, without the written consent of the investors. The October 8% Notes all bear interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note and the October 8% Notes shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the October 8% Notes, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the October 8% Note Investor.                  
Stock Issued During Period, Shares, New Issues             425,000                    
Securities Purchase Agreement [Member] | 8% Convertible Promissory Notes Payable [Member] | Common Stock [Member]                                  
Short-Term Debt [Line Items]                                  
Number of shares issued on conversion                 200,000                
Share price                 $ 0.50                
Securities Purchase Agreement [Member] | 8% Convertible Promissory Notes Payable [Member] | Common Stock [Member] | May Investor [Member]                                  
Short-Term Debt [Line Items]                                  
Number of shares issued on conversion             2,125,000                    
Securities Purchase Agreement [Member] | Senior Unsecured Convertible Note [Member] | Common Stock [Member]                                  
Short-Term Debt [Line Items]                                  
Debt conversion, description             Pursuant to the purchase agreement for the Securities, for a period of twelve (12) months after the closing date, the investors have a right to participate in any issuance of the Company’s Common Stock, Common Stock equivalents, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of the subsequent financing. The Company and the October 8% Note Investors have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.                  
Securities Purchase Agreement [Member] | Senior Unsecured Convertible Note [Member] | Beneficial Owner [Member]                                  
Short-Term Debt [Line Items]                                  
Debt conversion, description             The conversion of the May 2022 Notes are each subject to beneficial ownership limitations such that the investors may not convert the May 2022 Notes to the extent that such conversion or exercise would result in an investor being the beneficial owner in excess of 4.99% (or, upon election of the Investor, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company. The conversion of the October 8% Notes and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the October 8% Note Investors may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.                  
Securities Purchase Agreement [Member] | Convertible Notes Payable [Member]                                  
Short-Term Debt [Line Items]                                  
Debt conversion, description               The 8% Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the 8% Note shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the 8% Note, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the 8% Note Investor.                  
Securities Purchase Agreement [Member] | Convertible Notes Payable [Member] | Common Stock [Member]                                  
Short-Term Debt [Line Items]                                  
Debt conversion, description               The Company and the 8% Note Investor have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.                  
Securities Purchase Agreement [Member] | Convertible Notes Payable [Member] | Beneficial Owner [Member]                                  
Short-Term Debt [Line Items]                                  
Debt conversion, description               The conversion of the 8% Note and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.                  
Securities Purchase Agreement [Member] | Second 8% Convertible Promissory Notes [Member]                                  
Short-Term Debt [Line Items]                                  
Debt instrument, face amount               $ 50,000                  
Warrant to purchase of common stock               150,000                  
Warrants exercise price               $ 0.50                  
Number of shares issued on conversion               100,000                  
Share price               $ 0.50                  
Proceeds from convertible debt               $ 50,000                  
Debt conversion, description               The Second 8% Note bears interest at a rate of eight percent (8%) per annum, may be voluntarily repaid in cash in full or in part by the Company at any time in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest. Fifty percent (50%) of the Second 8% Note shall be mandatorily repaid in cash in an amount equal to 120% of the principal amount of the underlying notes and any accrued and unpaid interest in the event of the consummation by the Company of any public or private offering or other financing pursuant to which the Company receives gross proceeds of at least $2,000,000 and one-hundred percent (100%) of the underlying notes plus accrued interest shall be mandatorily repaid in an amount equal to 120% of outstanding principal and interest in cases in which the Company receives gross proceeds of at least $3,000,000. In addition, pursuant to the Second 8% Note, so long as the underlying notes remain outstanding, the Company cannot enter into any financing transactions pursuant to which the Company sells its securities at a price lower than $0.50 cents per share without the written consent of the Second 8% Note Investor.                  
Securities Purchase Agreement [Member] | Second 8% Convertible Promissory Notes [Member] | Series B Preferred Stock [Member]                                  
Short-Term Debt [Line Items]                                  
Warrants exercise price               $ 0.05                  
Securities Purchase Agreement [Member] | Second 8% Convertible Promissory Notes [Member] | Common Stock [Member]                                  
Short-Term Debt [Line Items]                                  
Debt conversion, description               The Company, the Second 8% Note Investor have agreed that for so long as the underlying warrants remain outstanding, the investors have the right to participate in any issuance of Common Stock, conventional debt, or a combination of such securities and/or debt, up to an amount equal to thirty-five percent (35%) of such subsequent financing.                  
Securities Purchase Agreement [Member] | Second 8% Convertible Promissory Notes [Member] | Beneficial Owner [Member]                                  
Short-Term Debt [Line Items]                                  
Debt conversion, description               The conversion of the Second 8% Note and the exercise of the underlying warrants are each subject to beneficial ownership limitations such that the 8% Note Investor may not convert the underlying notes or exercise the underlying warrants to the extent that such conversion or exercise would result in any of the investors being the beneficial owner in excess of 4.99% (or, upon election of the investors, 9.99%) of the number of shares of the Common Stock outstanding immediately after giving effect to the issuance of shares of Common Stock issuable upon such conversion or exercise, which beneficial ownership limitation may be increased or decreased up to 9.99% upon notice to the Company, provided that any increase in such limitation will not be effective until 61 days following notice to the Company.                  
v3.23.2
Schedule of Accrued Liabilities (Details) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Payables and Accruals [Abstract]    
Accrued rent $ 614,918 $ 614,918
Accrued Nicaragua Concession fees 544,485 544,485
Accrued lease operating costs 41,634
Total accrued liabilities $ 1,201,037 $ 1,159,403
v3.23.2
Accrued liabilities (Details Narrative)
Jun. 30, 2023
a
Payables and Accruals [Abstract]  
Area of Land 1.4
v3.23.2
Schedule of Stock-Based Compensation (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Total stock-based compensation $ 71,716 $ 378,341 $ 317,807 $ 608,247
Share-Based Payment Arrangement, Option [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Total stock-based compensation 51,000 127,499
Restricted Stock [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Total stock-based compensation 255,625 174,375 336,875
Warrant [Member]        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Total stock-based compensation $ 71,716 $ 71,716 $ 143,432 $ 143,873
v3.23.2
Summary of Stock Option Activity (Details) - USD ($)
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]    
Number of Options, Outstanding, Beginning 1,442,000 1,892,000
Weighted Average Exercise Price Per Share, Outstanding, Beginning $ 2.38 $ 1.93
Weighted Average Remaining Contractual Term, Outstanding, Beginning 7 years 11 months 15 days 9 years 25 days
Aggregate Intrinsic Value, Outstanding, Beginning
Number of Options, Granted
Weighted Average Exercise Price Per Share, Granted
Number of Options, Exercised
Weighted Average Exercise Price Per Share, Exercised
Number of Options, Forfeited (2,000) (350,000)
Weighted Average Exercise Price Per Share, Forfeited $ 30.00 $ 0.50
Number of Options, Outstanding, Ending 1,440,000 1,542,000
Weighted Average Exercise Price Per Share, Outstanding, Ending $ 2.34 $ 2.26
Weighted Average Exercise Price Per Share, Outstanding, Ending 7 years 5 months 19 days 8 years 5 months 26 days
Aggregate Intrinsic Value, Outstanding, Ending  
Number of Options, Outstanding and Exercisable 1,440,000 1,542,000
Weighted Average Exercise Price Per Share, Outstanding and Exercisable $ 2.34 $ 2.26
Weighted Average Remaining Contractual Term, Outstanding and exercisable 7 years 5 months 19 days 8 years 5 months 26 days
Aggregate Intrinsic Value, Exercisable
v3.23.2
Summary of Exercise Price and Weighted Average Remaining Contractual Life (Details) - $ / shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise price per share $ 2.34 $ 2.26 $ 2.38 $ 1.93
Number of options, outstanding 1,440,000 1,542,000 1,442,000 1,892,000
Weighted average remaining contractual life, outstanding 7 years 5 months 19 days 8 years 5 months 26 days    
Number of Option, exercisable 1,440,000 1,542,000    
Weighted average remaining contractual life, exercisable 7 years 5 months 19 days 8 years 5 months 26 days    
Exercise Price One [Member]        
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise price per share $ 0.50      
Number of options, outstanding 1,350,000      
Weighted average remaining contractual life, outstanding 7 years 11 months 4 days      
Number of Option, exercisable 1,350,000      
Weighted average remaining contractual life, exercisable 7 years 11 months 4 days      
Exercise Price Two [Member]        
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]        
Exercise price per share $ 30.00      
Number of options, outstanding 90,000      
Weighted average remaining contractual life, outstanding 6 months 14 days      
Number of Option, exercisable 90,000      
Weighted average remaining contractual life, exercisable 6 months 14 days      
v3.23.2
Schedule of Restricted Stock Unit Activity (Details) - Restricted Stock [Member] - $ / shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Restricted shares, Granted 387,500 1,250,000
Weighted average grant date fair value, Nonvested balance, beginning $ 0.45 $ 0.13
Number of Restricted shares, Granted 1,550,000
Weighted average grant date fair value, Granted $ 0.45
Number of Restricted shares, Vested (387,500) (1,637,500)
Weighted average grant date fair value, Vested $ (0.45) $ (0.21)
Number of Restricted shares, Forfeited
Weighted average grant date fair value, Forfeited
Number of Restricted shares, Nonvested balance, end 1,162,500
Weighted average grant date fair value, Nonvested balance, end $ 0.45
v3.23.2
Stock Options (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
May 31, 2022
Aug. 31, 2020
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Oct. 13, 2021
Sep. 25, 2015
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Stock-based compensation expense in connection with vesting of options granted     $ 71,716 $ 378,341 $ 317,807 $ 608,247      
Share-based payment award, options, vested and expected to vest     0   0   $ 0    
Unrecognized compensation cost     0   0   $ 0    
Stock-based compensation expense         317,807 608,247      
Unrecognized compensation costs     $ 0   $ 0        
2015 Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Issuance of reserved common stock, shares                 500,000
2021 Plan [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Issuance of reserved common stock, shares               5,000,000  
2021 Plan and the 2015 [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Issuance of reserved common stock, shares     5,500,000   5,500,000        
Share based payment award number of shares available for grant     5,500,000   5,500,000        
Equity Option [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Stock-based compensation expense in connection with vesting of options granted     $ 0 51,000 $ 0 127,499      
Restricted Stock [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Stock-based compensation expense in connection with vesting of options granted     255,625 $ 174,375 $ 336,875      
Number of restricted shares, granted         1,550,000      
Stock-based compensation expense     $ 0 $ 255,625 $ 174,375 $ 336,875      
Restricted Stock [Member] | Officers Directors and Consultants [Member]                  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                  
Number of restricted shares, granted 1,550,000 5,000,000              
v3.23.2
Summary of Warrant Activity (Details) - Warrant [Member] - $ / shares
6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of warrants, Outstanding and exercisable, Beginning balance 20,430,783 17,580,784
Weighted Average Exercise Price Per Share, Outstanding and exercisable, Beginning balance $ 0.45 $ 0.47
Number of warrants, Issued 15,000,000 1,666,667
Weighted Average Exercise Price Per Share, Issued $ 0.05 $ 0.30
Number of warrants, Issued   700,000
Weighted Average Exercise Price Per Share, Issued   $ 0.50
Number of warrants, Exercised
Weighted Average Exercise Price Per Share, Exercised
Number of warrants, Forfeited/expired
Weighted Average Exercise Price Per Share, Forfeited/expired
Number of warrants, Outstanding and exercisable, Ending balance 35,430,783 19,947,451
Weighted Average Exercise Price Per Share, Outstanding and exercisable, Ending balance $ 0.19 $ 0.45
v3.23.2
Schedule of Calculating Estimated Fair Value of Warrants (Details)
Jun. 30, 2023
shares
May 04, 2023
$ / shares
shares
Contractual term 4 years 2 months 12 days  
Number of warrants in aggregate | shares 5,256,410 9,056,409
Warrant [Member]    
Contractual term 4 years 2 months 12 days  
Number of warrants in aggregate | shares 9,056,409  
Measurement Input, Price Volatility [Member]    
Exercise price   345.8
Measurement Input, Price Volatility [Member] | Warrant [Member]    
Exercise price   345.8
Measurement Input, Risk Free Interest Rate [Member]    
Exercise price   3.41
Measurement Input, Risk Free Interest Rate [Member] | Warrant [Member]    
Exercise price   3.41
Measurement Input, Expected Term [Member] | Minimum [Member]    
Contractual term   3 years 4 months 24 days
Measurement Input, Expected Term [Member] | Maximum [Member]    
Contractual term   4 years 9 months 18 days
Measurement Input, Exercise Price [Member]    
Exercise price   0.05
Measurement Input, Exercise Price [Member] | Minimum [Member]    
Exercise price   0.30
Measurement Input, Exercise Price [Member] | Maximum [Member]    
Exercise price   0.50
v3.23.2
Summary of Warrant Range of Exercise Prices and Weighted Average Remaining Contractual Life (Details)
Jun. 30, 2023
$ / shares
shares
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Outstanding and exercisable warrants, number of warrants 35,430,783
Outstanding and exercisable warrants, weighted average remaining contractual life 4 years 2 months 12 days
Exercise Price One [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Common stock per share | $ / shares $ 0.05
Outstanding and exercisable warrants, number of warrants 24,056,409
Outstanding and exercisable warrants, weighted average remaining contractual life 4 years 8 months 12 days
Exercise Price Two [Member]  
Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items]  
Common stock per share | $ / shares $ 0.50
Outstanding and exercisable warrants, number of warrants 11,374,374
Outstanding and exercisable warrants, weighted average remaining contractual life 3 years
v3.23.2
Warrants (Details Narrative)
3 Months Ended 6 Months Ended 12 Months Ended
Nov. 09, 2021
USD ($)
a
$ / shares
shares
bbl
Jun. 30, 2023
USD ($)
a
$ / shares
shares
Jun. 30, 2022
USD ($)
shares
Jun. 30, 2023
USD ($)
a
$ / shares
shares
Jun. 30, 2022
USD ($)
shares
Dec. 31, 2022
USD ($)
shares
May 04, 2023
$ / shares
shares
Warrants term   4 years 2 months 12 days   4 years 2 months 12 days      
Warrants to purchase shares   5,256,410   5,256,410     9,056,409
Area of land | a   1.4   1.4      
Fees receivable per month | $ $ 8,000            
Excess of cash receivable | $ $ 25,000     $ 25,000      
Unearned receipts | $       $ 25,000   $ 25,000  
Initial Term       5 years      
Share based compensation | $       $ 317,807 $ 608,247    
Letter Agreement [Member]              
Area of land | a 11,000            
Price per barrel | bbl 5,000            
Sale of Stock, Number of Shares Issued in Transaction 2,060,000            
Warrant, Exercise Price, Increase | $ / shares $ 0.50            
Warrant to purchase of common stock 3,260,000            
Share price | $ / shares $ 0.44            
Letter Agreement [Member] | Board of Advisors [Member]              
Exercise price of warrants | $ / shares $ 0.50            
Warrant to purchase of common stock 1,200,000            
USNG Letter Agreement [Member]              
Warrants term 5 years            
Exercise price of warrants | $ / shares $ 0.50            
Warrant to purchase of common stock 3,260,000            
Minimum [Member]              
Exercise price of warrants | $ / shares   $ 0.05   $ 0.05      
Maximum [Member]              
Exercise price of warrants | $ / shares   $ 0.39   $ 0.39      
Warrant [Member]              
Warrants term   4 years 2 months 12 days   4 years 2 months 12 days      
Common stock purchase warrants and intrinsic value | $       $ 0 0    
Warrants to purchase shares   9,056,409   9,056,409      
Exercise price of warrants | $ / shares             $ 0.05
Equity-based warrants   3,799,999   3,799,999      
Derivative-liability-based warrants       5,256,410      
Adjustment of warrant | $       $ 793      
Equity-based warrants | $   $ 126   126      
Derivative-liability-based warrants, value | $   $ 667   $ 667      
Warrant to purchase of common stock   5,256,410   5,256,410   5,256,410 5,256,410
Warrant [Member] | Letter Agreement [Member]              
Warrant to purchase of common stock 3,260,000 3,260,000   3,260,000      
Share based compensation | $   $ 71,716 $ 71,716 $ 143,432 $ 143,873    
Share based payment award non option equity instruments forfeitures and expirations   0 0 0 0    
Stock option granted, value | $ $ 1,434,313     $ 956,207      
Warrant [Member] | Minimum [Member]              
Exercise price of warrants | $ / shares   $ 0.30   $ 0.30      
Warrant [Member] | Maximum [Member]              
Exercise price of warrants | $ / shares   $ 0.50   $ 0.50      
v3.23.2
Income Taxes (Details Narrative)
6 Months Ended
Jun. 30, 2023
USD ($)
Income Tax Disclosure [Abstract]  
Percentage on valuation allowance 100.00%
Net operating loss carry-forwards $ 64,710,000
Net operating loss carry-forwards subject to expiration 61,045,000
Net operating loss carry-forwards not subject to expiration $ 1,935,000
Income tax examination, description In addition, the Tax Cuts and Jobs Act limits the usage of net operating loss carryforwards to 80% of taxable income per year.
v3.23.2
Schedule of Estimated Gain on Exchange and Extinguishment of Debt (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Short-Term Debt [Line Items]        
Total gain on exchange and extinguishment of liabilities $ 24,190 $ 193,152
Convertiable Notes Payable Two [Member]        
Short-Term Debt [Line Items]        
Total gain on exchange and extinguishment of liabilities 24,190 24,190
Convertiable Notes Payable Three [Member]        
Short-Term Debt [Line Items]        
Total gain on exchange and extinguishment of liabilities 103,977
Convertiable Notes Payable Four [Member]        
Short-Term Debt [Line Items]        
Total gain on exchange and extinguishment of liabilities $ 64,985
v3.23.2
Schedule of Assets Retirement Obligation (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Asset Retirement Obligation Disclosure [Abstract]        
Asset retirement obligation at beginning balance     $ 1,732,486 $ 1,730,264
Additions    
Accretion expense during the period $ 1,218 $ 302 2,436 580
Asset retirement obligation at ending balance $ 1,734,922 $ 1,730,844 $ 1,734,922 $ 1,730,844
v3.23.2
Asset Retirement Obligations (Details Narrative) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Oct. 31, 2012
Operating Loss Carryforwards [Line Items]      
Asset retirement obligation current $ 1,716,003 $ 1,716,003 $ 45,103
Texas and Wyoming Wells [Member]      
Operating Loss Carryforwards [Line Items]      
Asset retirement obligation current $ 1,733,704 $ 1,732,486  
v3.23.2
Summary of Warrant Valuation Assumption (Details) - Warrant [Member]
6 Months Ended 12 Months Ended
Jun. 30, 2023
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
May 04, 2023
$ / shares
shares
Number of warrants in aggregate | shares 5,256,410 5,256,410 5,256,410
Measurement Input, Price Volatility [Member]      
Risk free rate 347.2 342.2 345.8
Measurement Input, Risk Free Interest Rate [Member]      
Risk free rate 4.13 3.99 3.41
Measurement Input, Expected Term [Member]      
Contractual term 3 years 2 months 26 days 3 years 8 months 26 days  
Measurement Input, Exercise Price [Member]      
Risk free rate | $ / shares 0.05 0.39 0.05
v3.23.2
Summary of Changes in Fair Value Derivative Financial Instruments (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Beginning balance     $ 577,269  
Unrealized derivative gains included in other income/expense for the period $ 292 (367,175)
Ending balance 210,094   210,094  
Warrant [Member]        
Beginning balance     577,269
Unrealized derivative gains included in other income/expense for the period     (367,175)
Ending balance $ 210,094 $ 210,094
v3.23.2
Warrant Derivative Liability (Details Narrative)
3 Months Ended 6 Months Ended 12 Months Ended
May 04, 2023
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Jun. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
$ / shares
shares
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares 9,056,409 5,256,410 5,256,410  
Unrealized derivative gains | $   $ 667 $ 667  
Warrant [Member]        
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares   9,056,409 9,056,409  
Warrants exercise price $ 0.05      
Number of warrants in aggregate | shares 5,256,410 5,256,410 5,256,410 5,256,410
Warrant [Member] | Measurement Input, Price Volatility [Member]        
Risk free rate 345.8 347.2 347.2 342.2
Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]        
Risk free rate 3.41 4.13 4.13 3.99
Warrant [Member] | Measurement Input, Expected Term [Member]        
[custom:DerivativeLiabilityMeasurementInputTerm]     3 years 2 months 26 days 3 years 8 months 26 days
Warrant [Member] | Measurement Input, Exercise Price [Member]        
Risk free rate 0.05 0.05 0.05 0.39
Maximum [Member]        
Warrants exercise price   $ 0.39 $ 0.39  
Maximum [Member] | Warrant [Member]        
Warrants exercise price   0.50 0.50  
Minimum [Member]        
Warrants exercise price   0.05 0.05  
Minimum [Member] | Warrant [Member]        
Warrants exercise price   $ 0.30 $ 0.30  
Minimum [Member] | Warrant [Member] | Measurement Input, Expected Term [Member]        
[custom:DerivativeLiabilityMeasurementInputTerm] 3 years 4 months 24 days      
Minimum [Member] | Warrant [Member] | Measurement Input, Exercise Price [Member]        
Risk free rate 0.39      
v3.23.2
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 6 Months Ended 12 Months Ended
Nov. 09, 2021
Dec. 08, 2014
Aug. 15, 2014
Oct. 18, 2013
Oct. 31, 2012
Jun. 30, 2023
Dec. 31, 2022
Dec. 31, 2013
Loss Contingencies [Line Items]                
Asset retirement obligations         $ 45,103 $ 1,716,003 $ 1,716,003  
Fees receivable per month $ 8,000              
Excess of cash receivable $ 25,000         25,000    
Unearned receipts           $ 25,000 $ 25,000  
Initial Term           5 years    
Seeking of reclamation costs         30,000      
Estimated liability relating each operating well         $ 45,103      
Liability relating to all operating wells, description         Management estimates that the liabilities associated with this matter will not exceed $780,000, calculated as $30,000 for each of the 26 Infinity-Texas operated wells.      
Total estimated liability relating to all operating wells         $ 780,000      
Consulting Agreement [Member]                
Loss Contingencies [Line Items]                
Payment for investor relations services       $ 7,000       $ 14,000
Issuance of preferred stock with detachable warrants to purchase common stock, shares       15,000       15,000
Torrey Hills Capital Inc [Member]                
Loss Contingencies [Line Items]                
Payment for demand     $ 56,000          
Number of shares issued during period settlement of final termination agreement     2,800          
Damages amount     $ 79,594          
Cambrian Consultants America Inc [Member]                
Loss Contingencies [Line Items]                
Default judgment granted against the company   $ 96,877            
Consultants [Member]                
Loss Contingencies [Line Items]                
Fees receivable per month           $ 8,000    
v3.23.2
Schedule of Series A and B Convertible Preferred Stock Activity (Details) - shares
1 Months Ended 6 Months Ended
May 04, 2023
Jun. 15, 2022
Mar. 26, 2021
Sep. 30, 2022
Aug. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Series A Convertible Preferred Stock [Member]              
Class of Stock [Line Items]              
Number of Shares, Outstanding, Beginning           25,526 22,076
Issued   5,000 22,776 1,450 1,450 5,000
Converted to common stock           (250) (2,700)
Redeemed            
Number of Shares, Outstanding, Ending           25,276 24,376
Series B Convertible Preferred Stock [Member]              
Class of Stock [Line Items]              
Number of Shares, Outstanding, Beginning           0
Issued 7,500         7,500
Converted to common stock          
Redeemed          
Number of Shares, Outstanding, Ending           7,500
v3.23.2
Stockholder’s Deficit (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
May 04, 2023
May 03, 2023
Jan. 13, 2023
Jun. 15, 2022
Mar. 26, 2021
Mar. 16, 2021
Sep. 30, 2022
Aug. 31, 2022
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Dec. 31, 2022
Class of Stock [Line Items]                          
Preferred stock, shares authorized                 10,000,000   10,000,000   10,000,000
Preferred stock par value                 $ 0.0001   $ 0.0001   $ 0.0001
Adjusted per share due to the dilutive issuance                 $ (0.01) $ (0.04) $ (0.01) $ (0.07)  
Proceeds from issuance of convertible preferred stock                     $ 750,000 $ 500,000  
Contractual term                 4 years 2 months 12 days   4 years 2 months 12 days    
Number of warrants in aggregate 9,056,409               5,256,410   5,256,410    
Ozark Capital, LLC [Member]                          
Class of Stock [Line Items]                          
Converted to common stock 5,000,000       2,222,000                
Stock Issued During Period, Shares, New Issues 2,500       1,111                
Warrants exercise price $ 0.05       $ 0.05                
Number of warrants in aggregate 5,000,000       256,410                
Total cash $ 250,000       $ 100,000                
Percentage of common shares hold                 10.00%   10.00%   10.00%
Beneficial ownership, description         All holders of the March 2021 Series A Convertible Preferred Stock, including Ozark, have agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days’ advance notice to the Company.                
Series A Convertible Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Number of shares converted     46,296               250 2,700  
Accrued interest     $ 3,704                    
Converted to common stock     500,000               500,000 843,750  
Preferred stock, shares authorized           27,778     27,778   27,778   27,778
Preferred stock liquidation preference       $ 100 $ 100 $ 100 $ 100 $ 100 $ 100   $ 100   $ 100
Preferred stock liquidation preference, value           $ 100              
Preferred stock conversion price           $ 0.32              
Cumulative dividends           10.00%              
Proceeds from issuance of convertible preferred stock       $ 500,000 $ 1,929,089 $ 5,000,000 $ 145,000 $ 145,000          
Payment of financing and stock issuance costs       $ 500,000 $ 2,050,000   $ 145,000 $ 145,000          
Stock Issued During Period, Shares, New Issues       5,000 22,776   1,450 1,450     5,000  
Contractual term       5 years 6 months 5 years 6 months   5 years 6 months 5 years 6 months          
Warrant rights       1,666,667 5,256,410   483,332 483,332          
Warrants exercise price       $ 0.30 $ 0.39   $ 0.30 $ 0.30          
Beneficial ownership, description       The holder of the June 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its June 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.     The holders of the August/September 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its August/September 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company. The holders of the August/September 2022 Series A Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its August/September 2022 Series A Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.          
Dividends preferred stock cash                 $ 63,516 $ 52,289 $ 126,457 $ 105,150  
Unpaid dividends preferred stock cash                     137,816   $ 77,124
Series A Convertible Preferred Stock [Member] | Ozark Capital, LLC [Member]                          
Class of Stock [Line Items]                          
Dividends preferred stock cash                 $ 2,770 2,739 5,509 $ 5,479  
Unpaid dividends preferred stock cash                     $ 2,770   $ 2,800
Series B Convertible Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Preferred stock, shares authorized   50,000             50,000   50,000   50,000
Preferred stock liquidation preference $ 100 $ 100             $ 100   $ 100   $ 100
Preferred stock liquidation preference, value   $ 100                      
Adjusted per share due to the dilutive issuance $ 0.05 $ 0.05                      
Cumulative dividends   8.00%                      
Proceeds from issuance of convertible preferred stock   $ 5,000,000                      
Payment of financing and stock issuance costs $ 750,000                        
Stock Issued During Period, Shares, New Issues 7,500                   7,500  
Contractual term 5 years 6 months                        
Warrant rights 15,000,000                        
Warrants exercise price $ 0.05                        
Beneficial ownership, description The holders of the May 2023 Series B Convertible Preferred Stock agreed to a 4.99% beneficial ownership cap that limits the investors’ ability to convert its May 2023 Series B Convertible Preferred Stock and/or exercise its Common Stock purchase warrants. Such limitation can be raised to 9.99% upon 60 days advance notice to the Company.                        
Preferred stock convertible shares issuable 15,000,000                        
Working capital purposes $ 750,000                        
Dividends preferred stock cash                 $ 9,600 0 $ 9,600 $ 0  
Unpaid dividends preferred stock cash                     9,600   $ 0
Series B Convertible Preferred Stock [Member] | Ozark Capital, LLC [Member]                          
Class of Stock [Line Items]                          
Dividends preferred stock cash                 $ 3,353 $ 0 3,353 $ 0  
Unpaid dividends preferred stock cash                     $ 3,353   $ 0
v3.23.2
Related Party Transactions (Details Narrative) - USD ($)
Mar. 31, 2021
Jun. 30, 2023
Dec. 31, 2022
Jun. 29, 2022
Related Party Transaction [Line Items]        
Debt instrument principal amount       $ 112,500
Convertible Promissory Note [Member] | Debt Settlement Agreement [Member]        
Related Party Transaction [Line Items]        
Issuance of warrants and stock $ 762,407      
Debt instrument principal amount $ 7,624      
Convertible Promissory Note [Member] | Debt Settlement Agreement [Member] | Related Party [Member]        
Related Party Transaction [Line Items]        
Due to related parties   $ 0 $ 0  
Convertible Promissory Note [Member] | Debt Settlement Agreement [Member] | Warrant [Member]        
Related Party Transaction [Line Items]        
Debt instrument interest rate 3.00%      
Convertible Promissory Note One [Member] | Debt Settlement Agreement [Member]        
Related Party Transaction [Line Items]        
Issuance of warrants and stock $ 1,789,208      
Debt instrument principal amount $ 17,892      
Debt instrument interest rate 3.00%      
Employee related liabilities current   0 0  
Convertible Promissory Note Two [Member] | Debt Settlement Agreement [Member]        
Related Party Transaction [Line Items]        
Issuance of warrants and stock $ 26,113      
Debt instrument principal amount $ 261      
Debt instrument interest rate 3.00%      
Convertible Promissory Note Two [Member] | Debt Settlement Agreement [Member] | Related Party [Member]        
Related Party Transaction [Line Items]        
Due to related parties   $ 0 $ 0  
v3.23.2
Subsequent Events (Details Narrative) - $ / shares
6 Months Ended
Aug. 02, 2023
Jun. 30, 2023
Jun. 30, 2022
Subsequent Event [Line Items]      
Stock option exercise price  
Subsequent Event [Member]      
Subsequent Event [Line Items]      
Number of shares issued in acquisition 10,000,000    
Stock option exercise price $ 0.05    

American Noble Gas (QB) (USOTC:AMNI)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more American Noble Gas (QB) Charts.
American Noble Gas (QB) (USOTC:AMNI)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more American Noble Gas (QB) Charts.